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ABSTRACT 
Monoclonal antibodies to the gamete surface antigens of Plasmodiurn 
falciparum, Pfs230 and Pfs48/45, can abolish the infectivity of gametes to 
mosquitoes, hence these antigens have been proposed as candidates for 
inclusion in a malaria transmission-blocking vaccine. One possible 
mechanism of antibody-mediated transmission-blocking is complement-
mediated gamete lysis. A cohort of human sera, from geographically 
distinct malaria-endemic regions, was used to investigate whether this 
may be a mechanism of naturally acquired transmission-blocking 
immunity to P.falciparum. By immunoprecipitation, it was shown that 
antibody recognition of Pfs230 and Pfs48/45 is limited, despite universal 
exposure to P.falciparum gametocytes. In vitro complement-mediated 
lysis of P.falciparum gametes was positively associated with the presence 
of antibodies to Pfs230, but not with antibodies to the N-terminal region of 
the precursor molecule (Pfs260) which is shed from the gametocyte surface 
at the time of gametogenesis. Similarly, antibodies to two other 
gametocyte-specific proteins, Pfs48/45 and Pfg27/25 were not associated 
with gamete lysis. All sera which mediated gamete lysis contained IgGi 
and / or IgG3 antibodies to gamete surface proteins as determined by ELISA. 
These data suggest that Pfs230 is a major target of complement-fixing 
antibodies which may be important for antibody-mediated transmission-
blocking immunity. 
A selection of these malaria-immune human sera were tested for their 
ability to affect the infectivity of P. falciparum gametocytes to Anopheles 
mosquitoes. It was found that transmission-reducing effects of the sera 
were associated with the presence of IgGi antibodies to the gamete surface, 
specifically against the protein, Pfs230. Enhancement of transmission, 
manifest as elevated numbers of oocysts relative to controls, was observed 
for a number of sera, but was not found to be significantly associated with 
antibodies against Pfs230 or Pfs48/ 45. Consistent with the data above, the 
ability to mediate in vitro complement-dependent gamete lysis was also 
significantly associated with reduction of infectivity to mosquitoes. 
The role of complement in transmission blocking immunity was further 
investigated by testing the effects, on gametocyte infectivity, of serially 
diluted malaria-immune sera in the presence of active and inactive 
human complement. These studies revealed a complex interaction of 
mosquito bloodmeal components, which, in the absence of complement, 
led to enhancement of transmission at low serum concentrations and 
reduction of transmission at high serum concentrations. In the presence of 
active complement, levels of enhancement were less than in inactive 
complement and infectivity was lowest at the highest serum 
concentration. 
Phagocytosis of sexual stages in the presence of malaria-immune sera was 
assayed to assess its role in transmission-blocking immunity. In vitro 
phagocytosis was positively correlated with the level of specific antibody to 
both Pfs230 and Pfs48/45, and with IgGi to a crude extract of gamete surface 
proteins. Despite this, transmission-blocking could not be associated with 
phagocytosis in vivo. 
Taken together, these data support the role of antibodies to the gamete 
surface protein Pfs230, in naturally acquired transmission blocking 
immunity against P. falciparum. 
P. falciparurn oocysts on An. stephensi midguts 
oocyst containing sporozoites 
Day lOoocyst 
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1.1 	 Malaria: A Brief History 
Malaria probably entered the history books with Hippocrates, who noted 
with some accuracy of fever victims that 'their flesh dissolves to feed their 
spleens'. In ancient India, malaria occupied a prestigious position as the 
'King of Diseases' through which the god Shiva could wreak havoc. It was 
not until 1880, however, that the aetiology of the disease was unravelled by 
Laveran, who saw in the blood of malaria patients, spherical pigmented 
objects with 'motile filaments of an animated nature of which there was no 
room for doubt'. What Laveran saw was the exflagellation of malarial 
gametocytes, which represents the first phase of the mosquito developmental 
stages. From then on, the race was on to track the 'flagellum', and the 
transmission of malaria through mosquitoes eventually came to light 
through the work of Ronald Ross in 1898. The final piece of the puzzle was 
put into place some 50 years later by Shortt and Garnham, who inoculated a 
monkey with sporozoites and found the pre-erythrocytic forms exclusively 
in the monkey's liver. 
By the time of Ross's discovery, a concerted European effort had determined 
that the different periodicities of malaria were due to different Plasmodium 
species. Golgi had identified Plasmodium malariae, and P. vivax, while 
1 
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Marchiafava and Bignami had named the agent of malignant tertian 
malaria, P. falciparum (Garnham 1988). 
1.2 	Intraerythrocytic development of P.falciparum 
P. falciparum causes the most lethal form of malaria. The pathogenicity of P. 
falciparum is enhanced by the ability of the intraerythrocytic stages to 
sequester by attachment to the endothelium of post-capillary venules in 
various organs. This adaptation allows the maturing intraerythrocytic 
parasites to escape clearance by the spleen (Langreth & Peterson 1985) and in 
some individuals, may contribute to the onset of cerebral malaria by 
reducing blood flow in the brain (Macpherson et al. 1985; Pongponratn et al. 
1991). Intra-erythrocytic P. falciparum parasites are able to escape detection by 
the host's immune system by changing the antigens expressed on the 
erythrocyte surface (Smith et al. 1995). While sequestered, the parasites 
asexually reproduce, and emerge as 16 genomic copies after a period of 48 
hours. These parasites can continue to reproduce and eventually kill the host 
if he, or she, doesn't kill the parasite first. Their escape route is the female 
anopheline mosquito who, needing blood to nourish her eggs, may ingest 
circulating malaria parasites. 
In order to perform the double feat of survival in the body of the mosquito, 
and sexual reproduction (in order to shuffle its genetic deck), the parasite 
must transform itself into a gametocyte. The environmental cues that 
stimulate asexual to gametocyte conversion are poorly understood (reviewed 
2 
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in (Carter & Gwadz 1980)) but there is some evidence, at least in vitro, that a 
high density of asexual intra-erythrocytic parasites is associated with 
increased gametocytogenesis (Carter & Miller 1979). 
Gametocytes of P. falciparum require a maturation time of about 10-12 days, 
most of which is spent sequestered in the spleen and bone marrow (Carter & 
Gwadz 1980). Their longevity in the peripheral circulation is thought to be 2-
3 days, after which they become senescent, and are non-infectious to 
mosquitoes (Smalley & Sinden 1976). 
From floating around inside a protective shell at 37°C, the gametocytes are 
sucked into a potentially lethal environment, surrounded by blood 
components, such as antibodies and complement, and mosquito midgut 
enzymes aiming to digest the bloodmeal. Inside the midgut, the mature 
gametocytes are activated by the change in temperature and pH (Sinden et al. 
1996). They dissolve the membrane of their erythrocyte shell. The male 
gametocyte becomes eight sperm-like microgametes, which swim off in all 
directions to find a female macrogamete. When they meet, the gametes' 
cytoplasmic and nuclear membranes fuse and they become a zygote. 
Following fertilisation, and for only a brief interlude in the malaria life cycle, 
diploidy is acquired. Then follows an immediate meiotic division which re-
establishes the haploid genome (Sinden & Hartley 1985). As an ookinete, the 
parasite is able to escape the hostile environment inside the mosquito 
midgut. It crawls through the midgut, penetrating the peritrophic membrane 
3 
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by means of a chitmase enzyme (Shahabuddin & Kaslow 1994), finally 
escaping through some special cells in the epithelium, which are not yet 
fully characterised. There, the ookinete anchors itself onto the outside of the 
basement lamina on the haemocoel side, and becomes an oocyst (reviewed 
in (Billingsley & Sinden 1997)). After 12 days, the oocysts burst, liberating 
thousands of sporozoites which migrate to the salivary glands from where 
they are injected into the next host. 
	
1.3 	Development of sexual stage-specific antibodies 
Numerically, the gametocyte stage is a bottleneck. Most gametocytes are 
never ingested by mosquitoes, but are cleared by the spleen. Here, they are 
engulfed by phagocytes which display gametocyte antigens to lymphocytes, 
which ultimately produce antibodies against them. These antibodies have no 
role in elimination of a malaria-infection because the antigens of 
gametocytes are not present on the surfaces of merozoites, trophozoites or 
schizonts which cause the disease. But, if taken up by a mosquito along with 
gametocytes, these antibodies have the potential to latch on to the surface of 
the gamete once it has emerged from within the erythrocyte. In doing so, 
such antibodies may inhibit further development of the parasite, preventing 
its transmission. 
1.4 	 Transmission Epidemiology 
There is no evidence which suggests that gametocytes are the targets of 
specific, antibody-mediated, immunity which reduces their numbers in the 
4 
Chapter 1 
circulation. Gametocyte densities decline with age, proportional to the 
decline of asexual parasite density (Christophers 1924). However, it is known 
that gametocyte density alone is not a good predictor of infectiousness 
(Dearsley et al. 1990). In malaria-endemic regions, some individuals 
consistently fail to infect mosquitoes despite being gametocyte carriers 
(Boudin et al. 1993; Graves et al. 1988a; Muirhead-Thompson 1957). 
One of the factors responsible for this is the phenomenon known as 
transmission-blocking immunity. If we could understand how this works in 
nature, then it may be possible to use this knowledge to intervene artificially 
by means of a vaccine to induce transmission-blocking immunity in 
individuals who would not naturally make such a response. It is assumed 
that in so doing, transmission of malaria in endemic regions would be 
reduced, relieving the burden of this disease. 
1.5 	Rationale for the development of a transmission- 
blocking vaccine 
Although the immunity induced by a putative transmission-blocking 
vaccine would not directly protect the vaccinee from malarial disease, 
development of such a vaccine can be justified for three reasons: 
a) reduction of the malaria inoculation rate. In certain circumstances, 




to prevent the spread of drug-resistant or vaccine-escape mutants into 
other regions. 
as a quarantine vaccine, to prevent the reintroduction of malaria into non-
endemic situations. 
Although a prototype transmission-blocking vaccine based on the ookinete 
antigen Pfs25 has already entered phase I and II trials, it is not expected that 
titres of antibodies resulting from vaccination will be boosted by natural 
infection with P. falciparum, as Pfs25 is not expressed on parasite stages 
outwith the mosquito. Therefore, should vaccine-induced immunity wane, 
P. falciparum transmission will be only temporarily affected. 
Thus, it may be preferable to concentrate more effort on those antigens 
which have been shown to be associated with natural transmission-blocking 
immunity in humans; : Pfs230 and Pfs48/45. Following vaccination with 
these Ags, Ab levels could be boosted by subsequent exposure to malarial 
gametocytes. 
1.6 	Experimental Transmission-blocking Immunity 
The first forays into the science of transmission-blocking immunity were 
made in 1952 by Eyles (Eyles 1952), who showed that humoral factors, 
associated with the peak of parasitaemia, reduced the infectivity of 
gametocytes to mosquitoes. These factors were probably not antibodies, but 
cytokines, which affect the ability of gametocytes to establish within 
mosquitoes, as demonstrated in later studies with P. cynomolgi (Naotunne et 
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al. 1993) and P. vivax (Karunaweera et al. 1992). It was Huff (Huff et al. 1958) 
who realised that active immunisation could produce a suppression of 
infectiousness to mosquitoes. In these experiments, turkeys were immunised 
with formalin-treated blood from birds infected with P. fallax, and it was 
found that blood from immunised birds was much more effective at 
reducing gametocyte infectiousness than blood from unimmunised birds. A 
much more extensive study in which chickens were artificially immunised 
with extracellular gametes of P. gallinaceum was performed by Carter and 
Chen in 1976 (Carter & Chen 1976). They injected X-irradiated micro- and 
macrogametes into chickens and found that subsequent blood-induced 
infections produced no oocysts in mosquitoes. These studies had shown that 
neither the asexual parasitaemia nor gametocytaemia were affected by 
immunisation, and others found that gametocytes could recover 
infectiousness when resuspended in non-immune serum and fed to 
mosquitoes through a membrane (Gwadz 1976). The effect of immunisation 
was shown, by Gwadz, to be mediated by immunoglobulins which 
agglutinated the extracellular microgametes, preventing fertilisation. 
Later studies showed that immunisation with ookinetes gave rise to 
immunity which affected post-fertilisation stages (Grotendorst et al. 1984). 
1.7 	Sexual stage-specific antigens of P.falciparum 
Most of the known targets of transmission-blocking antibodies against P. 
falciparum gametes are membrane-bound proteins expressed on the gamete 
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surface. Studies using monoclonal antibodies (MAbs) raised against gamete 
surface antigens have identified two major proteins namely Pfs230 and 
Pfs48/45 (Rener et al. 1983; Vermeulen et al. 1985a). When MAbs against 
these proteins are fed to mosquitoes with an infectious bloodmeal, they can 
completely suppress oocyst development (Quakyi et al. 1987; Rener et al. 
1983; Vermeulen et al. 1985b). 
1.7.1 Pfs230 
Early studies of gamete surface antigens used radiolabelling procedures and 
detergent separation techniques to identify Pfs230. It was found on the 
surface of both male and female gametes and appeared on non-reducing 
SDS-PAGE as a protein of 230 KDa (Kumar & Carter 1984; Vermeulen et al. 
1985a). Its synthesis begins early in gametocyte development (stage II), and 
MAbs against it demonstrated that it was present in two forms in 
gametocytes, with the larger protein, Pfs260, being absent from the surface of 
gametes (Quakyi et al. 1987). The stage-specific processing of Pfs230 came to 
light more recently, after cloning and expression of the Pfs230 gene 
(Williamson et al. 1993), in a study which showed that full length Pfs230 
(with a predicted size of 360KDa) is processed to a shorter form (310 KDa) as 
the parasite emerges from the erythrocyte (Williamson et al. 1996). In this 
thesis I refer to the gametocyte form of the protein as Pfs260, and the gamete 
surface form as Pfs230. The gene is referred to as Pfs2601230. Analysis of its 
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sequence has revealed several interesting motifs (Carter et al. 1994; 
Williamson et al. 1993). 
Figure 1.1 shows that the 5' region of Pfs2601230 begins with a presumptive 
signal sequence, consistent with Pfs260/230 being a non-integral membrane 
protein. The downstream amino acid sequence contains a stretch of 25 
consecutive glutamic acid residues followed by 8 complete repeats of a 
tetrapeptide sequence (EEVG) followed by 4 copies of an 8-amino acid repeat 
(EEVGEEIGE/VG). After amino acid 452 there is a putative cleavage site, 
which has not been fully characterised. There are 3 regions of highly negative 
net charge, which are possibly involved in some type of electrostatic charge 
repulsion to prevent gamete autoagglutination (Williamson et al. 1993). 
There are 6 copies of a 7-cysteine motif. In all, there are 70 cysteine residues 
in the Pfs260/230 sequence, pairs of which are disulphide-bonded to create 
the framework for the molecule's tertiary structure (Carter et al. 1994). Apart 
from the signal peptide, the functions of these regions are unknown. Such a 
convoluted structure (predicted structure shown in Figure 1.2) has made 
analysis of this large protein notoriously difficult, and as yet, it has been 
impossible to produce conformationally intact recombinant proteins in 
either E. coli (Riley et al. 1995), J. Healer unpublished, or yeast (R. Carter pers. 
comm.). Nevertheless, a maltose-binding fusion protein produced in E. coli, 
representing the first cysteine-rich motif of Pfs230 gave rise to transmission-
blocking antibodies in immunised mice (Williamson et al. 1995). 
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A schematic representation of the amino acid sequence of Pfs260. 
S represents the signal sequence, E represents the 25 glutamic acid residues. 
Rpt represents the EEVG repeat sequence, CR represents cysteine-rich motifs, 
and pink signifies an area of net negative charge. The arrow shows the 
position of the presumptive cleavage site. 
Underneath, are the corresponding regions encoded by the Pfs260 
recombinant proteins A-F, produced in E. coli (Williamson et al. 1995). 
S E Rpt 	CR1 CR2 CR3 CR4 CR5 CR6 CR7 
I I 
AL 	 F 
Region A: amino acids 304-378, between the 25 E residues and the EEVG 
repeat region. 
Region B: amino acids 375-452, encodes the EEVG repeat and 10 amino acids 
3' of repeat. 
Region C: amino acids 443-1132, extends from the repeat to motif CR2 
Region D: amino acids 1166-1541, encodes half of CR2 and all of CR3 
Region E: amino acids 1727-2397, encodes motifs CR4 and CR5. 
Region F: amino acids 2398-3135, encodes motifs CR6 and CR7. 
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Figure 1.2 
Schematic of the secondary structure of Pfs230 and Pfs48/45, as 
deduced from their amino acid sequence. 
from Carter et a! 1994 
- B A - Glutamic acid repeats 
B - Tetrapeptide repeats 
(EEVG). 




Monoclonal antibody studies of Pfs 230 indicate that, with the exception of a 
single linear epitope (Wizel & Kumar 1991), all of the MAbs capable of 
blocking transmission of malaria are against conformational epitopes 
(Quakyi et al. 1987; Read et al. 1994). All of these conformation-dependent 
MAbs are of complement-fixing isotypes (IgG2a), and are only effective when 
complement is present within the bloodmeal (Read et al. 1994). Further 
evidence of the dependence on complement for transmission-blocking by 
anti-Pfs230 MAbs came from a study by Roeffen et a! (Roeffen et al. 1995b) 
who found that an isotype switch from a complement-fixing IgG subclass to a 
non-complement-fixing subclass resulted in the loss of transmission-
blocking capacity of the MAb. 
1.7.2 Pfs48/45 
Pfs48/45 was identified on gametes at the same time as Pfs230 (Kumar & 
Carter 1984; Vermeulen et al. 1985a). The Pfs 48145 gene encodes a single 
hydrophobic, non-repetitive product which is post-translationally modified 
in the gametocyte to produce two distinct proteins (Kocken et al. 1993). The 
predicted protein contains a putative signal peptide at the N-terminal end, 
and a stretch of hydrophobic amino acids at the C-terminal end, which are 
believed to form a glycosylphosphatidylinositol (GPI) membrane anchor. 
Predicted amino acid structure of Pfs48/45 reveals a secondary structure 
similar to that of Pfs230 (Fig. 1.2) (Carter et al. 1994). Only one other protein 
from the database showed structural similarity to Pfs230 and Pfs48/45. This 
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was Pf12, an asexual stage malaria protein. It may be that Pfs 230 and Pfs 48/45 
form such a close association on the surface of the gametocyte/gamete that 
their tertiary structure has to be complementary. It has been observed that 
monoclonal antibodies to Pfs 230 can co-precipitate Pfs 48/45 (Kumar & 
Carter 1984), but that the complex is dissociated by a non-ionic detergent 
(Kumar 1985). Such treatment results in Pfs 230, the more hydrophilic 
molecule, separating into the aqueous phase, and the hydrophobic Pfs 48/45 
entering the detergent phase, suggesting that the latter is tightly bound in the 
surface membrane with Pfs 230 protruding into the outside environment. 
Analysis of Pfs48/45 using MAbs has uncovered a plethora of epitopes, 
which are both linear and conformational. Different MAbs bind to different 
epitopes, and in this way a structural map has been formed of Pfs48/45 
epitopes. These studies have revealed five independent, non-overlapping 
epitopes, antibodies to four of which are capable of blocking oocyst 
development. Carter et al (Carter et al. 1990) found that MAbs to epitope I 
would prevent transmission in the absence of complement, but those against 
epitopes II and III would not, unless used in a particular combination. In the 
presence of complement, a MAb to epitope II was effective at reducing 
infectivity. Targett et a! (Targett 1988) reported that both blocking and non-
blocking MAbs react with the same epitope. As with Pfs 230, most of the 
epitopes on Pfs48/45 are destroyed by reduction, except for those designated 
by Targett et a! (Targett 1988) as epitopes IV and V, which are linear and 
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insensitive to reducing agents. MAbs to epitope V are associated with 
transmission-blocking but MAbs to epitope IV are not. 
The expression of Pfs 48/45 has been achieved using the baculovirus system, 
where recombinant proteins are targeted to the surface of the insect cell and 
can be recognised by conformation-dependent transmission-blocking 
monoclonal antibodies (Kocken et al. 1993). However, rabbits immunised 
with this expression product do not produce transmission-blocking 
antibodies (Roeffen et al. 1995a). 
1.7.3 Other sexual stage antigens under development as potential 
vaccine candidates 
Pfs25 
Pfs25 is the antigen which has received the most attention as a candidate for 
inclusion in a transmission-blocking vaccine. Expressed in the post-
fertilisation stages, Pfs 25 becomes the predominant component of the 
ookinete surface. The gene encoding Pfs 25 has been cloned and analysis of 
the sequence has exposed the molecular basis of its peculiar biochemical 
nature (Kaslow et al. 1988). The cysteine spacing derived from the amino acid 
sequence is remarkably similar to that found in mammalian Epidermal 
Growth Factor (EGF). Pfs25 is inserted into the surface membrane of the 
ookinete by a GPI anchor (Kaslow 1993). 
Its function is thought to relate to survival of the ookinete within the 
proteolytic environment of the mosquito midgut, and mobility of the 
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ookinete towards and through the gut epithelium (Ponnudurai 1988). It has 
been postulated that the EGF-like domains may participate in intercellular 
contact for the migrating ookinete (Alano 1991). Consistent with this 
hypothesis, it has been shown that monoclonal antibodies raised against Pfs 
25 can completely block transmission of P. falciparum in the absence of 
complement (Vermeulen et al. 1985b). Anti-Pfs 25 transmission-blocking 
MAbs are also capable of penetrating the oocyst and can reduce the number 
of sporozoites developing within (Lensen et al. 1992). 
Recombinant Pfs 25 produced in yeast reacts with conformation-dependent 
transmission-blocking antibodies and elicits transmission-blocking 
immunity in experimental animals (Barr et al. 1991). This has resulted in the 
development of a prototype recombinant transmission-blocking vaccine for 




Pfs28 is a recently identified P. falciparum target antigen of transmission-
blocking antibodies. It is genetically linked to Pfs25 on chromosome 10 and 
shows structural similarity to it. A Saccharomyces cerevisiae expression 
product of Pfs28 was used to immunise mice, and the resulting antibodies, in 
combination with those against Pfs25, produced a synergistic transmission-
blocking response, with an efficacy was greater than either antibody 
population alone (Duffy & Kaslow 1997) 
1.7.4 Other sexual-stage specific antigens 
Table 1.1 contains details of other proteins identified to date which are 




Other sexual stage proteins of P. falciparum 
Ref. Protein Cellular Location Target of stage of earliest 
TX-Abs expression 
1 Pfs4O Gamete surface ? ? 
2 Pfg27/25 gametocyte/gamete yes? Stage I gametocytes 
cytoplasm 
3 Pfsl6 gametocyte PVM no Stage I gametocytes 
4 Pfg377 gametocyte no Stage II gametocytes 
osmiophilic bodies 
5 Pf 11.1 gametocyte cytoplasmic no gametocyte 
granules 
6 Pf2400 gametocyte cytoplasmic yes gametocyte 
granules 
7 Pf77 ? ? Stage III gametocytes 
Refs. 
Rawlings & Kaslow 1992 	 ? = not known 
Wizel & Kumar 1991 
Moelans & Schoenmakers 1992 
Alano et al. 1995 
Scherf et al. 1993 
Feng et al. 1993 
Baker et al. 1995 
1.8 	Naturally acquired transmission-blocking immunity 
1.8.1 Transmission-blocking immunity to P. vivax 
Several studies have been carried out on the induction of transmission-
blocking immunity in human malarial infections. It was found that around 
two thirds of patients suffering their first attack of P. vivax malaria in Sri 
Lanka developed antibodies which suppressed the infectivity of homologous 
parasites to mosquitoes (Mendis et al. 1987). In most cases the suppression 
was much greater in the presence of complement. Further studies found that 
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transmission-blocking immunity was increased during subsequent infections 
of P. vivax, suggesting that memory responses are generated (Ranakawa et al. 
1988). Maintenance of transmission-blocking responses to P. vivax requires 
frequent boosting; the loss of transmission-blocking antibodies can occur 
within 4 months in the absence of reinfection (Gamage-Mendis et al. 1992). 
1.8.2 Transmission-blocking immunity to P.falciparum 
Sera taken from individuals living in areas endemic for P. falciparum has 
the capacity to block malaria transmission if presented to mosquitoes in a 
membrane feeder with infectious gametocytes (Graves et al. 1988b; Mulder et 
al. 1994; Premawansa et al. 1994). A study carried out in Papua New Guinea 
on P. falciparum transmission-blocking immunity foimd that half of the sera 
tested had antibodies to Pfs 230, and a quarter had antibodies to Pfs 48/45 
(Graves et al. 1988b). When these sera were tested for transmission-blocking 
activity against a laboratory-grown isolate, many of the sera suppressed 
infectivity to mosquitoes to various degrees. In this study the presence of 
antibodies to Pfs 230, but not those to Pfs 48/45, correlated with the 
suppression of infectivity. In later studies in Cameroon, transmission-
blocking activity of sera was found to be associated with antibody reactivity to 
Pfs48/45 and not Pfs230 (Roeffen et al. 1995a; Roeffen et al. 1995c; Roeffen et 
al. 1996). 
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1.9 Mechanisms of transmission-blocking immunity 
1.9.1 Antibody-mediated transmission-blocking responses 
Antibody-mediated immunity acts on the extracellular sexual stage parasites 
within the mosquito i.e. gametes, zygotes and ookinetes.. Some antibodies 
induce complement-mediated lysis of gametes (Mendis et al. 1987; Quakyi et 
al. 1987; Read et al. 1994), whereas some antibodies cause agglutination of 
gametes (Rener et al. 1983). Additional mechanisms could involve 
antibodies obscuring receptor sites for fertilisation (Carter et al. 1990), or 
antibody-dependent cellular cytotoxicity (ADCC) mechanisms whereby 
antibody bound to surface antigens could interact with phagocytes or other 
cytotoxic cells via their Fc region, resulting in killing of the parasite. There is 
no direct evidence for ADCC mechanisms acting against the sexual stages 
within the mosquito, however ADCC has been observed acting against 
asexual stage parasites in vitro (Druithe & Perignon 1994). 
Phagocytosis of gametes in the mosquito midgut has been proposed as an 
antibody-mediated mechanism of transmission-blocking immunity to P. 
falciparum (Lensen et al. 1998; Sinden & Smalley 1976), although attempts to 
demonstrate this have been somewhat inconclusive. Following one study 
(Sinden & Smalley 1976), it was concluded that although effective in vitro, 
phagocytosis of gametocytes was not as efficient in vivo, and therefore not a 
major mechanism of transmission-blocking immunity. Further in vitro 
studies suggest that anti-gamete antibodies enhance activation of neutrophils 
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by gametes but, phagocytosis was not directly measured in this study (Lensen 
et al. 1997). 
1.9.2 Cytokine-mediated transmission-blocking mechanisms 
A direct role for T lymphocytes in gametocyte inactivation was demonstrated 
by immunisation of mice with microgametes of the rodent malaria P. yoellii 
(Harte et al. 1985). Specific T-cells were induced, giving rise to antibody-
independent transmission-blocking immunity. It is believed that the effects 
of these T cells were mediated by cytokines. 
While antibody-mediated mechanisms fail to act against viable gametocytes 
within the circulation of the vertebrate host, because the target antigens are 
hidden by the erythrocyte membrane, cytokine-mediated mechanisms can act 
against the intracellular gametocyte. Considerable attention has been focused 
on the role of cytokines in malaria infections, and several studies have 
demonstrated their importance in reducing the infectivity of gametocytes to 
mosquitoes. Cytokines induced during infections of P. cynomolgi in the 
toque monkey, and during clinical paroxysms of P. vivax in humans, 
mediate inactivation of gametocytes (Karunaweera et al. 1992; Naotunne et 
al. 1991). Tumour necrosis factor a (TNF(x) and interferon-? (IFN-?) are 
thought to modulate nitric oxide levels which are toxic to the gametocyte 
(Naotunne et al. 1993). By delaying the onset of gametocytogenesis until 
relatively late in the infection, P. falciparum may have evolved a life-history 
strategy to avoid the high levels of cytokines which are potentially lethal to 
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gametocytes. As a result of this delayed maturity, mature gametocytes are not 
present at the time when the majority of schizonts are rupturing and 
cytokine levels are high. Additionally, developing gametocytes sequester in 
sites away from the cytoadherent asexual stages, which may induce 
conditions potentially lethal to gametocytes (Macpherson et al. 1985; Smalley 
et al. 1980). 
1.10 	Problems of vaccine development 
1.10.1 Diversity in transmission-blocking candidate antigens 
An important consideration for vaccine design is the extent of diversity in 
the amino acid sequences of these transmission-blocking target antigens in 
natural populations of P. falciparum. Diversity among sexual stage antigens 
is not as extensive as that seen in asexual stage vaccine-candidate antigens. 
However, it will still be important to ensure that the majority of parasite 
strains will be affected by a potential transmission-blocking vaccine. 
By monoclonal antibody analysis, Graves et a! (Graves et al. 1985) found 
limited variation amongst Pfs48/45 epitopes in 40 different isolates. The 
nucleotide sequences of Pfs 48/45 from 8 isolates have also been compared 
and again, show limited diversity (Kocken et al. 1993; Kocken et al. 1995). 
Differences were found in amino acids 253 and 254, probably corresponding 
to MAb epitopes ila and llc. A further study found that geographical 
variation between isolates was also restricted to these epitopes, with African 
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isolates containing the type lic allele and Asian and Central American 
isolates containing the type ha allele (Drakeley et al. 1996). 
Limited polymorphism has also been detected in the EEVG repeat region and 
in the second 7-cysteine motif of Pfs 230 amongst geographically distinct 
isolates and clones of P. falciparum (Williamson & Kaslow 1993). However, 
it is not yet known how these polymorphisms affect transmission-blocking 
immunity to Pfs230. 
Studies of sequence diversity among antigens expressed within the mosquito 
stages (Pfs25 and Pfs28) demonstrate that they show minimal sequence 
variation (Hafalla et al. 1997; Kaslow et al. 1989; Ya-Ping et al. 1992). 
Conservative substitutions have been found in the first EGF-like domains of 
Pfs25 and in the second EGF-like domain of Pfs28, although the exact 
immunological relevance of these findings has not been determined. 
1.10.2 Reproducing the tertiary structure of Pfs230 and Pfs48/45 
The convoluted tertiary structure of native Pfs230 and Pfs48/45 means that 
they are difficult to recreate in the form of recombinant proteins. Mapping 
the B-cell and T helper cell epitopes may be critically important for vaccine 
design (Kaslow 1993). The large size of Pfs230 means that a full-length clone 
will probably be impossible to express in one piece. However, six regions of 
the Pfs260 molecule (including the N-terminal region that is cleaved off at 
gametogenesis) have been produced in E. coli, as recombinants with 
maltose-binding protein fusion partners (Fig. 1.1). Polyclonal antibodies 
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which had been induced against these proteins by immunisation recognised 
the native molecule in Western blot; those against one region, Pfs260C (see 
Fig. 1.1), blocked transmission of P. falciparum in membrane feeding assays 
(Williamson et al. 1995). However, none of the transmission-blocking Pfs230 
MAbs recognised the recombinant proteins, and few human sera, which had 
previously been shown to contain anti-Pfs230 Abs, recognised the 
recombinants in ELISAs (Riley et al. 1995). 
Recombinant proteins representing Pfs48/45 have been made in a 
baculovirus system (Kocken et al. 1993), but serum from rabbits immunised 
with these proteins failed to block malaria transmission (Roeffen et al. 
1995a). It is likely that eukaryotic expression systems such as yeast, COS cells 
or baculovirus, will be required to reproduce the secondary structure of 
conformational epitopes before any more progress can be made on the 
inclusion of these proteins in a transmission-blocking vaccine. Additionally, 
the high cysteine content of Pfs230 will probably frustrate many attempts to 
express this molecule in a form recognisable to MAbs. 
1.10.3 Limited Immunogenicity of Pfs230 and Pfs48145 
Immunogenicity and boosting of transmission-blocking antibody titres 
following a natural infection are two critical factors in the design of a subunit 
vaccine to block the transmission of P. falciparum. In order to be effective, a 
subunit vaccine depends on widespread immunological responsiveness. 
Immunoresponsiveness to the gamete surface antigens Pfs230 and Pfs48/45 
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has been tested using an H-2 congenic mouse model (Good et al. 1988), and by 
testing immune sera from individuals living in malaria-endemic regions 
(Carter et al. 1989b; Graves et al. 1988b; Graves et al. 1988c; Quakyi et al. 1989; 
Riley et al. 1990). Studies in immune populations have suggested that only a 
proportion of malaria-exposed individuals produced Abs to Pfs230 and 
Pfs48/45 (Carter et al. 1989b; Quakyi et al. 1989; Riley et al. 1994; Riley et al. 
1990). The reasons for this apparent non-responsiveness were studied. In two 
studies, one in Papua New Guinea (Graves et al. 1989) and one in The 
Gambia (Riley et al. 1990) it was found that immune response genes (of the 
MHC locus) do not have a major influence on antibody recognition of the 
gamete surface antigens Pfs230 and Pfs48/45. However, a high degree of 
concordance of anti-gamete responses was found in a study of Gambian 
mono- and dizygous twin pairs (Riley et al. 1994), suggesting that some 
shared environmental factor, e.g. exposure to infected mosquitoes, may be 
involved in determining the subsequent immune response. 
When studies were made comparing responses to native Pfs230 by 
immunoprecipitation and recombinant Pfs230 (rPfs230) by ELISA (Riley et al. 
1995) it was found that over half of the individuals tested had antibodies to 
the tetrapeptide repeat sequence EEVG, suggesting a possible immune-
evasion mechanism by the parasite to avoid a transmission-blocking 
immune response. Many malaria proteins, including GLURP, Pf155/RESA, 
Pf332 and Pf11.1 contain stretches of glutamic acid-rich repeat regions which 
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appear to be immunodominant for B cells, leading to high levels of Ab-
production (Moelans & Schoenmakers 1992). Some of these sequences are 
immunologically cross-reactive (Mattei et al. 1989b), which may explain the 
presence of Abs to gametocyte protein repeats in otherwise non-responsive 
individuals. Antigenic cross-reactivity may interfere with the process of 
affinity maturation of B lymphocytes (Anders 1986) perhaps leading to high 
titre but low affinity Ab-responses to repeat regions. These repeats may also 
generate T-independent antibody production by B cells, which do not 
undergo affinity maturation, and show a lack of immunological 'memory'. 
In the case of Pfs230, antibodies reacting with the glutamic acid-rich repeats 
may inhibit the development of a transmission-blocking response to 
epitopes of the mature gamete-surface protein (Riley et al. 1996). Factors 
which may explain non-responsiveness to Pfs230, such as concurrent 
exposure to other antigens which may inhibit antibody production to Pfs230 
(Riley et al. 1996), or clonal imprinting of B cells (Taylor et al. 1996) which 
might focus antibody production towards repetitive epitopes, at least have 
the advantage, from the vaccine perspective, that they have the potential to 
be overcome by judicious vaccine design. 
1.11 	 Aims of the project 
The main point of this thesis was to define mechanisms of naturally-
acquired transmission-blocking immunity to P. falciparum. These are of 
interest not only from a biological viewpoint, but perhaps more importantly, 
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for future transmission-blocking vaccine design: it is important to identify 
which responses cause maximum reduction of malaria infectivity, and 
which have no functional significance against the parasite. Identification of 
responses which have the potential to enhance malaria infectivity is also an 
important part of this study. 
Specifically, experiments were designed in order to address the following 
questions: 
What proportion of sera from malaria-exposed individuals of different 
ages, and from different malaria-endemic regions, recognise the P. 
falciparum sexual stage-specific antigens Pfs230 and Pfs48/45? 
Do sera from malaria-exposed individuals mediate complement-
dependent lysis of P. falciparum gametes in vitro? Is this associated with 
antibodies to particular gamete-surface antigens? 
Is phagocytosis a major mechanism of P. falciparum transmission-
blocking immunity? 
Do sera from malaria-immune adults mediate transmission-blocking 
immunity against P. falciparum? Is this associated with antibodies 
against specific gamete-surface antigens? 
What effect does serum dilution, and therefore antibody concentration, 
have on the transmission modulatory effects of malaria-immune 
serum? Does the presence of complement affect the transmission-
modulatory activity of malaria-immune serum? 
26 
Chapter 1 





Materials and Methods 
	
2.1 	 Human serum 
Serum was collected during a single malaria transmission season (1988), 
from 91 villagers aged between 1 and 77 years, living near the town of 
Farafenni, situated on the North bank of the river Gambia. We also had 
access to sera from 27 adults, collected as part of a longitudinal survey, from 
the village of Brefet, south of the river Gambia. Malaria is seasonally 
endemic in all areas of The Gambia (Greenwood et al. 1987). Finally, 27 
samples collected in Papua New Guinea as part of a cross-sectional malaria 
survey of individuals over 4 years of age from the villages of Tau, in East 
Sepik Province and Agan in Madang province were used (Graves et al. 
1988c). Malaria is highly endemic in both of these villages (Graves et al. 
1988b). Ethical clearance for serum collection in The Gambia was given by 
MRC/Gambian government medical ethics committee. All Gambian donors 
were aparasitaemic and healthy at the time of collection. See Graves et a! 
1988b for ethical clearance details of Papua New Guinea serum collection. 
Further details of serum donor identification, age and parasite status are 
given in Appendix 2. 
Control sera (n=40) were obtained from non-exposed European donors. 
2.2 	 Culture of gametocytes 
Gametocytes of Plasmodium falciparum clone 3D7A (Walliker et al. 1987) 
were grown in culture as previously described (Ifediba & Vanderberg 1981), 
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using RPMI 1640 (Gibco; Paisley, Scotland), (pH 8.7) supplemented with 10% 
heat-inactivated normal human serum, 25mM HEPES, hypoxanthine 
(50mg/ml) and 5% NaHCO3 (complete medium). Cultures were set up at 6% 
haematocrit using group 0+ blood (collected weekly from the Blood 
Transfusion Service) which had been washed three times in RPMI 1640 
medium to remove citrate and the buffy coat of white blood cells. Parasitised 
erythrocytes from asexual stock cultures, with parasitaemia of between 3-10% 
were used to initiate gametocyte cultures at a parasitaemia of 0.5-0.7%, which 
ensures a high rate of commitment to sexual development (Carter et al. 
1993). The medium was changed daily from a stock kept at 37 °C. 4-5 days after 
setting up, the cultures were examined by blood smear for changes in 
morphology indicative of stress. These include triangulation of the ring 
forms and precede gametocyte development. At this time, the haematocrit of 
the cultures was reduced to 4% to further encourage gametocyte conversion. 
Culture conditions were slightly different for gametocytes for mosquito 
feeding experiments and those destined for other experiments (see below). In 
both cases, a temperature of 37 °C is essential, and fluctuations from this 
temperature are detrimental to gametocyte development. However, 
development of gametocytes which are infectious to mosquitoes requires a 
more rigorously controlled culture technique. 
2.2.1 Culture of gametocytes for in vitro experiments 
These cultures were set up in a volume of 8ml, with 0.96m1 washed 
erythrocytes, in an upright 75cm 2 sterile culture flask (Bibby-Sterilin, 
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Staffordshire, UK). Following gametocyte induction, culture medium 
volume was increased to 12m1, thereby reducing the haematocrit to 4%. They 
were maintained at 37°C in a CO2 (5%) incubator (LEEC). Lids of flasks were 
left unscrewed to allow adequate gaseous exchange within the incubator. The 
use of the bacteriostat, gentamycin (Sigma, Poole, UK) at a final 
concentration of 1250J1g in the medium, was tolerated in these cultures, but 
was only used in minority of cases, at times when there appeared to be a 
succession of bacterial contamination of the cultures. Medium was removed 
with a sterile pasteur pipette attached to a vacuum pump via a collecting 
bottle. All manipulations during the 14-17 day period were carried out in a 
laminar flow hood (Gelaire, Flow Laboratories) to minimise contamination 
from the atmosphere. All pipettes etc. were sterilised before use and were 
disposed of after a single use. Blood and spent medium was collected into 
10% bleach solution, which was changed daily. 
2.2.2 Culture of infectious gametocytes for mosquito feeding experiments 
These cultures were set up in 75cm 2 sterile culture flasks as above, but placed 
in the incubator in a horizontal position. The starting volume was 15m1, 
with 1.8m1 erythrocytes (at a 50% haematocrit), and the volume of medium 
was increased at the appropriate time to 25ml. The use of gentamycin was 
contraindicated in these cultures, as the resulting gametocytes will not be 
infectious (Ponnudurai et al. 1989). These were grown at 37°C as above, but 
the gaseous mixture required for infectivity was 3% CO 2, 1% 02  and 96% N2 . 
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The medium was changed on the bench using sterile technique, and all 
culture equipment was sterilised before and after use. 
	
2.3 	 Preparation of gametocytes 
Mature gametocytes were harvested 14 days after expansion of a culture with 
fresh erythrocytes. These were centrifuged to remove the culture medium 
then resuspended in RPMI 1640 medium to a final haematocrit of 20%. This 
suspension was spun through a discontinuous Percoll (Pharmacia, Uppsalla, 
Sweden) gradient consisting of layers of 30%, 45% and 52.5% Percoll in RPMI. 
Mature gametocytes were recovered from the interface between the 30% and 
45% Percoll layers. The parasites were resuspended in 50 ml RPMI and 
centrifuged to remove the Percoll, then the pellets were washed in imi RPMI 
and counted with a haemocytometer to determine the yield. Gametocytes 
were either used immediately, or frozen as pellets at -70 °C until required. 
2.4 	 Preparation of macrogametes 
15-17 days after expansion of a culture with fresh erythrocytes, mature 
gametocytes were harvested and stimulated to undergo gametogenesis in 
complete medium containing NaHCO 3, which adjusted the pH to 8.7, and an 
extract of mosquito pupae (MEF: mosquito exflagellation factor) (Nijhout 
1979). Sixty to 90 minutes later, gametes were enriched on a discontinuous 
Nycoprep (Nijegaard, Norway) gradient (Vermeulen et al. 1985b), composed 
of 16%, 11% and 6% Nycoprep in M199 medium (Gibco). The gamete fraction 
was recovered from the interface between 11% and 6% Nycoprep, and 
washed twice in RPMI 1640. 
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2.5 	I-1abe11ing of Plasmodiumfalciparum gametocyte 
proteins. 
2.5.1 Preparation of IODOGEN Tubes. 
IODOGEN reagent (Sigma) was dissolved in methylene chloride (Sigma), to a 
concentration of approximately 1mg/mi in a polypropylene tube. Once 
dissolved, 100-200j.fl of this was dispensed into a 1.5ml eppendorf tubes in a 
fume cabinet and allowed to evaporate. These tubes were closed and could be 
used up to a month later if stored at 4 °C, although it was noted that optimal 
labelling was obtained with freshly prepared tubes. 
2.5.2 Triton X-100 extraction of gametocyte proteins. 
Mature gametocytes were purified on discontinuous Percoll gradients as 
described above. Approximately 6x10 7 gametocytes were washed twice in 
RPMI 1640 medium by centrifugation and pelleted cells were extracted with 
50pi NETTI buffer (Carter et al. 1993), (0.15M NaCl, 5mM EDTA, 50 mM Tris 
pH 7.4, 0.5% Triton X-100 (Sigma), 0.05% Na Azide and protease inhibitors 
(Sigma): PMSF 1mM; Pepstatin 0.1pM; TPCK 0.1mM; EDTA 1mM; EGTA 
1mM; NEM 1mM) by vortexing for 1 minute, followed by spinning at 14 000 
rpm in a microcentrifuge for 5 minutes at 4 °C. The supernatant from this 
extraction was then respun at 14 000 rpm for a further 5 minutes, in order to 
ensure no particulate matter remained. The extract was labelled immediately 
. 
with 1251 usmg the IODOGEN method as described previously below (2.5.4). 
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Gametocytes which had been frozen at -70
0
C could also be successfully 
labelled by this procedure. 
2.5.3 Preparation of sephadex columns 
Sephadex spin columns were required for the removal of unbound 
125k 
 from 
the gametocyte material (Carter et al. 1993). The free iodine sticks to the beads 
whilst the radioiodinated proteins pass through the column. These were 
prepared by the expansion of approximately 0.5m1 of sephadex-G25 beads 
(Sigma) in imi NETTI buffer in 1.5ml eppendorf tubes. Once the beads were 
expanded, a tiny hole was made in the bottom of the tube using a fine gauge 
needle (26G), and the eppendorf tube was placed inside a 1.8m1 cryotube, 
which was in turn placed inside a 15m1 centrifuge tube on a cushion of 
tissue. These tubes were then spun at 1000 RPM for 10 minutes in a chilled 
centrifuge to expel buffer from the beads, then to test that the output volume 
equalled the input, 50p.l NETTI buffer was added to the top of the beads and 
the tubes were respun for 5 mins at 1000 RPM, and 50j.il was recovered. The 
tubes were now ready for radioactive material. 
2.5.4 Labelling procedure 
50jil of the cleared supernatant obtained following Triton X-100 extraction 
was transferred to an IODOGEN tube (see 2.5.1 above) inside a fume cabinet. 
500 p.Ci of NaT 125 in NaOH, pH 7-11 (Amersham, Buckinghamshire, UK) was 
added to the aqueous extract. The tube was agitated intermittently for 5 
minutes then the radioactive mixture (vol=55-60p.1) was placed onto a spin 
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column to separate iodmated proteins from unbound iodide (2.5.3). 
Following a 5 minute spin in a chilled centrifuge at 1000 RPM, the effluent 
from the column was removed from the cryotube collecting vial, and the 
volume was made up to 5m1 with NETTI and stored at 4°C until use. 
Although the radioactive half-life of I' 25 is 59.6 days, it was found that 
gametocyte extract labelled in this way could only be stored for about 1 
month before degradation of proteins occurred. 
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2.6 	Immunoprecipitation and SDS-PAGE analysis of 
radiolabelled proteins. 
In order to test for the efficiency of the labelling process, 25jil of labelled 
material was incubated with 5jil of mouse ascites fluid containing MAbs 
12F10 (against Pfs230) (Read et al. 1994) and 1H12 (Pfg27/25) (Carter et al. 
1989a) and control immmunoprecipitations were performed. If the 
gametocyte antigens Pfs260/230 and Pfg25/27 were visible on 
autoradiographs of 5-15% SDS-PAGE gradient gels, then the material was 
used to test endemic human sera for the presence of antibodies to gametocyte 
antigens. 
20pi neat, heat-inactivated human serum, 40jil 25% protein-C sepharose 
(Pharmacia), 25tl radiolabelled gametocyte extract and 400il NEIT were 
incubated together on a rotating wheel, overnight at 4 °C. The beads were 
washed once with NETT, followed by NETTS (NETT with 0.65M NaCl), then 
NETT. After washing, the beads were resuspended in 60pi non-reducing 
SDS-PAGE sample buffer (62.5mM Iris, 5% SDS, 10% glycerol and 0.01% 
bromophenol blue). Samples were incubated at 100 °C for 5 minutes and spun 
at 14000 rpm in a microcentrifuge for 5 minutes, before loading onto a 5-15% 
gradient SDS-PAGE gel. Control immunoprecipitations were performed 




2.7 	1 I-labe11ing of gamete surface proteins 
Purified gametes were labelled as for gametocytes except that detergent 
extraction was performed after surface proteins were iodinated, such that 
only those proteins on the gamete surface were radio-labelled. 
Immunoprecipitations were performed as above, with the addition of the 
control MAb 3E12 which is specific to Pfs48145 (Carter et al. 1990). 
2.8 	Assay for complement-mediated lysis of gametes 
Approximately 2x10 5 gametes of P. falciparum , freshly isolated on a 
Nycodenz gradient (2.4), in lOpi of M199 medium were aliquoted into each 
well of a sterile, round-bottomed, 96-well microtitre plate. lOpi of 20% fresh, 
non-immune human serum in PBS was added to each well as a source of 
complement. This serum had been absorbed on swollen agarose, then 
preincubated for 30 minutes with 5x10 5 gametes to remove non-specific 
cytotoxic activity. Control wells received lOjfl non-immune human serum 
which had been heat-inactivated at 56 °C for 30 minutes to destroy the 
complement activity. Test sera (malaria-exposed) were heat-inactivated at 
56°C, and 10i1 of each serum was then added to paired gamete wells, one of 
which contained active complement and the other in which complement 
was heat-inactivated. The final dilution of test serum was 30%. Plates were 
incubated at 37°C for 40 minutes. The contents of each well were pipetted 
onto single wells of a multispot slide and allowed to dry overnight at room 
temperature before being stained with Giemsa's stain. Slides were then 
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analysed (blind) by oil-immersion microscopy, and results were confirmed by 




2.9 	 Infectivity experiments 
2.9.1 Routine maintenance of mosquitoes 
Anopheles freeborni and An. stephensi mosquito colonies were maintained 
in insectaries in which the relative humidity was around 60-80% and 
ambient temperature was between 20-25°C. Briefly, eggs from a stock cage 
containing >2000 adult mosquitoes fed on anaesthetised rats were collected 
and allowed to hatch into distilled water treated with NaHCO3 to 
approximately adjust to pH 7. The resulting larvae were fed with a small 
bolus of homogenised rodent meal (A. stephensi), or ground tetramin 
goldfish food (A. freeborni) each day until they reached the pupal stage, 
whereupon they were collected into a small bowl of distilled water and 
placed within a net cage to allow hatching of the adult mosquitoes. Adults 
were maintained on a daily diet of 5% glucose/0.05% PABA aqueous 
solution, with twice weekly bloodfeeds and eggs were collected 2 days after 
each bloodfeed. 
2.9.2 Collection of mosquitoes for infectivity experiments 
Two days before an infectious bloodfeed was performed, adult females of 
between 3 and 5 days old (non bloodfed) were collected via a pooter apparatus 
into waxed paper cartons with a lid of a double layer of bridal veil secured 
tightly with elastic bands and autoclave tape and a double latex entrance 
hole. Each pot contained at least 40 females. These mosquitoes were then 
transferred to the secure insectary, where they were given cottonwool pads 
Chapter 2 
soaked in the 5% glucose/PABA solution for 24 hours followed by 24 hours 
with distilled water alone, to encourage them to feed on the bloodmeal. 
2.9.3 Preparation of infectious bloodmeal 
The preparation of the infectious bloodmeal was performed in the same way 
for all three infectivity experiments. The actual composition of the 
bloodmeal i.e. volumes of the components was slightly different, and this 
will be explained in detail in each of the relevant chapters. 
In each case, the bloodmeal consisted of a mixture of the following 
components: 
freshly washed uninfected erythrocytes (rbc) 
mature gametocyte-infected rbc (irbc) 
non-immune human serum 
heat-inactivated malaria-endemic human serum (or non- immune 
human serum as control) 
Firstly, 15ml centrifuge tubes were warmed in a 37 °C waterbath. Packed, 
washed, bloodgroup 0+ erythrocytes (see section 2.2) were also warmed to 
37°C. Most of the medium was removed from flasks of 14 and 17 day-old 
infectious gametocyte cultures (section 2.2.2) and the parasitised erythrocytes 
were mixed and placed in a warm centrifuge tube. These were spun at 2000 
rpm for 10 minutes to pellet the red blood cells. All medium was removed 
following centrifugation and rbc and irbc were distributed accordingly into 
labelled, warmed tubes containing serum. Care was taken during these 
manipulations, to keep the temperature of the bloodmeal at 37 °C as much as 
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possible, to prevent activation of the gametocytes, and work was carried out 
as swiftly as possible. Tubes containing bloodmeals were transferred to the 
secure insectary in a polystyrene 37 °C mini-waterbath, where they were 
transferred to membrane feeders for mosquito feeds. 
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2.9.4 Delivery of infectious bloodmeal to mosquitoes 
Pots of mosquitoes (section 2.9.2), still in the dark phase of their 12-hour light 
cycle were allowed to feed on gametocyte-infected blood through badrouche 
membrane-bottomed (Long & Long Co., Belleville, New Jersey, USA), water-
jacketed feeders (Rutledge et al. 1964). The surface area of these feeders was 
approximately 1.7cm2, and their capacity was 500 jil. These were prepared by 
washing in antibacterial detergent (Jeyes,  UK), rinsing in distilled water and 
drying, before assembly with badrouche membrane and non-perishable 
elastic bands. Membranes were prepared by cutting into squares and rinsing 
in distilled water, before being stretched until taut over the base of the feeder. 
Assembled feeders were connected to each other and a circulating waterbath 
(Grant Instruments, Cambridge, UK) at 37 °C before introduction of the 
bloodmeal. Individual bloodmeals were placed in feeders by separate glass 
pasteur pipettes. The membranes were smeared with saliva before placing 
mosquito pots underneath. This is believed to act as an attractant for 
mosquitoes. Once all the pots had been set up in this way, the lights in the 
insectary were turned off again, and mosquitoes allowed to feed for 15-30 
minutes on the bloodmeal. 
After a bloodmeal, feeders were dissembled, soaked in detergent overnight 
and rinsed in distilled water. Membranes were checked for holes, dried on 
filter paper and reused where possible, as mosquitoes appeared to feed more 
readily and easily on previously used membranes. 
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2.9.5 Killing and dissection of P. falciparum infected mosquitoes 
Following the infectious bloodmeal, non-engorged mosquitoes were 
removed from the experiment and killed, and the remainder were 
maintained on a diet of the 5% glucose/PABA solution for 9-10 days, after to 
allow oocysts to develop. A killing jar composed of a plastic pot with a 
double latex entrance for a pooter, and removable net lid, was assembled 
with a chloroform soaked pad on top. No more than 6 mosquitoes at a time 
were pootered from a single experimental pot into the killing jar. These were 
left for a few seconds until immobile, then tipped out into a watchglass filled 
with 100% ethanol to ensure they were dead. They were then transferred into 
a 7m1 bijou bottle, containing phoshate buffered saline (PBS) pH 7.4. All 
mosquitoes from one experimental pot were killed at a time, as above. The 
bijou bottle was then removed from the secure insectary to the microscope 
area for dissection of the mosquitoes. 
Mosquitoes were then placed on a drop of PBS on a microscope slide and 
midguts were dissected out under a binocular microscope, using 21.5 gauge 
needles as dissection instruments (Gwadz & Vanderberg 1985). Isolated 
midguts were placed three at a time in a drop of PBS on a separate slide and a 
clean coverslip gently place on top. This slide was transferred to a phase 
contrast microscope and examined under x 400 magnification. Excess liquid 
was carefully removed from between slide and coverslip with a piece of 
tissue, allowing slight compression of the midguts - enough to visualise both 
sides with fine focusing, and oocysts were counted on each midgut. In the 
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great majority of cases, at least 20 midguts per experimental pot were 
dissected and counted for oocysts. 
2.9.6 Calculations of infectivity 
In each of the infectivity experiments, certain calculations were routinely 
performed. For each feed, the numbers of oocysts in each midgut were 
entered into an Excel file (Microsoft, USA). This allowed preliminary data 
manipulation. From these counts it was possible to assess the maximum, 
minimum, mean and median numbers of oocysts in each group. The data 
were then exported to Minitab (release 8.21), or Statview software for further 
statistical analysis. Significance of any differences between test and control 
groups were tested by the non-parametric Mann-Whitney U-test, and where 
indicated, on logarithmically-transformed data, by the paired t-test. Relative 




where GM is the geometric mean, calculated by taking the antilog-i of the 
mean of loge (oocyst count+i). 
Also, where indicated, infectivity was calculated as a quotient of prevalences 
of infected mosquitoes in test and control groups. 
2.10 	Enzyme-linked immuno-sorbent assay (ELISA) 
ELISAs were used for various purposes in this study. The unifying aim of 
these experiments, however, was to assess antibody reactivity in malaria-
exposed sera to the sexual stage-specific antigen, Pfs230. In order to study the 
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response to specific parts of Pfs230, we used bacterial fusion proteins or 
synthetic peptides as antigen in ELISA. Precise details of these experiments 
are to be found in the corresponding chapter (3.2.2). 
Exact details of the composition of buffers etc. are to be found in appendix 1 
(A3) 
2.10.1 ELISA to determine IgG subclass of gamete-reactive antibodies 
Purified gametes (2.4) were extracted in 500.tl Triton X-114 (1% in 10mM Tris-
Cl, pH7.4). The aqueous fraction was diluted in PBS to give the equivalent of 
106  gametes per ml and 100p.1 adsorbed to each well of 96-well Immulon-4 
microtitre plates (Dynex, Billinghurst, UK) overnight at 4°C. Between 
incubations, plates were washed three times in PBS containing 0.05% Tween 
(PBS-T). Plates were blocked for 4 hours at room temperature with 2% 
skimmed milk in PBS. Sera were added to duplicate wells overnight at 4°C at 
a dilution of 1/200 in 1% skimmed milk - PBS-T, before washing and 
incubation of plates for 3 hours at room temperature with horseradish 
peroxidase (HRP)-conjugated rabbit a-human IgG (Dako, Denmark) or sheep 
a -human IgG subclasses 1-4 (The Binding Site, Birmingham, UK). Plates 
were developed using H202 as substrate and o-phenylenediamine (OPD; 
Sigma) as chromogen. Absorbance at 492nm was measured using a Titertek 
MultiScan (ICN Flow, Thame, Oxon, UK) and ElisaLite 30 software 
(Dynatech, UK). Specific absorbance values were calculated as (OD for 
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immune serum) - (mean OD + 2 standard deviations of 12 non-malaria 




Recognition of sexual stage-specific antigens 
3.1 	 Introduction 
The manifestations of P. falciparum malaria are notoriously varied and even 
now, more than one hundred years after discovery of its causal agent, the 
diagnosis of clinical infection is still cause for debate. One common 
characteristic of malaria infection is production of antibodies to a wide range 
of parasite proteins. Most of these antibodies will have no role in controlling 
the either the disease symptoms or parasitaemia, i.e. they have no direct 
effect on live parasites. Antibodies of this type are usually called non-
protective. Identification of protective antibody responses is of fundamental 
importance to malaria research. They offer one route to the discovery of 
antigenic targets which could be incorporated into vaccines and lead 
ultimately to easing the burden of the disease. 
Most of this work has focused on identifying antigens of asexual stage 
parasites, either pre-erythrocytic or erythrocytic forms. An alternative 
approach is to prevent the spread of malaria by inducing transmission-
blocking immunity, which acts against the sexual stages of the life cycle 
within the mosquito (Carter et al. 1988). 
Gametocyte antigens are naturally immunogenic and antibodies to them 
have been identified in sera from individuals in malaria-endemic regions 
(Carter et al. 1989b; Graves et al. 1988b; Riley et al. 1994; Riley et al. 1990; 
Roeffen et al. 1995c). In all of these studies, it has been observed that 
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although antibodies against one antigen, Pfg27/25, were produced by all 
individuals, there was also widespread immunological non-responsiveness 
to other gametocyte antigens. There are several possible reasons for this 
phenomenon. These include antigenic polymorphism, common among 
antigens of asexual stage parasites, and genetic restriction of the antibody 
response. Although diversity in the sequences of both Pfs 48/45 and Pfs230 is 
limited when compared to most asexual stage antigens, polymorphisms 
have been reported amongst geographically distinct isolates (Drakeley et al. 
1996; Foo et al. 1991; Graves et al. 1985; Kocken et al. 1993; Williamson & 
Kaslow 1993); nevertheless, this is unlikely to explain immunological non-
responsiveness. Data from a study on twins in the Gambia (Riley et al. 1994), 
suggests that MHC-related restricted recognition is an improbable 
explanation. Another possibility is that the presence of potentially cross-
reactive, immunodominant, repetitive amino acid repeat sequences (at least 
in Pfs260) may be a mechanism for immune evasion (Riley 1996). 
Immunodominant, glutamic acid-rich repeats are found in a variety of 
asexual stage antigens, including Pf155/RESA, Pf332, D260, and GLURP 
(Barnes et al. 1995; Cowman et al. 1984; Mattei et al. 1989a) and in the sexual 
stage antigen, Pf2400 (Scherf et al. 1988). These may interfere with the process 
of affinity maturation of B-cells (Anders 1986), and hence impair the 
development of a potential transmission-blocking antibody response. It was 
demonstrated by Riley et a! (1994), in a longitudinal survey of anti-
gametocyte responses, that individuals were either consistently seropositive 
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or seronegative for Pfs230, and this was thought to be evidence of some type 
of epitope selection. 
Gametes, which develop from and are antigenically similar to gametocytes, 
emerge from the infected red blood cell upon ingestion by a feeding 
mosquito. Antigens which are effectively hidden by the erythrocyte 
membrane while in the human bloodstream, become exposed in the midgut 
of the mosquito to immune factors ingested in the bloodmeal. This sudden 
unveiling of target antigens, renders gametes vulnerable to attack by 
antibodies, complement and phagocytic cells. 
Monoclonal antibodies to two gamete surface proteins, Pfs230 and Pfs48/45, 
have been implicated in transmission-blocking immunity to P. falciparum 
(Quakyi et al. 1987; Rener et al. 1983; Vermeulen et al. 1985b) (See section 1.5). 
Post-infection antibody profiles are also an important epidemiological tool, 
used in order to retrospectively diagnose malaria infection in cross-sectional 
and longitudinal surveys of endemic populations. This chapter represents a 
sero-epidemiological analysis of the antibody responses of individuals living 
in three different malaria-endemic regions, to defined gametocyte and 
gamete proteins, which are currently the subject of investigation as potential 
candidate antigens for inclusion in a malaria transmission-blocking vaccine. 
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3.2 	 Materials and Methods 
Several immunological techniques can be employed to examine anti-P. 
falciparum antibody responses, including immunoprecipitation, ELISA and 
Western blot. Immunoprecipitation of radiolabelled parasite proteins by 
immune human sera and subsequent separation on SDS-PAGE and 
autoradiography, allows visualisation of parasite antigens recognised by 
antibodies in individual sera. Comparisons of specific antibody profiles 
between different individuals, or groups of individuals, can then be made. 
Immunoprecipitation is more sensitive than Western blot, as it is possible to 
expose radiolabelled proteins to autoradiography film for longer time periods 
until the desired exposure is achieved. Immunoprecipitation is thought to be 
the best method for detecting anti-gametocyte responses among human sera, 
particularly those against Pfs230, as many of the antibodies present will be 
directed towards conformational epitopes, which are poorly reproduced in 
bacterially-produced recombinant proteins used in ELISA (Riley et al. 1995). 
The main drawback of immunoprecipitation, apart from its laborious nature, 
is the relative lack of quantitative data gained. Semi-quantitative data can be 
obtained by visual of scoring bands on autoradiographs. However, the results 
presented in this chapter are given simply as antibody positive or negative, 
due to the difficulty of standardising band intensity across the many antigen 




Sera were collected from 144 villagers, aged between 1 and 77 years, living 
near the town of Farafenni, on the North bank of the river Gambia. We also 
analysed sera from 27 adults, collected as part of a longitudinal survey, from 
the village of Brefet, south of the river Gambia. Malaria is seasonally 
endemic in all areas of The Gambia (Greenwood et al. 1987). Finally, samples 
collected in Papua New Guinea, as part of a cross-sectional malaria survey of 
individuals over 4 years of age from the villages of Tau, in East Sepik 
Province and Agan in Madang province, were used. Malaria is highly 
endemic in both of these villages (Graves et al. 1988b). 
Control sera (n=40) were obtained from age-matched, non-exposed European 
donors. 
Full details of the immunoprecipitation protocol are described in sections 
2.5-2.7. 
3.2.2 	ELISA 
ELISA was used for the study of serum antibody responses to specific regions 
of Pfs260, either expressed in E. coil with a Maltose-Binding Protein (MBP) 
fusion partner (Fig. 1.1), or as synthetic peptides, conjugated to bovine serum 
albumin (BSA) (Fig. 3.1). Fusion proteins, which were obtained from Kim 
Williamson (NIH, USA), (Williamson et al. 1995) were diluted to lj.tg/ml in 
carbonate buffer pH9.6 and used to coat Jmmulon-4 microtitre plates (Dynex). 
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Following an overnight incubation at 4°C, plates were washed and blocked, 
to minimise false positive reactions, as described in 2.10. Sera were blocked at 
room temperature for 3 hours with MBP at lojig/ml in blocking buffer, at a 
dilution of 1/1000, and plates were incubated for 3 hours at room 
temperature. Plates were washed, coated with anti-human IgG conjugated to 
horseradish peroxidase (FIRP) (Dako), and incubated for 3 hours. Plates were 
developed using H202 as substrate and OPD as chromogen, as described in 
2.10. 
Peptides were designed from the published Pfs260 amino acid sequence 
(Williamson et al. 1993), and synthesised at the Chemistry Department, 
University of Edinburgh. 
Figure 3.1 
Amino acid sequences of synthetic peptides used in ELISA 
Peptide 1 EEVGEEEGEEVGEEEGEYVD 
Peptide 2 	EDVDEEVGEEVGEEVGEEVGEEVG 
Peptide ELISAs were performed largely as described in 2.10. Xenobind 
microtitre plates (Xenopore Corp., New Jersey, USA) were coated overnight 
with BSA-conjugated peptides at lp.g/ml in PBS. Sera were pre-blocked 
overnight with lOp.g/ml BSA-glutaraldehyde in 1% skimmed milk blocking 







3.3.1 	Immunoprecipitation of gametocyte/gamete proteins 
Sera were use to immunoprecipitate radiolabelled gametocyte and gamete 
surface proteins extracted in Triton X-100 (Figs 3.2 and 3.3). Protein C 
Sepharose was used to precipitate immune complexes formed by all 
subclasses of IgG. Visual inspection of autoradiographs of exposed SDS-PAGE 
gels of immunoprecipitated gametocyte antigens revealed that sera from all 
individuals contained antibodies against the gametocyte-specific protein, 
Pfg27/25, indicating that all study individuals had been previously exposed 
to gametocytes of P. falciparum. In contrast, recognition of the proteins 
Pfs260/230 and Pfs48/45 was restricted (Table 3.1 and Figures 3.2 & 3.3). Table 
3.1 shows numbers and percentages of individuals sero-positive for each 
antigen in the 3 geographical regions. 
There was some variation in the prevalence of antibody responses to the 
various antigens by individuals of different ages from different geographical 
areas, but none of this variation was statistically significant in a series of Chi 
squared tests (See Appendix 2). Specifically, antibody responses to each 
antigen were independent of age, both within and across geographical areas 
(A 3.1, A 3.2). Neither was there any association between the geographical 
origin of sera and their ability to recognise specific gametocyte antigens. 
Overall, 71.4% of individuals recognised Pfs260, 43.2% recognised Pfs230 and 





Figure 3.2. Immunoprecipitation of I 25-I-labelled garnetocytes extracted in 1'X- 100 
with immune human sera from The Gambia. 




Immunoprecipitation of gamete surface proteins of Plasmodium falciparum 
by individual malaria-immune sera of different geographical origin 
Sera were tested for antibodies to 
Pfs260, the gametocyte-specific Pfs230-precursor protein, by 
immunoprecipitation of iodinated TX-100 aqueous extracts of whole 
gametocytes 
to the gamete surface proteins, Pfs230 and Pfs48/45 by 
immunoprecipitation of iodinated gamete surface proteins, solubilised after 
labelling, in TX-100 buffer. Values in parentheses represent percentages. 
No. of sera recognising antigen form indicated 
(% of sera recognising antigen form indicated) 
geographical origin of numb e anti- anti- anti- 
sera r of sera Pfs260 +ve Pfs230+ve Pfs48145+ve 
tested  
Farafenni (all ages) 139 99 (71.2) 60 (43.1) 53 (58.9)1 
under 16 yrs 67 48 (71.6) 25 (37.3) 27 (58.7)2 
over 16 yrs 72 51 (70.8) 35 (48.1) 26 (59.1) 
Brefet (over 16 years) 27 21 (77.8) 13 (48.1) 21 (77.8) 
PNG (all ages) 26 17 (65.4) 10 (38.5) 14 (53.8) 
under 16 yrs 8 5(62.5) 2(25.0) 4(50.0) 
over 16 yrs 18 12 (66.6) 8(44.4) 10 (55.5) 
'number tested (n)=90, 2n=46, 3n=44 
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3.3.2 	Restricted recognition of Pfs260/230 
In immunoprecipitations of mature gametocyte proteins, all sera which 
recognised Pfs230, also recognised its precursor molecule Pfs260 (see Fig. 3.2). 
However, not all sera which recognised Pfs260 appeared to recognise Pfs230. 
Table 3.2 shows details of sero-responsiveness to Pfs260/230 among the 
different populations of individuals. No significant differences were 
observed in the ability of individuals in the two age groups, or from different 
geographical locations to respond to Pfs260/230 (A 3.3). Although not 
statistically significant, there was however a tendency in both Farafenni and 
PNG sera, for a higher proportion of children than adults to recognise Pfs260 
only, rather than Pfs260 and Pfs230 i.e. children were less likely to recognise 
Pfs230. Overall, 43.2% of individuals recognised Pfs260/230, whereas a 
further 28.1% appeared to recognise only the precursor molecule. Presumably 
these antibodies are directed against epitopes within the region of Pfs260 
which is cleaved from the nascent protein at gametogenesis. This result was 
confirmed in immunoprecipitations of radiolabelled gamete surface 
proteins, where all of the Pfs230 is found in the mature form (Fig 3.3). None 
of the sera which recognised only Pfs260 were able to precipitate Pfs230 in 
these gels. Twenty-nine percent of the study population were completely 




Differential recognition of the precursor form (Pfs260) and 
mature form of Pfs230 of Plasmodium falciparum in different age 
groups of geographically distinct populations. 
No. of sera recognising antigen form indicated 
(% of sera recognising antigen form indicated) 
geographical origin of number anti- anti- anti- 
sera of sera Pfs260+1230+ Pfs260+1230- Pfs260-1230- 
tested  
Farafenni (all ages) 139 60 (43.2) 39 (28.1) 40 (28.8) 
under 16 yrs 67 25 (37.3) 23 (34.3) 19 (28.4) 
over 16 yrs 72 35 (48.6) 16 (22.2) 21 (29.2) 
Brefet (over 16 years) 27 13 (48.1) 8(29.6) 6(22.2) 
PNG 26 10 (38.5) 7 (26.9) 9(34.6) 
under 16 yrs 8 2(25.0) 3(37.5) 3(37.5) 
over 16 yrs 18 8(44.4) 4(22.2) 6(33.3) 
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3.3.3 	ELISA for detection of antibodies against epitopes within the N- 
terminal region of Pfs260 
An ELISA was designed to further investigate antibody responses to the N-
terminal region of Pfs260. This was done primarily in an attempt to confirm 
the results of the immunoprecipitations and to obtain more quantitative 
data, but also to address the possibility that there may be immunodominant 
epitopes present within this region. 
Recombinant Pfs260 A and B (rPfs260 A & B) are MBP-fusion proteins of 8.4 
and 8.6KDa, respectively (Fig. 1.1). Pfs260 A encodes the region between the 
25 consecutive glutamic acid residues and the tetrapeptide repeats, and Pfs260 
B encodes the tetrapeptide repeats and 10 amino acid residues (AA) 3' of 
these repeats (Williamson et al. 1993). Peptide 1 is a 20mer whose sequence 
begins within rPfs260 B and extends 5 AA into rPfs260 C, and represents the 
5' section of degenerate tetrapeptide repeats. Peptide 2 represents 24 amino 
acids near the 3' end of the tetrapeptide (EEVG) repeats of the Pfs260 protein 
(Fig 3.1). Only Gambian sera were tested in these ELISAs. Responses of these 
individuals to the various antigens are shown in Table 3.3. 
In assays using bacterially-produced recombinants, more children than adults 
(from Farafenni) tended to respond to epitopes within the N-terminal 
region, although this difference was not significant (p=0.15, r260A; p=1.0, 
r260B, MWU). Whereas, when synthetic peptides were used as coating Ag, 
adults' responses were proportionately greater than those of children (p=0.04, 
peptide 1; p=0.0002, peptide 2, MWU). 
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Table 3.3 
Numbers of sera from individuals from The Gambia which were 
antibody positive by ELISA for recombinant proteins or peptides representing 
the N-terminal sequence of Pfs260 of Plasmodium falciparum. 
No. of sera recognising recombinant protein or 
peptide indicated 
(% of sera recognising recombinant protein or 
peptide_indicated)  
geographical origin no. sera rPfs260 A rPfs260 B peptide pep tide 
of sera tested 1 2 
Farafenni (total) 110 31 (28) 19 (17) 11 (9) 33 (30) 
<16 years 52 19 (36) 11 (21) 2 (4) 7 (14) 
> 16 years 58 12 (21) 8 (14) 9 (16) 26 (45) 
Brefet (>16 years) 27 9 (33) 10 (37) 5 (18) 16 (59) 
Total 138 40 (29) 29 (21) 16 (12) 49 (36) 
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3.3.4 	Association between recognition of Pfs260 N-terminal region by 
immunoprecipitation and ELISA results 
Data was combined from r260A and r260B ELISAs and examined for 
associations (by X 2 test) with positive results in immunoprecipitation. It was 
found that for sera from adults in Brefet, there was a significant association 
between immunoprecipitation and ELISA data (X 2 =6.17, p=O.Ol for sera 
recognising both Pfs230 and Pfs260 and X 2 =4.2, p=0.04 for sera recognising 
Pfs260 only) (Table 3.4). This association was even stronger for recognition of 
peptide 2 in ELISA and Pfs260 in immunoprecipitation (X 2=11.22, p=0.0008 
for sera recognising both Pfs230 and Pfs260, and X 2=7.88, p=0.005 for sera 
recognising Pfs260 only). 
Among the Farafenni sera, there was a significant association between sera 
from children positive for Pfs260 only in immunoprecipitation and those 
positive by rPfs260 A/B ELISA (X 2= 4.23, p=0.04). Farafenni adults' responses 
showed no correlation between immunoprecipitation and ELISA data (Table 
3.4). 
These results indicate there is a greater level of association between 
immunoprecipitation of Pfs260 and response in Pfs260- N-terminal region-
specific ELISA, if all sera (including those recognising Pfs230) are included. 
This suggests that sera which appear to precipitate Pfs260 along with Pfs230 
do actually contain antibodies to epitopes within the N-terminal region, and 
are not just precipitating the precursor form due to Pfs230-specific antibodies. 
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Table 3.4 	Statistical comparison of the antibody responses in human sera 
from The Gambia to different molecular regions of the Plasmodium 
falciparum gametocyte protein Pfs260 as measured by 
immunoprecipitation and in ELISA. 
Variables n 	x2 d.f. p value 
Pfs230 and Pfs260 antibody 
+ve by immunoprecipitation 
r260A/B by ELISA 
Farafenni Children 70 	1.33 1 0.25 
Farafenni Adults 71 0.36 1 0.50 
Brefet Adults 27 	6.17 1 0.01* 
Pfs260 only Ab +ve by 
immunoprecipitation 
r260A/B by ELISA 
Farafenni Children 	 35 4.23 	1 	0.04* 
Farafenni Adults 42 0.38 1 0.54 
Brefet Adults 	 14 4.2 	1 	0.04* 
Pfs230 and Pfs260 Ab +ve by 
immunoprecipitation 
peptide 2 (EEVG repeats) by 
ELISA 
Farafenni Children 	 57 0.25 	1 	0.87 
Farafenni Adults 63 	1.21 1 0.27 
Brefet Adults 	 27 11.22 	1 	0.0008* 
Pfs260 only Ab +ve by 
immunoprecipitation 
peptide 2 (EEVG repeats) by 
ELISA 
Farafenni Children 	 29 	1.52 	1 	0.22 
Farafenni Adults 27 1.80 1 0.18 
Brefet Adults 	 14 	7.88 	1 	0.005* 




3.3.5 	Recognition of Pfs230 in ELISA (r260 C-F) 
Table 3.5 shows reactivity of Gambian sera against MBP-fusion proteins 
representing most of the gamete-surface protein, Pfs230 (Fig. 1.1). 
Among individuals from both Farafenni and Brefet, rPfs260 C was the region 
recognised by most sera. This was the protein which induced transmission-
blocking antibodies when used to immunise mice (Williamson et al. 1995). 
Interestingly, among Farafenni sera, children were more likely to have 
antibodies recognising Pfs230 in ELISA than were adults (Maim-Whitney U-
test p=0.7, 0.02, 0.06, >0.0001, regions C-F, respectively). When ELISA results 
were compared with those of Pfs230 immunoprecipitations, the only 
(marginally) significant association was found for Brefet sera and r260F 
(X2=3.6, p=0.06). Generally, there was a lack of concordance between 




Endemic human sera from The Gambia tested by ELISA for Ab 
responses to different bacterially expressed fusion proteins representing 
different regions of the Plasmodium falciparum gamete surface protein 
Pfs230. 
See Figure 1.1 for details of fusion proteins. 
Results are expressed as number (%) whose OD values were above (a) mean 
plus 2 standard deviations (sd) and (b) mean plus 3 (sd) of age- matched 
European control sera. 
No. of sera with OD above indicated mean +sd for given protein 
(% of sera with OD above indicated mean +sd) 
geographical no. rPfs230C rPfs230 D rPfs230 E rPfs230 F 
origin of sera sera 
tested  
a b a b a b a b 
Farafenni 144 37 (26) 19 (13) 30 (21) 17 (12) 19 (17) 13 (9) 30 (21) 16 (11) 
(all ages) 
<16 yrs 109 30 (28) 17 (16) 25 (23) 15 (14) 17 (16) 11 (10) 28 (26) 14 (13) 
> 16 yrs 35 7 (20) 2 (6) 5 (14) 2 (6) 2 (6) 2 (6) 2 (6) 2 (6) 
Brefet 27 6 (22) 6 (22) 2 (7) 0 (0) 1 (4) 1 (4) 3 (11) 2 (7) 
(>16 years) 
total 171 43 (25) 25 (15) 32 (19) 17 (10) 20 (12) 14 (8) 33 (19) 18 (10) 
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3.4 	 Discussion 
Prevalence of potential transmission-blocking antibody responses 
The results of the immunoprecipitations confirm those of previous studies 
in Papua New Guinea (Carter et al. 1989b; Graves et al. 1988b), Sri Lanka 
(Premawansa et al. 1994) and The Gambia (Riley et al. 1994), where all 
malaria-exposed individuals made antibodies to the gametocyte-specific 
protein Pfg27/25, but not everyone responded to the gamete-surface proteins 
Pfs230 and Pfs48/45. In this study, 43% of individuals were positive for 
antibodies against Pfs230, the same proportion as that found in an earlier 
survey of anti-gamete responses in The Gambia (Quakyi et al. 1989). 
However, responses to Pfs48/45 were higher than found previously. It is 
recognised that an 1gM response to gametocyte/gamete proteins would not be 
detectable in this system, and could be important in vivo. 
Recognition of Pfs260/230 by immunoprecipitation 
All of the sera which precipitated Pfs230 also precipitated its precursor form 
Pfs260 in mature gametocyte extracts. However, a significant proportion of 
the sera appeared to recognise Pfs260 and not Pfs230 (overall, 28% of 
individuals). These antibodies must be directed towards epitopes which are 
present in the N-terminal region of the molecule which is cleaved from the 
nascent protein at gametogenesis (Williamson et al. 1996). Although not 
statistically significant, differences were found in the proportions of sera 
from children and adults which responded to Pfs230 and/or Pfs 260, with 
children tending to respond to Pfs260 in the absence of a Pfs230 response, and 
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adults predominantly recognising both forms. Perhaps if more children's 
sera had been available, it would have been possible to further age-stratify 
the sera, and significant differences may have been found. This was further 
investigated in ELISA using E. coli recombinant proteins and synthetic 
peptides corresponding to regions within the N-terminal part of the protein. 
ELISA responses to regions within N-terminus of Pfs260 
It was found that sera from children tended to recognise r260 fusion proteins 
more frequently than adults (not statistically significant), but significantly 
higher proportions of adult sera responded to BSA-conjugated synthetic 
peptides encoding epitopes within this region. This was especially noticeable 
for the peptide representing the tetrapeptide repeat sequences. The reason for 
this could be that the peptide epitopes, being much smaller than 
recombinant proteins, may be being recognised by cross-reactive antibodies 
which have actually been induced by other, not necessarily sexual stage, 
antigens. In the recombinant proteins, these cross-reactive epitopes may be 
partially obscured by other parts of the protein. However, responses to the 
recombinants representing the N-terminal region were proportionately 
higher than those directed towards the mature, gamete-surface associated 
protein. The predominant response to recombinants within the N-terminal 
region was to r260A in both children and adults from Farafenni, but in adults 
from Brefet, more sera recognised r260B: the region representing the 
tetrapeptide repeats. This result confirmed that of a previous study (Riley et 
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al. 1995), which demonstrated persistent antibody responses to these 
recombinant proteins among Brefet sera. 
ELISA responses to rPfs230 antigens 
The antibody response to recombinant proteins representing mature Pfs230 
was also examined in ELISA. There was a lack of correlation between 
immunoprecipitation and ELISA results (also found by (Riley et al. 1995). 
This is explained by the lack of appropriate tertiary structure in bacterially-
produced proteins i.e. recombinant Pfs230 does not assume the same 
conformational structure as native Pfs230. Children were found to respond 
more frequently to Pfs230 recombinants than adults. This may indicate that 
children preferentially recognise linear, rather than conformational epitopes 
on this protein. This tendency is also found when one compares the 
proportions of sera in each age group recognising Pfs260 only or Pfs260 and 
Pfs230 by immunoprecipitation: there appears to be a shift in adulthood 
towards the recognition of conformational epitopes in Pfs230. It is possible 
that linear epitopes within this region are immunodominant, and that 
greater levels of exposure to gametocytes are required to induce an antibody 
response to conformational epitopes. 
Comparative analysis of results from immunoprecipitation and ELISA 
against Pfs260 N-terminal-specific epitopes, seems to suggest that sera which 
precipitated both Pfs260 and Pfs230 do contain Abs against the N-terminal 
region, as well to Pfs230. 
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Immune Evasion Hypothesis 
The basis of this hypothesis is that P. falciparum has evolved 
immunodominant B cell epitopes which divert the immune response away 
from potential transmission-blocking target epitopes (Riley et al. 1995). 
Evidence of this phenomenon has been found in a previous study of 
immune responses to Pfs2601230 among adults from Brefet (Riley et al. 1996), 
which found a significant negative association between recognition of the 
tetrapeptide repeat sequence in ELISA, and the Pfs230 mature protein by 
immunoprecipitation. The results in this chapter confirm this finding, and 
also suggest that there may be a maturation of a .potential transmission-
blocking immune response with parasite exposure. Perhaps if more 
children's sera were tested, the tendency which was observed may have 




Complement-Mediated Lysis of Plasmodiumfalciparum 
Gametes by Malaria-Immune Human Sera 
4.1 	 Introduction 
Gametocytes, gametes and zygotes of malaria parasites express novel, stage-
specific antigens on their surface rendering them susceptible to immune 
attack within the mosquito midgut. Both antibody-mediated and cell-
mediated effector mechanisms are believed to play a role in transmission-
blocking immunity (Targett 1988), although most attention has focused on 
defining the antigenic targets of antibody-dependent mechanisms. The major 
gametocyte and gamete surface antigens of Plasmodium falciparum, which 
might form the basis of a transmission-blocking vaccine, Pfs230 and Pfs48/45, 
are known to be targets of transmission-blocking monoclonal antibodies 
(MAbs) (Quakyi et al. 1987; Rener et al. 1983; Vermeulen et al. 1985b). Both 
proteins are synthesised early in gametocyte development (Kumar & Carter 
1984). 
All Pfs230-specific transmission-blocking MAbs studied so far are directed 
against conformational epitopes and do not recognise the protein in reduced 
form (Read et al. 1994). Another common feature is that they are all of 
complement-fixing IgG subclasses and do not block parasite development 
unless complement is present (Read et al. 1994; Roeffen et al. 1995b). Some 
MAbs against Pfs48/45 block infectivity without the requirement for 
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complement whilst others are dependent on the presence of complement; 
some require the presence of other MAbs with synergistic blocking effects 
(Carter et al. 1990; Rener et al. 1983; Targett 1988; Vermeulen et al. 1985b). 
In animal malaria models, several potential antibody-mediated mechanisms 
of transmission-blocking immunity have been described including 
complement-mediated lysis (Kaushal et al. 1983), agglutination of gametes 
(Aikawa et al. 1981), and antibody-dependent phagocytosis (Ranawaka et al. 
1994). The former two mechanisms have also been demonstrated for MAb-
mediated transmission-blocking immunity against P.falciparum gametes 
(Rener et al. 1983). In a study of transmission-blocking immunity in P. vivax 
patients, about half of the sera which mediated transmission-blocking were 
dependent upon complement to various degrees (Mendis et al. 1987). 
However, the mechanisms by which naturally acquired antibodies to P. 
falciparum gamete antigens mediate transmission-blocking immunity have 
not yet been elucidated. 
In this chapter, human sera from The Gambia and Papua New Guinea were 
tested for their ability to mediate complement-dependent lysis of 
macrogametes of P.falciparum in vitro. The relationship between the ability 
of sera to mediate gamete lysis and antibody status was evaluated. 
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4.2 	 Materials and Methods 
Details of the procedures used in this chapter are described in chapter 2 as 
follows 
In vitro assay for complement-mediated gamete lysis 	2.8 
1 I-label1ing and preparation of gametocyte proteins 	2.5 
1251-1abelling and preparation of gamete surface proteins 	2.6 
Immunoprecipitation and SDS-PAGE analysis 	 2.7 
ELISA to determine IgG subclass of antibodies 	 2.10.1 
4.2.1 	Statistical analysis 
Multiple regression analysis of the results presented in this chapter was 
performed by David McGuinness. 
Multiple logistic regression was used to test for association between lysis and 
each of the antibody variables. Odds ratios (OR) and 95% confidence intervals 
[C.I.], corrected for potential confounding by age and geographical area, were 
calculated. All computation was carried out using GLIM 3.77 software. 







4.3.1 	Complement-mediated lysis 
Sera from 114 malaria-exposed individuals were screened for their ability to 
mediate in vitro lysis of P.falciparum macrogametes in the presence or 
absence of active human complement. Each serum was classed as either 
positive or negative based on microscopic analysis of Giemsa-stained slides. 
Lysis was detectable as fragmentation of gametes, with extracellular malaria 
pigment scattered liberally across the slide (Fig. 4.1). A serum was given a 
negative score if gametes remained intact following incubation with active 
complement (Fig. 4.2). Each serum was tested on at least two separate 
occasions and repeatable results were obtained. No non-specific cytotoxicity 
was observed when sera were incubated with gametes and heat-inactivated 
complement. European control sera were negative in the assay. 
Table 4.1 shows the numbers of sera which mediated complement-
dependent gamete lysis. Overall, 47% of the sera were positive in the assay 
(95% C.I. 38.5%, 56.5%). No significant differences were found in the 
proportions of sera which mediated gamete lysis based on age, sex or 
geographical origin of the donor (p>0.2 in all cases). 
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Figure 4.1 Lysed gametes after 
incubation with malaria-endemic 
human sera and complement. 
Figure 4.2 Intact gametes following 
incubation with malaria-endemic human 







Proportions of sera from different malaria-endemic regions a) 
mediating complement-dependent lysis of Plasmodium fa 1 c ip a rum 
gametes in vitro, and b) with antibody recognition by immunoprecipitation 
of radiolabelled gametocyte/gamete specific antigens Pfs260/230 and 
Pfs48/45. n (%) of antibody- 	positive immune sera in each case. 
Number of sera +ve in each test (%) 
Antibody +ve 
geographical 	Total 	complement Pfs260/230 	Pfs260 	Pfs48/45 
origin of sera no. of lysis +ve 	 (N-terminus only) 
sera 
Farafenni 
children 20 8 (40 0) 8(40.0) 7(35.0) 11 (55.0) 
adults 41 18 (43.9) 19 (46.3) 17 (41.5) 24 (58.5) 
Brefet 
adults 27 13 (48.2) 15 (55.6) 8 (29.6) 21 (77.8) 
Papua New 
Guinea 
children 8 3(37.5) 2(25.0) 3 (37.5) 4(50.0) 
adults 18 12 (66.7) 8(44.4) 4 (22.2) 10 (55.6) 
overall total 114 54 (47.4) 52 (45.6) 39 (34.2) 70 (61.4) 
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4.3.2 	Relationship between the presence of sexual stage-specific 
antibodies and complement-mediated lysis of gametes in 	vitro 
Each of the 114 sera were scored for their ability to mediate gamete lysis, and 
whether they were positive for antibodies to Pfs260, Pfs230 and Pfs48/45. 
Details of sexual-stage antigen recognition by malaria-immane sera are given 
in Chapter 3. All sera were positive for antibodies to Pfg27/25. Associations 
between the ability of particular sera to mediate gamete lysis and the presence 
antibodies against Pfs260, Pfs230 and Pfs48/45 were tested by logistic 
regression analysis. (Table 4.2). This revealed a highly significant association 
between gamete lysis and antibodies to Pfs230 (p<0.0001). 
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Table 4.2 Association of in vitro complement-mediated gamete lysis and 
presence of antibodies to P. falciparum gametocyte/gamete specific 
antigens Pfs260, Pfs230 and Pfs48/45. 
crude odds ratio (O.R.) comparing the odds of lysis 
between antibody positive (Ab+) and antibody 
negative (Ab-) sera (based on 114 sera) 
O.R. adjusted for age and area. 
O.R. adjusted for age, area and the effect of the 
other two antibodies. 
% lvsis +ve sera 
	
Antibody I 	Ab + (n) 	I Ab- (n) I 	O.R. (95% C.I.) 	p value 
Pfs260 48.9(90) 41.7(24) 1.34 (0.54, 3.33)a 	0.53 
1.45 (0.56, 374)b 0.71 
0.37 (0.11, 1 . 2)C 	0.10 
Pfs230 73.1(52) 25.8(62) 7.81 (3.39, 17. 96)a 	<0.0001 
8.79 (3.65, 21.18)b <0.0001 
12.88 (4.53, 36 . 64)C 	<0.0001 
Pfs48/45 51.4(70) 40.9(44) 1.53 (0.71, 3.28) a 	0.28 
1.56 (0.71, 3.43)b 0.27 
1.05 (0.42, 2.65) C 	0.91 
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A serum in which anti-Pfs230 antibodies were present was thirteen times 
more likely to mediate gamete lysis than an anti-Pfs230 negative serum, with 
73% of the sera which contained anti-Pfs230 antibodies able to mediate 
gamete lysis. In contrast, no association was found between antibodies to 
either Pfs260, or Pfs48/45 and lysis. However, lysis in the absence of 
antibodies to Pfs230 was detectable in a few cases (n=16/144); antibodies to 
Pfs48/45 were detectable in some (9/16) but not all of these cases suggesting 
that antibodies to another antigen may also be mediating lysis. The adjusted 
odds ratio for the relationship between anti-Pfs230 antibodies and lysis 
increased substantially after the effects of the other antibodies had been 
accounted for (Table 4.2), however there was an overlap in the 95% Cl 
between the unadjusted and adjusted models, therefore the difference in OR 
is unlikely to be statistically significant. When the regression estimates for 
lysis in the presence of anti-Pfs230 antibodies are adjusted for age and area, 
there is again an increase in odds ratio (Table 4.2) which may suggest a 
difference between sera from adults and children in their ability to mediate 
gamete lysis (50% of adults' sera mediated lysis compared with 39% of 
children's sera). But again, due to the overlapping CI, this is likely to be due 
to confounding factors arising through chance, rather than a real effect. 
However, by X2 analysis, the association between lysis and the presence of 
antibodies against Pfs230 is weaker for children's sera than it is for adults 
(X2=3.59, p=0.058, n=28 for children; X 2=24.1, p<0.0001, n=86 for adults), but 
the sample size is also smaller for children. 
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In contrast to Pfs230, the odds ratio for Pfs48/45 decreases when adjustments 
are made for other antibodies, suggesting that any effect of anti-Pfs48/45 
antibodies may be due to interaction with antibodies against Pfs230. 
4.3.3 	Gametocyte-Specific IgG Subclass Analysis. 
The IgG subclass of gametocyte-specific responses was determined for the 
majority of sera, using a Pfs230-enriched gametocyte antigen preparation in 
an ELISA assay. It was apparent that IgGi and IgG3 were the predominant 
isotypes in both lysing and non-lysing sera; this was the case for both 
children and adults (Table 4.3). 
77 
Chapter 4 
Table 4.3. IgG subclasses of antibodies present within lysing and non-
lysing human endemic sera which recognise P. falciparum 
gametocyte/gamete-specific proteins Pfs260, Pfs230 and Pfs48/45. 
protein 
& age of 
recognised  
Lysis +ve Lysis -ye 
no. IgGI IgG2 IgG3 IgG4 no IgGI lgG2 IgG3 IgG4 
donors sera (%)  sera 
Pfs260 only 7 6 (86) 0 (0) 7 (100) 0 (0) 27 25 (93) 3 (11) 27 (100) 4 (15) 
I lI 
>16 years 6 6 (100) 0 (0) 6 (100) 0 (0) 23 20 (87) 3 (13) 21(91) 4 (17) 
Pfs260/230 36 26 (72) 9 (25) 29 (80) 2 (6) 13 10 (77) 6 (46) 12 (92) 1 (8) 
16, vear 4 3 (0) 4 (67) 4 2 	50) (7 4 (1UO) 
>16 years 29 22 (76) 6 (21) 25 (86) 2 (7) 9 8 (89) 3 (33) 9 (100) 1 (11) 
Pfs48/45 32 25 (78) 7 (22) 26 (81) 2 (6) 33 22 (67) 9 (27) 27 (82) 3 (9) 
earc, :  (50) 2 ( 3 (0) U (0) S 2 	2:i 2 	25) 5(02: U(0 
>16 years 25 22 (88) 5 (20) 22 (88) 2 (20) 25 20 (80) 7 (28) 22 (88) 3 (12) 
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The broad similarity in the isotypes of lysing and non-lysing sera hides some 
interesting differences. Firstly, IgGi and IgG3 were significantly less prevalent 
in children (IgGi was present in 82.4% of adults (n=86) compared with 48.1% 
(n=28) of children. X 2=11.20, p=0.0008; IgG3 was present in 92.2% of adults 
compared with 70.2% of children. X 2=11.55, p=0.0007). IgG2 was more 
prevalent in children (26%) than in adults (18%) (X 2=1.05, p=0.48) and 
importantly, all sera which mediated complement-dependent lysis contained 
IgGi and/or IgG3 antibodies which reacted with Pfs230-enriched gametocyte 
extract. Table 4.4 shows a summary of the results obtained from logistic 
regression analysis, which was used to test for a relationship between IgG 
subclass and lysis. No associations were found between the isotype of the 
anti-gametocyte antibodies present and their ability to mediate gamete lysis, 
however, the number of IgG2 and IgG4 positive sera was low compared to 
the number of IgGi and IgG3 positive sera. Of the 13 non-lysing sera which 
were anti-230 antibody positive and were tested in the ELISA, all appeared to 
have IgGi and/or IgG3 antibodies present, thus the lack of complement-




Table 4.4. 	Association of in vitro complement-mediated gamete 	lysis 
by endemic human sera and IgG subclass of P. 	falciparum 
gametocyte/gamete-specific antibodies. Odds ratio (O.R.) based on 106 sera, 
adjusted for age, area and the other 	IgG subclasses. 
% lysis +ve sera 
Ab+(n) Ab-(n) 
46.8 (77) 41.4 (29) 
47.4 (19) 44.8 (87) 
47.7 (86) 35 (20) 
33.3(9) 46.4 (97) 
46.5 (99) 28.6(7) 






IgGi and/or IgG3 
IgG2 and/or IgG4 
O.R. (95% C.I.) 	p value 
1.15 (0.44, 2.97) 0.78 
1.22 (0.39, 3.77) 
	
0.73 
1.63 (0.55, 4.83) 
	
0.38 
0.50 (0.10, 2.38) 
	
0.39 
1.83 (0.31, 10.84) 
	
0.51 




A potentially interesting, although not statistically significant finding was 
that IgG2 was more prevalent in anti-230/260 positive, non-lysing sera, than 
in anti-230/260 positive, lysing sera (O.R.=0.39, C.I. [0.08, 1.761, p=O.l?') (Table 
4.3). Or, to look at it another way, the proportions of sera which were anti-
Pfs230 positive and lysis negative were higher when IgG2 was present (60%), 
than when IgG2 was absent (14%). If non-complement-fixing antibodies were 






4.4 	 Discussion 
The aims of the experiments in this chapter were to test a panel of human 
sera from malaria-endemic regions for their ability to mediate complement-
dependent lysis of gametes in vitro and to look for an association between 
the presence of antibodies against P.falciparum gamete surface antigens 
(Pfs230 and Pfs48/45 in particular) and gamete lysis. 
Forty-seven percent of endemic sera mediated complement-dependent lysis 
of P.falciparum gametes. When results from the complement assay were 
compared with those of the immunoprecipitations, it was clear that gamete 
lysis was strongly associated with the presence of antibodies against Pfs230 
but not with antibodies to either Pfg27/25, Pfs48/45, or the N-terminal 
processing product of Pfs260. 
An ELISA was designed assess the influence of antibody isotype on gamete 
lysis. This was done primarily in an attempt to explain why some sera failed 
to mediate gamete lysis when they appeared to recognise Pfs230 by 
immunoprecipitation. It is known that, principally, y-globulins of subclass 
IgGi and IgG3 fix complement, whereas IgG2 and IgG4 do not (Bruggemann 
et al. 1987). All sera which mediated lysis contained IgGi and IgG3 antibodies, 
but a lack of complement-fixing isotypes did not appear to be the explanation 
for failure of Pfs230-positive sera to mediate gamete lysis, since all Pfs230-
positive lysis-negative sera apparently contained gamete-specific IgGi or 
IgG3. 
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However, there are considerable practical difficulties in obtaining purified 
Pfs230 to use in immunoassays. The majority of epitopes recognised by 
transmission-blocking antibodies are dependent on preserving the intact 
tertiary structure of this molecule (Quakyi et al. 1987; Read et al. 1994). 
Furthermore, it has not yet been possible to express the Pfs230 gene in a 
manner which produces conformationally correct proteins. In this study, an 
extract of gametocyte proteins was used as the antigen source for the ELISA. 
SDS-PAGE analysis of the extract indicated that Pfs260 and Pfs230 were the 
major components. However, it cannot be ruled out that other antigens, 
which are not amenable to iodination, may also be present. It is also likely 
that epitopes not exposed in the native proteins may be accessible to 
antibodies in the ELISA system, where partial degradation of the antigens 
may occur. This may explain why some sera which recognised neither Pfs230 
nor Pfs48/45 by immunoprecipitation were positive in the ELISA. 
Furthermore, the detectable IgGi and IgG3, may be directed towards epitopes 
within the N-terminal 50 KDa region of Pfs260, and as such, have no role in 
mediating gamete lysis. 
Despite these reservations, the ELISA system was suitable for isotyping of 
specific antibodies to gametocyte antigens, with up to 79% of malaria-exposed 
sera giving OD values above the normal range for non-exposed sera, for one 
or more of the 4 subclasses tested. 13/114 sera (12%) contained antibodies to 
Pfs230 (by immunoprecipitation) which appeared (by ELISA) to be of 
complement-fixing isotypes but did not mediate gamete lysis. It is possible 
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that these antibodies recognise epitopes which are not accessible on the 
gamete surface and are thus unable to bind live gametes. Alternatively, the 
proximity of the epitope to the plasma membrane of the gamete may be 
critical in determining whether lysis can occur (Williamson et al. 1995). In 
this hypothesis, epitopes furthest removed from the parasite membrane bind 
antibodies, but membrane penetration of the membrane attack complex, the 
ultimate step in the complement cascade, is inhibited. Such evasion 
mechanisms exist in bacteria (Cooper 1991), and with a large, complex 
molecule such as Pfs230, such a scenario is conceivable. 
Another possible explanation for Pfs230-positive sera failing to lyse gametes, 
is that non-complement-fixing antibodies compete for epitopes with 
complement-fixing antibodies, which would otherwise mediate gamete lysis. 
It is known from monoclonal antibody studies that non-complement-fixing 
antibodies can compete for epitopes with complement-fixing antibodies, 
resulting in inhibition of transmission-blocking activity (Roeffen et al. 
1995b). In our study, over half of the non-lysing sera which were anti-230 
positive and IgGi or IgG3 positive, also contained IgG2 or IgG4 antibodies to 
gamete surface antigens, suggesting that competition may be an explanation 
in some cases. 
Sixteen of the sera tested were able to lyse gametes in the absence of 
antibodies to Pfs230, and although most of these were positive for anti-
Pfs48/45 antibodies, some appeared to be seronegative for both of these 
antigens. It is possible that another surface antigen is the target of 
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complement-fixing antibodies in these sera. Scrutiny of the 
immunoprecipitations of surface-labelled gametes revealed a variety of other 
antigens, most of them recognised to some degree by all of the sera. Other 
antigens with limited recognition were more difficult to detect; a 40KDa 
antigen does seem to be differentially recognised, but it does not appear to be 
associated with gamete lysis. The possibility remains that there are targets of 
complement-fixing antibodies on gametes which we cannot easily detect in 
our system which has been optimised for recognition of Pfs230 and Pfs48/45. 
Although antibodies to the mature, processed form of Pfs230 are associated 
with complement-mediated lysis, antibodies to the N-terminal processing 
product of Pfs260/230 are not. This is consistent with the absence of this 
region from the surface of extracellular gametes (Williamson et al. 1996). 
In conclusion, it was found that whilst antibodies to Pfs230 are positively 
associated with complement-dependent lysis, antibodies to other gametocyte-
specific proteins (Pfs48/45, the N-terminal region of the Pfs260 precursor 
molecule and Pfg27/25) are not. All sera which mediated gamete lysis 
contained IgGi and/or IgG3 antibodies to gamete surface antigens, but not all 
antibody-positive sera were able to mediate lysis suggesting that the epitope 
specificity of the antibody, as well as its isotype and subclass, may be 
important for its function. 
These results indicate that naturally acquired antibodies to Pfs230 act to 
suppress gamete development in a complement-dependent manner, and are 
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Association between antibodies to the gamete surface 





During its life cycle, P. falciparum undergoes an obligate sexual phase 
which is dependent on the uptake of gametocytes into the midgut of a 
mosquito. A feeding anopheline ingests not only gametocyte-infected 
erythrocytes, but also other blood components, such as leukocytes, 
antibodies and complement. Thus, the mosquito phase of the malaria life 
cycle represents a potential target of immune attack and the development 
of a transmission-blocking vaccine is seen as a useful adjunct to any long-
term anti-malarial strategy. 
Transmission-blocking immunity has been demonstrated in various 
experimental (Gwadz 1976; Gwadz & Green 1978; Winger et al. 1988) and 
natural situations (Graves et al. 1988b; Mendis et al. 1987; Mulder et al. 
1994) and four P. falciparum sexual stage-specific antigens are being 
studied as potential components in a transmission-blocking vaccine. The 
zygote surface protein, Pfs25 has been shown to induce transmission-
blocking antibodies following immunisation (Kaslow et al. 1991) and 
together with Pfs28 (Duffy & Kaslow 1997) may yet prove to be a highly 
effective vaccine. Although promising results have been obtained in 
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animal models with Pfs25 (Kaslow & Schiloach 1994), it is not expressed 
in the stages of the parasite which infect the human host, and thus 
antibodies induced by immunisation would not be boosted by natural 
infection. It may be preferable therefore, to target those antigens which 
elicit transmission-blocking immunity following natural infections. 
The gamete surface proteins Pfs230 and Pfs48/45 are the targets of 
transmission-blocking monoclonal antibodies (MAbs) (Carter et al. 1990; 
Quakyi et al. 1987; Rener et al. 1983; Vermeulen et al. 1985b) and, as they 
are present on gametocytes, are capable of inducing antibodies in a 
natural infection (Carter et al. 1989b; Graves et al. 1988b). 
Several studies have demonstrated the ability of immune human serum 
to reduce infectivity of P. falciparum gametocytes to mosquitoes (Foo et 
al. 1991; Graves et al. 1988c; Mulder et al. 1994; Ong et al. 1990; Roeffen et 
al. 1995c). One such study found a significant correlation between 
antibodies against Pfs230 and transmission-blocking activity (Graves et al. 
1988b). Other studies have found an association between transmission-
blocking activity of human sera and recognition of MAb-defined epitopes 
of Pfs48/45 (Graves et al. 1988c; Roeffen et al. 1995c). 
In this chapter, the ability of individual sera to modify the infectivity of 
gametocytes to mosquitoes was tested in membrane feeding experiments. 
Results from these experiments were correlated with antibody responses 
to gametocyte and gamete-specific antigens, and with the ability of 
individual sera to mediate in vitro complement-dependent gamete lysis. 
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It is shown that some sera significantly reduce the number of 
transmission stages developing within mosquitoes and that this is 
associated both with the ability to mediate complement-dependent 
gamete lysis and with the presence of antibodies against Pfs230, but not 
with antibodies to the other gamete-surface protein, Pfs48/45. 
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5.2 	 Materials and Methods 





In vitro assay for complement-mediated gamete lysis 	2.8 
' 251-labelling and preparation of gamete surface proteins 	2.6 
Immunoprecipitation and SDS-PAGE analysis 	 2.7 
ELISA to determine IgG subclass of antibodies 	 2.10.2 
5.2.1 Subjects 
Sera were collected from 27 adults, as part of a longitudinal survey, from 
the village of Brefet, south of the river Gambia, West Africa. Malaria is 
seasonally endemic in all areas of The Gambia (Greenwood et al. 1987). 
All endemic sera were heat-inactivated before use. 
Control sera were obtained from non malaria-exposed European donors. 
Serum to be used as a complement source was freshly frozen at -70°C, 
otherwise it was heat-inactivated at 56°C for 30 minutes to destroy the 
complement (C') activity. Aliquots were tested for C' activity (or the lack 
of C' activity) in an assay using 20 j.tl per well of fresh sheep erythrocytes 
(Scottish Antibody Production Unit) and goat anti-sheep erythrocyte 
antisera (1/50) (Sigma). These were incubated with human sera at 
dilutions from 1/20 - 1/100 in RPMII 1640 medium, for 30 mins at 37°C in 
sterile, round bottom, 96-well plates. Where C' was active, lysis of sheep 
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erythrocytes was evident by visual examination of the rbc pellet and by 
the red colouration of the medium. 
	
5.2.2 	Triton X-114 extract of radiolabelled gamete surface proteins 
iO 1 I-surface-labe1led gametes (Section 2.6) were extracted in a 50091 
solution of 1% Triton X-114 (TX-114, Sigma) and 10mM Tris-Cl pH 7.4 
containing a protease inhibitor cocktail (Calbiochem-Novobiochem, 
Nottingham, UK). TX-114 extraction enriches for Pfs230 in the aqueous 
fraction (Bordier 1981; Kumar 1985). The aqueous fraction was removed 
for immunoprecipitation with either malaria-immune sera or with the 
monoclonal antibody 121710, specific for Pfs230 (Read et al. 1994), or 3G12, 
specific for Pfs48/45 (Carter et al. 1990) (as positive controls); and protein-
G Sepharose (Pharmacia, Uppsala, Sweden). Presence of Pfs230 in these 
fractions (as detected by Pfs230-specific MAb 12F10, (Read et al. 1994) was 
confirmed by SDS-PAGE and autoradiography before use (Section 2.7). 
5.2.3 	Quantitation of Pfs230-specific antibodies in sera 
Quantitation of Pfs230-specific antibodies in sera was determined in two 
ways. In the first, levels of immunoprecipitated Pfs230 and Pfs48/45 from 
Triton X-100 - extracted 19-surface-labelled gametes were assessed by 
visual analysis of autoradiographs and scoring of band intensity from 0-3 
(Table 5.1, anti-Pfs230a & anti-Pfs48/45). Secondly, more accurate 
quantitation of Pfs230 was achieved by phosphorimaging 
(Phosphorimager SI, Molecular Dynamics, Sunnyvale, CA, USA) of 
immunoprecipitated Triton X-114 - extracted 1 I-surface-1abel1ed gametes 
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separated on 5-15% SDS-PAGE gradient gels. Phosphorimager output data 
were analysed using ImageQuant software version 1.0 (Molecular 
Dynamics). 
In this method, Coomassie-stained and dried SDS-Page gels of 
immunoprecipitations were placed directly onto radiation-sensitive 
screens inside phoshorimager cassettes, and exposed for 17 days. 
Following exposure, screens were read in the phosphorimager apparatus 
and the image of the radiolabelled proteins in the gel was visible via 
ImageQuant software on a computer monitor. Tracks representing 
immunoprecipitations with Pfs230-specific MAb were located. Boxes were 
drawn around the bands corresponding to the position of Pfs230 to allow 
quantification of Pfs230-specific antibodies in the endemic sera. 
Background values were established from each track, and subtracted from 
the Pfs230 box, in order to calculate the specific density of the Pfs230 band. 
Data included in the analysis represents the background-corrected means 
of two separate immunoprecipitation experiments for each Gambian 
serum. 
5.2.4 Statistical analysis 
The Mann-Whitney U-test was employed to test for significant 
differences in oocyst numbers between test and control mosquitoes. 
Spearman's Rank test was used to test for correlation between mean 
relative infectivity and antibody (Ab) levels against gamete surface 
proteins. Non-parametric analyses were used as the intensity of oocyst 
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infections was of a non-normal distribution. Statview software release 4.1 
(Abacus Concepts, Berkeley, CA, USA) was used in all analyses described 
above 
Statistical model 
The following data analysis was performed by David McGuinness. The 
number of oocysts per mosquito (y) was analysed as a log linear function 
of serum antibody level (x). Variation between mosquitoes was assumed 
to follow a Poisson model. To take into account dependence between 
observations taken from different mosquitoes feeding on the same 
serum, a random effects 'frailty' model was used. 
The following statistical model was used: 
log ( E(Yij) ) = log ( Ci) + bO + bl* Xi 
where Yij is the number of oocysts observed for the jth mosquito feeding 
on the ith serum (i=1,2,...,26 ; j = 1,2,....). E(Yij) is the expected (average) 
number of oocysts per mosquito. Ci is the geometric mean for control 
oocyst data corresponding to the ith serum. The variable Ci was included 
in the model to allow for the effect of experimental variation. Xi is the 
antibody level for serum i measured on a categorical scale. 
Antibody response variables were divided into two categories by splitting 
the data at the median value. The aim of the analysis was to estimate the 
regression coefficient bi and its standard error and to deduce whether Y 
and X are associated. Stata software, release 5.0 (Statacorp, Texas, USA) 
was used in these analyses. 
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5.3 	 Results 
5.3.1 Infectivity Assay 
The infectivity of gametocytes to mosquitoes in the presence of 
individual malaria-exposed sera and normal human complement was 
measured by counting oocysts on mosquito midguts. Relative infectivity 
(RI), calculated relative to the infection intensity in control mosquitoes, 
was found to vary from serum to serum (Table 5.1). The Mann-Whitney 
U-test was used to test for significant differences between oocyst 
intensities in mosquitoes given bloodmeals. containing immune or non-
immune (control) serum. An RI value =1 means there is no difference 
between test and control. Some sera had obvious transmission-reducing 
activity (e.g. sera 2, 6, 9, 12 and 24) whereas others apparently enhanced 
the infectivity of gametocytes compared to controls (sera 1, 5, 8, 13, 14, 15 




Characterisation of malaria-immune human sera from The Gambia for 
presence of (i) antibodies to major gamete surface proteins of P. falciparum, (ii) 
in vitro complement-dependent P. falciparum gamete lysis and (iii) effects on 
the infectivity of gametocytes of P. falciparum to Anopheles stephensi 
mosquitoes. 
Footnote 
Anti-Pfs230a and anti-Pfs48/45 results were estimated, following gamete surface 
radioiodination, immunoprecipitation and separation in SDS-PAGE, from visual assessment of 
autoradiographs of SDS-PAGE gels. 
Anti-Pfs230b was measured by phosphorimaging of exposed SDS-PAGE gels of TX-i 14 extracts of 
radiolabelled gamete surface proteins (mean of 2 experiments). 
Lysis-, sera were negative in the in vitro C'-mediated gamete lysis assay, lysis positive sera+, 
were positive in the in vitro C'-mediated gamete lysis assay. 
Reducing/enhancing: E=statistically significant increase in oocyst burdens compared with control 
mosquitoes, R= statistically significant decrease in oocyst burdens compared with control 
mosquitoes, = not significantly different from control mosquitoes, Mann-Whitney U test; 
significance level p<z0.05. 
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Table 5.1. 
(i) (i) (i) (ii) (iii) (iii) 
Serum anti- anti- anti- lysis relative infectivity reducing! 
Pfs230 a Pfs230 b Pfs48/45  enhancing 
based on based on 
oocyst no. proportions 
(RI) of infected 
mosquitoes 
1 0 2.61 2 - 3.81 0.30 E 
2 1 12.08 1 - 0.32 0.37 R 
3 1 0.82 3 + 2.02 1.34 * 
4 0 0 0 - 1.72 1.19 * 
5 3 20.78 3 + 1.39 0.88 E 
6 0 1.20 2 + 0.10 0.15 R 
7 1 0.04 0 - 1.99 1.42 * 
8 0 0.16 1 - 1.93 0.90 E 
9 2 1.08 1 + 0.33 0.88 R 
10 1 0.36 1 + 0.80 1.19 * 
11 3 0.26 1 + 0.70 1.03 * 
12 3 19.74 2 + 0.06 0.21 R 
13 0 0.01 1 + 11.70 0.33 E 
14 0 1.17 2 - 10.06 0.33 E 
15 0 0.17 1 - 2.03 1.04 E 
16 2 2.71 0 - 0.70 0.94 * 
17 0 1.10 0 - 0.34 0.49 * 
18 0 0.26 1 + 0.56 0.8 * 
19 3 26.36 2 - 1.75 1.27 * 
20 0 1.56 2 - 1.56 1.16 E 
21 0 0.16 1 - 2.19 1.36 * 
22 0 0.02 1 - 1.59 1.25 * 
23 0 0 0 + 0.92 1.15 * 
24 1 3.10 1 + 0.23 0.69 R 
25 1 9.08 1 + 0.92 0.83 * 
26 0 0.94 2 + 1.29 0.94 * 
total 12 24 21 13 
5.3.2 Measurement of antibodies to gamete surface proteins 
Antibody responses to an extract of gamete antigens were tested in a 
subclass-specific ELISA. Gamete-reactive IgG was found in high amounts 
in all sera, with absorbance values well above cut-offs for non-exposed 
European control sera (Fig. 5 1). 
25/26 (96%) individuals were positive for IgGi, 23/26 (88%) were positive 
for IgG2, 26/26 (100%) were positive for IgG3 and 21/26 (81%) were 
positive for IgG4. Mean values were as follows:- IgG, 2.0; IgGi, 0.44; IgG2, 
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Figure 5.1 
IgG response of 26 Gambian sera to TX-114 extracted P. falciparum 
gamete-surface antigens by ELISA. All sera were diluted 1/200. Data 
represents individual serum mean absorbance values (OD) (of duplicate 
wells). Cut-off values (indicated by horizontal bars), calculated as the 
mean +2 standard deviations of 12 non-immune European sera were; IgG 
0.852, IgGi 0.127, IgG2 0.167, IgG3 0.077, IgG4 0.084 
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5.3.3 Measurement of specific antibodies against gamete surface proteins 
Immunoprecipitation of 'I-labelled gamete surface proteins (Figure 5.2) 
allowed quantitation of specific antibodies to gamete surface proteins 
within individual sera. The first measurement was by visual analysis of 
autoradiographs and scoring of immunoprecipitated Pfs230 and Pfs48/45 
from TX-100 extracted gamete surface proteins, depending on band 
intensity (Table 5.1, anti-Pfs230a, anti-P fs48/45). A more precise 
quantitation of Pfs230 antibody was achieved by phosphorimaging of 
immunoprecipitated TX-114 extracted 1 I-labelled gamete surface proteins 
(Table 5.1, anti-Pfs230b). By the former method, 12/26 (46.2%) sera 
recognised Pfs230. In the latter, 24/26 (92.3%) recognised Pfs230; of these, 
11 sera showed a very weak antibody response (reading <1), and 13 had 
stronger antibody responses. The results of the two methods of detection 
are highly correlated, with most of the sera which were negative for 
Pfs230 antibodies by visual assessment giving low positive values for 
Pfs230 antibody by the more sensitive phosphorimaging experiment. 
Immunoprecipitation of TX-100-extracted 1 I-1abelled gamete surface 
proteins also allowed visual quantitation of Pfs48/45-specific antibodies 
in individual sera (Table 5.1 & Fig. 5.2). Of the 26 sera tested, 21 (80.8%) 
were positive for Pfs48/45 antibodies. Pfs 48/45 antibody was not 
quantifiable by phosphorimaging, as the aqueous phase of a gamete 
surface TX-114 extract was enriched for Pfs230, but not for Pfs48/45, and 
Pfs48/45 was not routinely detectable in these gels. 
Figure2. Immunoprecipitation of 1 I-labelled gamete surface 
proteins. 
The arrows indicate position of Pfs230 and Pfs48/45 as 
determined by immunoprecipita tion by specific MAbs. 









5.3.4 In vitro complement-mediated lysis of gametes 
In this assay 13/26 (50%) sera mediated complement-dependent gamete 
lysis as determined by microscopic examination of Giemsa-stained slides 
(Table 5.1). 
5.3.5 Associations between infectivity modulation and serum 
antibodies to gametes 
A negative relationship was observed between relative infectivity and 
levels of anti-gamete antibodies. The statistical significance of these 
associations was tested in two ways. Where quantitative data was 
available, e.g. Pfs230 data from phosphorimager, or ELISA OD values, 
data were categorised into low Ab levels (below median value) and high 
Ab levels (above median value) and compared with oocyst numbers per 
mosquito (corrected for daily variation) using a random effects regression 
model (Table 5.2). The random effects Poisson regression model accounts 
for individual mosquito data and is thought to be a more accurate means 
of describing the data as the distribution of oocysts is so skewed. The 
skewness is assumed to follow a Poisson distribution. 
Where semi-quantitative data was available e.g. scores from 
autoradiographs, the Spearman's Rank Test was used to compare the RI 
values with Ab level. The Mann-Whitney U-test was used to compare 
data from in vitro complement-mediated lysis with RI. This revealed a 
significant association between the ability of sera to mediate gamete lysis 
in vitro and reduction of oocyst numbers in vivo (Table 5.3). 
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Table 5.2 	Associations between infectivity values of P. falciparum 
gametocytes to An. stephensi mosquitoes in the presence of endemic 
human serum and antibodies against P. falciparum gamete surface 
antigens (1) 
Results of Poisson regression model showing geometric mean (GM) 
oocyst numbers for sera above and below median values for each 
antibody variable, with standard deviation (sd) in parentheses. Variables 1- 
4 measured by ELISA, variable 5 measured by phosphorimaging of immunoprecipitations 
on SDS-PAGE gels. 
n= number of mosquitoes dissected, b= slope of regression line, p= probability value. * 
denotes statistical significance (p<0.05). 
Antibody variables direction of change 
measured against TX- Oocyst no. in sera Oocyst no. in sera in infectivity with 
114 extracted gamete below median above median antibody b p 
surface antigens value value 
n GM (sd) n GM (sd) variables 
1 	anti-gamete IgG 426 2.84 (10.35) 398 2.22 (16.11) decrease -0.49 0.1 
2 anti-gamete IgGi 374 2.70 (10.93) 450 2.44 (15.23) decrease -0.67 0.012  
3 	anti-gamete IgG2 353 2.61 (9.42) 471 2.47 (15.74) decrease -0.32 0.3( 
4 anti-gamete IgG3 451 2.10 (9.25) 373 3.13 (16.89) increase 0.04 0.9( 
5 	anti-gamete IgG4 424 2.17 (13.54) 400 2.96 (13.32) increase 0.73 0.01 
6 anti-Pfs230 370 3.72 (16.47) 454 1.79 (9.83) decrease -0.66 0.04 
102 
Chapter 5 
Table 5.3 	Associations between infectivity values of P. falciparum 
gametocytes to An. stephensi mosquitoes in the presence of endemic 
human serum and antibodies against P. falciparum gamete surface 
antigens (2) 
Results of Spearman's Rank Test for correlation between anti-gamete 
antibody levels and mean relative infectivity values; and Mann-Whitney 
U-test for association between mean relative infectivity values and the 
ability of sera to mediate in vitro complement-dependent gamete lysis. 
Variables 1&2 were measured by visual analysis of immunoprecipitation 
autoradiographs and variable 3 was assessed from microscopic 
examination of gametes after in vitro complement-mediated gamete lysis 
assay 
r5 = coefficient of rank correlation, U=Mann-Whitney statistic, 




3 complement-mediated lysis 
statistic p 
rs 	0.44 0.03* 




Both analyses revealed a significant negative correlation between oocyst 
number and levels of antibodies to Pfs230 (Fig. 5.3a, Tables 5.2 & 5.3). 
The random effects model revealed a significant negative correlation 
between oocyst number and amount of anti-gamete IgGi. Anti-gamete 
IgG2 and IgG3 were not significantly associated with transmission 
reduction, and IgG4 levels were positively correlated with infectivity 
(Figs. 5.3b-f & Table 5.2). However, as can be seen from Fig 5.3f, relative 
infectivity was not significantly increased by high levels of anti-gamete 
IgG4. 
Finally, infectivity was calculated from the proportion of infected 
mosquitoes in test and control groups (prevalence in test group divided 
by prevalence in control group) (Table 5.1). Values were averaged over 
consecutive experiments, as before. These infectivity measurements were 
tested for correlation with antibody levels using the Spearman's rank test. 
A significant negative correlation was found between numbers of 
infected mosquitoes and anti-Pfs230 antibodies (Table 5.4). Levels of anti-
gamete IgG were also negatively correlated with the proportion of 
infected mosquitoes. No associations were found with anti-Pfs48/45 
antibodies, or with any of the IgG subclasses, and reduction of numbers of 
infected mosquitoes. The infectivity values measured by oocyst number 





Scatter plots of relative infectivity (log to basee)  of P. falciparum gametocytes 
to An. stephensi mosquitoes in the presence of endemic human sera vs. 
antibody levels measured by ELISA (OD) or following immunoprecipitation 
of radioiodinated gamete surface proteins (phoshporimager units). 
a) anti-Pfs230b (log to bases), b) anti-gamete IgG, c) anti-gamete IgGi, d) anti-
gamete IgG2 e) anti-gamete IgG3 and (f) anti-gamete IgG4 (g) anti-Pfs230a and 
(h) anti-Pfs48 /45. 
Vertical blue line represents median values. Horizontal green line represents 
control infectivity and horizontal red line represents infectivity = 0.1% 
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Table 5.4 Results of Spearman's Rank Test of correlation between 
proportion of infected An. stephensi mosquitoes fed P. falciparum 
gametocytes in the presence of endemic human sera and Ab levels against 
gamete surface proteins in the sera. 
antibody variables rs p 
anti-Pfs230a -0.23 0.26 
anti-Pfs230b -0.53 0.01* 
anti-Pfs48/45 -0.02 0.94 
anti-gamete IgG -0.38 0.05* 
anti-gamete IgGl -0.28 0.16 
anti-gamete IgG2 -0.16 0.43 
anti-gamete IgG3 -0.24 0.23 
anti-gamete IgG4 0.01 0.96 
r5 = coefficient of rank correlation, p=probability 
Variables 1 &3 measured by visual analysis of autoradiographs from immunoprecipitation 
and SDS-PAGE of radioiodinated gamete surface antigens of P. falciparum. Variable 2 
measured by phosphorimager analysis of autoradiographs from irnmunoprecipitation with 
endemic human sera and SDS-PAGE of radioiodinated gamete surface antigens of P. 












In a separate analysis, sera were classified as either significant transmission 
reducers or enhancers based on their infectivity values (Table 5.1). The 
Mann-Whitney U test was employed to test for differences in serum antibody 
levels between transmission reducing and transmission enhancing sera. As 
shown in Table 5.5, anti-gamete IgG levels were significantly higher among 
transmission-reducing than transmission enhancing sera. 
No significant differences were found for any of the IgG subclasses and 
transmission reduction or enhancement. 
It was found that lower amounts of antibodies against Pfs 230 (Table 5.5) were 
present in those sera which enhanced transmission, compared with those 
which reduced transmission, although this was not statistically significant. 
Levels of Pfs48/45-specific antibodies were higher among transmission-
enhancing sera, than transmission-reducing sera, but again, the difference 
was not statistically significant. 
In this analysis, sera were separated into 3 categories, those which reduced 
transmission, those which had no significant effect on transmission, and 
those which enhanced transmission. From a biological perspective, it is 
likely that sera at first have no effect on transmission, then enter a phase of 
enhancing transmission, and may then progress to transmission reduction as 
the level of anti-gamete antibodies increase in the sera. 
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Table 5.5 	Association between antibodies in endemic human sera to 
gamete antigens of P. falciparum and reduction or enhancement of 
infectivity of gametocytes of P. falciparum to An. stephensi mosquitoes. 
Enhancing sera Reducing sera p 
Relative Infectivity 4.64 0.21 0.004* 
Antibody measurement Mean Ab level of 7 Mean Ab level of 
infectivity enhancing 5 infectivity 
sera reducing sera 
anti-Pfs230a 0.43 1.40 0.22 
anti-Pfs230b 3.78 7.44 0.22 
anti-Pfs48/45 1.71 1.40 0.18 
anti-gamete IgG 1.92 2.25 0.04* 
anti-gamete IgGl 0.27 0.42 0.37 
anti-gamete IgG2 0.13 .0.20 0.46 
anti-gamete IgG3 0.60 0.73 0.46 
anti-gamete IgG4 0.25 0.18 0.81 
Sera were grouped by their effect on parasite infectivity (5 caused significant reduction and 7 
caused significant enhancement of infectivity, p<O.OS in Mann-Whitney U-test). Values 
represent group means. 
230a: antibodies to Pfs230, as assessed by immunoprecipitation of radioiodinated gamete 
antigens of P. falciparum and visual inspection of autoradiographs. 
230b antibodies to Pfs230, as assessed by immunoprecipitation of radioiodinated gamete 
antigens of P. falciparum and phosphorimaging. 
48/45: antibodies to Pfs48/45 as assessed by immunoprecipitation of radioiodinated gamete 
antigens of P. falciparum and visual inspection of autoradiographs. 
Anti-gamete IgG and IgG subclasses measured by ELISA. 






The experiments included in this chapter were designed to address the 
question of whether naturally acquired antibodies to specific gamete antigens 
in mosquito bloodmeals significantly altered the infectivity of P. falciparum 
gametocytes to mosquitoes. It was found that individual sera had different 
effects on transmission, ranging from complete blocking to several-fold 
enhancement of infectivity. 
Although only 8% of sera blocked transmission (defined as an infectivity 
measurement of less than 10% of controls: (Lensen et al. 1996)); a further 12% 
mediated a significant reduction of oocyst burdens. Moreover, 27% sera 
mediated significantly higher oocyst numbers than controls. Higher levels of 
gamete-surface reactive IgGi, as well as increasing levels of anti-Pfs230 
antibodies were likely to cause reduced transmission through mosquitoes. 
These results confirm those of a previous study in Papua New Guinea which 
found a significant correlation between the level of antibodies to the gamete 
surface protein, Pfs230 and transmission blocking (Graves et al. 1988b). In 
both studies, it was found that sera with the highest levels of antibodies 
against Pfs230 showed the greatest degree of transmission-blocking activity 
within mosquitoes. 
No association was found between reduction of infectivity and the presence 
of antibodies to the other gamete surface antigen, Pfs48/45. This lack of 
association contrasts with a previous study in Cameroon where antibodies to 
Pfs48145 in sera from malaria-exposed individuals were found to be 
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associated with transmission reduction (Roeffen et al. 1995c). This apparent 
discrepancy may be because the Cameroonian study used serum from 
gametocyte carriers only, in whom antibody titres may be higher against 
crucial epitopes involved in transmission-blocking. This is in contrast to the 
present study, where none of the serum donors were carrying P. falciparum 
gametocytes at the time of collection. It has been suggested, following studies 
of other malaria species, that frequent boosting by exposure to gametocytes is 
required to maintain transmission-blocking immunity (Naotunne et al. 1990; 
Ranakawa et al. 1988). In favour of this hypothesis is the finding of a much 
higher overall level of transmission-blocking activity in the Cameroonian 
study compared with our study. Another explanation may be that the 
proportion of malaria-immune sera in the bloodmeal in the present study 
was less than that used in the previous study. Thus, it is possible that serum 
antibodies to Pfs48/45 mediate transmission reduction only at a high 
concentration. In contrast, antibodies to Pfs230 appear to mediate 
transmission reduction at lower serum concentration and in individuals 
with no history of recent gametocytaemia. 
The finding that a serum's ability to mediate in vitro gamete lysis is 
associated with a reduction in oocyst numbers is consistent with studies with 
Pfs230-specific MAbs (Quakyi et al. 1987; Read et al. 1994) and with the results 
presented in chapter 4, which demonstrated an association between the 
presence of antibodies to Pfs230 and in vitro complement-mediated lysis of 
gametes (Healer et al. 1997). This strongly suggests that complement- 
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mediated lysis is a significant mechanism of natural transmission-blocking 
immunity. The correlation between increasing levels of gamete-surface 
specific IgGi and infectivity reduction is consistent with the complement-
fixing ability of this IgG subclass. 
Despite the relatively small scale of this study (26 test sera of which 5 showed 
significant transmission reduction), statistically significant associations with 
antibody parameters were detectable. This is due, at least in part, to the design 
of the analysis itself. Previous studies have analysed 'collapsed' data (data 
representing infectivity values averaged across mosquitoes), thus ignoring 
much potentially relevant biological variation i.e. variation between 
mosquitoes fed on the same serum sample. The statistical model employed 
here represents a considerable advance on such an approach. By making use 
of all oocyst data, fitted to an appropriate error structure, it accounts for the 
variance inherent between individual mosquitoes. The more of the available 
information used, the more powerful the analysis is likely to be, hence 
reducing the chances of making both 'Type 1' and 'Type 2' errors in the 
interpretation of data (Sokal & Rohlf 1997). 
Quantitation of Pfs230- and Pfs48/45-specific antibodies in sera was achieved 
by immunoprecipitation. Previous studies have shown this to be a sensitive 
and reliable method, as compared to ELISA. Bacterium-produced 
recombinant proteins representing regions of Pfs230 were not recognised in 
ELISA by sera which had been shown to possess anti-230 antibodies by 
immunoprecipitation (Riley et al. 1995), and our unpublished data- see 
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chapter 3) or by Pfs230-specific MAbs (E. Riley, personal communication). 
This lack of concordance between the two procedures is undoubtedly due to 
the highly conformational state of native Pfs230 (Carter et al. 1994). Although 
transmission-blocking polyclonal sera have been raised in mice against a 
Pfs230 recombinant protein (Williamson et al. 1995), all Pfs230 MAbs which 
block transmission are against conformational epitopes and do not recognise 
Pfs230 in reduced form (Read et al. 1994). 
The high number of anti-Pfs-230 responsive individuals, appears to be 
somewhat at odds with previous findings in this region (Healer et al. 1997; 
Riley et al. 1994). This can be explained by the very high sensitivity of 
phosphorimager detection of radiolabelled antigen. Individuals with a very 
low antibody response as measured by phosphorimagery would have been 
previously classified as antibody negative. When results of visual analysis of 
autoradiographs were directly compared with phosphorimager data, we 
found that the majority of sera classified as anti-Pfs230 negative by the first 
method, had low but detectable levels of anti-Pfs230 antibodies by 
phosphorimaging. 
It was found that the prevalence of infected mosquitoes, as well as the 
intensity of oocyst infection, was significantly reduced in the presence of 
antibodies to Pfs230, but antibodies against Pfs48/45 showed no significant 
effect. This observation was made despite the very high numbers of oocysts 
commonly found in our experimentally infected mosquitoes; up to 120 
oocysts per gut were counted. However, it has been observed that the 
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proportions of mosquitoes infected in the presence of certain sera, remain 
constant regardless of oocyst density (K. Mendis personal communication). 
These numbers are presumably the result of the extremely high gametocyte 
densities found in culture, particularly with the clone used here (3D7) 
(Ponnudurai 1982), and do not reflect conditions in nature, where, on 
average, 1 or 2 oocysts per gut are found (Boudin et al. 1993; Muirhead-
Thompson 1957). In general, gametocyte density is positively correlated with 
infectiousness in both the proportion of mosquitoes infected and mean 
oocyst burden (reviewed by (Taylor & Read 1997). 
Relative infectivity as a function of prevalence of infected mosquitoes, is a 
more appropriate measure of transmission blocking than RI as a function of 
oocyst density, as the presence of one oocyst is enough to ensure 
transmission. 
The finding that some sera appear to enhance transmission of P. falciparum 
and that this is a reproducible finding for individual sera, is of obvious 
concern for the development of transmission-blocking vaccines. Although 
many researchers in the field have commented on finding an apparent 
increase in P. falciparum oocyst burdens with some sera (Graves et al. 1988c; 
Premawansa et al. 1994), the reasons behind this phenomenon have not been 
formally addressed. Enhancement of infectivity in P. vivax infections has 
been shown to be associated with low antibody titres (Gamage-Mendis et al. 
1992; Mendis et al. 1987; Peiris et al. 1988); sera and MAbs which blocked 
transmission at high concentration, caused enhancement at low 
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concentration. In the results presented here, infectivity enhancing sera had 
significantly lower levels of gamete-reactive IgG. Levels of antibodies to 
Pfs230 were also lower in transmission-enhancing sera than in neutral or 
reducing sera; the lack of statistical significance may have been due to the 
small size of the study. 
In conclusion, these results confirm that Pfs230 is a target of naturally 
acquired transmission-blocking antibodies, induced following exposure to P. 
falciparum gametocytes in vivo, but also raises the possibility that low levels 




Testing the role of phagocytosis of P. falciparum gametes 




One potential mechanism of transmission-blocking immunity that has 
received relatively little attention is the role of phagocytosis of gametes 
within the mosquito midgut by leukocytes present in the bloodmeal. In 
vitro, intraerythrocytic schizonts and free merozoites of Plasmodium 
falciparum are phagocytosed by polymorphonuclear neutrophils (PMN) 
(Trubowitz & Marek 1968) and monocyte-macrophages (MM) (Ferrante et 
al. 1990). Schizont-infected erythrocytes are more efficiently phagocytosed 
than those infected with immature ring stages (Turrini et at. 1992) 
presumably due to differential expression of parasite-derived antigens on 
the red cell surface. In contrast, little phagocytosis of gametocyte-infected 
erythrocytes occurs (Sinden & Smalley 1976). 
Recent attempts to correlate gamete phagocytosis with transmission-
blocking activity (Lensen et al. 1998; Lensen et at. 1997) have been 
somewhat inconclusive. In vitro studies suggest that (i) anti-gamete 
antibodies enhance activation of neutrophils by gametes and (ii) that 
leukocytes contribute to the transmission reduction potential of some 
immune sera, but that these two effects are not correlated in individual 
sera (Lensen et at. 1997). Membrane-feeding studies suggest that 
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infectivity of gametocytes from semi-immune carriers to mosquitoes was 
independent of the presence of leukocytes (Lensen et al. 1998). 
The experimental aims of this chapter were to attempt to quantify the 
extent of gametocyte and gamete phagocytosis in comparison to 
phagocytosis of asexual parasites, and to relate this to the presence of anti-
gamete antibodies. The phagocytic potential of PMN and MM was also 
compared and the role of these two cell types in suppressing gamete 
infectivity to mosquitoes was investigated in membrane-feeding 
experiments. 
The phagocytosis assays included in this chapter were conducted by a 
student, Antje Graszynski, under my supervision. 
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6.2 	 Materials and Methods 








1251..labelling and preparation of gametocyte proteins 	2.5 
1251-labelling and preparation of gamete surface proteins 	2.6 
Immunoprecipitation and SDS-PAGE analysis 	 2.7 
ELISA to determine IgG subclass of antibodies 	 2.10.1 
6.2.1 Subjects 
Sera from 22 malaria-immune adults from Brefet, The Gambia were 
used. Aliquots of these sera were pooled and a fraction was IgG depleted 
by affinity chromatography using Protein G Sepharose fast flow (Sigma). 
Control sera were obtained from twelve non-exposed European donors. 
Methods 6.2.2-6.2.5 were performed by Antje Graszynski. 
6.2.2 Preparation of monocytes and neutrophils 
Peripheral blood mononuclear cells (PBMC) were isolated from freshly 
obtained heparinized venous blood from healthy European donors and 
isolated by single step Ficoll Hypaque (Nycomed) density gradient 
centrifugation ( 1.077±0.001 g/ml density, 280±15 mOsm.). Cells were 
washed 3 times in RPMJ, counted using a haemocytometer and 
monocytes left to adhere at 37°C to glass coverslips in 24-well plates. After 
90 min non-adherent cells were washed away with 2 washes of RPMI and 
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the plates stored at 6°C until further use on the same day. About 30% of 
the cells added to the wells could be recovered through adherence to the 
coverslips; these were > 90% pure for monocytes and contained less than 
10% lymphocytes, erythrocytes and platelets as determined by microscopy 
after Giemsa staining. 
Serum was added in a 1:1 ratio (vol:vol) to the cell pellet obtained from 
the density centrifugation above and polymorphonuclear cells enriched 
by Ficoll Hypaque centrifugation (Nycomed, 1.113±0.001 g/ml density, 
460±5 mOsm.). Harvested cells were washed 3 times and counted as 
described above. Purity of neutrophils was > 98% with less than 1% 
mononuclear cells. 
Monocytes and neutrophils were derived from the same A+ve donor in 
all in vitro experiments. For in vivo experiments in mosquitoes O+ve 
European blood was used. Viability of the different cell populations was 
routinely determined by staining with trypan blue after blood cell 
separation and after incubation in in vitro experiments. Cells were 92-
97% viable. 
6.2.3 In Vitro Phagocytosis Assays 
Optimal incubation time, serum concentration, cell numbers and parasite 
numbers were determined in preliminary experiments. 4 x iO purified 
schizonts, gametocytes, gametes or uninfected erythrocytes were added to 
either the prepared iO monocytes on coverslips or to iO neutrophils in 
flat-bottomed 96 well plates and incubated for 2 h at 37°C in a total 
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volume of 250 pJ ( monocytes) or 50 gl (neutrophils), in the presence of 
16% immune or non-immune serum. This assay was also carried out 
using IgG-depleted, pooled immune serum and RPM! as controls. 
Experiments were carried out in triplicate. 
200 leukocytes were counted per sample and phagocytosis expressed as the 
% of leukocytes containing phagocytosed target cells. Only phagocytes 
with recognisable parasites were considered positive to avoid counts of 
uptake of cell debris, pigment or of parasites with damaged cell 
membranes. The 2 hour incubation time was chosen as this gave 
maximal detection of phagocytosed whole parasites. 
6.2.4 Phagocytosis under mosquito midgut conditions 
4 x 105  mature gametocytes were added to a mixture of 1x10 5 neutrophils 
and 1x105 adherent monocytes. These were incubated in 24-well plates at 
either 37°C or 18°C for 2 hours in the presence of 16% pooled immune or 
non-immune serum. 
Following incubation, coverslips (with adherent monocytes) were 
removed for staining and supernatants were taken for cytospin onto 
slides for neutrophil counts. Experiments were carried out in duplicate. 
6.2.5 Parasite phagocytosis within the mosquito 
Suspensions of gametocyte-infected erythrocytes were fed to mosquitoes 
via water-jacketed membrane feeders as described previously (Read et al. 
1994). Bloodmeals consisted of 16% packed gametocyte-infected 
erythrocytes, 20% packed 0+ uninfected blood, 16% heat-inactivated 
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pooled human serum (immune or non-immune) and 48% 0+ heat-
inactivated non-immune European serum. The final haematocrit of the 
feed was approximately 35%, and gametocytaemia ranged from 1.5-2.0%. 
At the time of infection, and at 0.5, 1, 2, 3, 4 and 5 hours post-infection, 
mosquitoes were killed and their midguts smeared onto slides for Giemsa 
staining and microscopic examination. 200 phagocytes per gut, in each 
group of twelve midguts were counted. 
6.2.6 Infectivity assays in the presence of immune serum, leukocytes 
and complement 
As a source of complement, serum was obtained from a healthy 0+ve 
European donor and tested for complement (C) activity before use (See 
section 5.2.1). Freshly drawn 0+ blood was also used as a source of 
leukocytes. A fraction of this blood was depleted of PMBC and 
neutrophils by centrifugation (as described above for the isolation of 
phagocytic cell populations (6.2.2)). 
Mosquitoes were allowed to feed on bloodmeals with or without C' 
and/or leukocytes, containing either pooled or individual sera (in the 
same proportions described above (6.2.5)), and non-engorged mosquitoes 
removed. The midguts of remaining mosquitoes were dissected and 
oocysts counted, 9-10 days later. Twenty midguts were counted per serum 
tested 
The intensity of mosquito infections was determined for each serum by 
calculation of the geometric mean (GM) number of oocysts per gut. 
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Infectivity in the presence of each serum relative to its pair-matched 
control, was calculated using the following formula: 
Relative infectivity= GM immune serum I GM control serum. 
6.2.6 Statistical Analyses 
The t-test was used to compare logarithmically transformedin vitro 
phagocytosis levels of different parasite stages, mediated by individual 
sera, by different cell populations and to compare in vitro phagocytosis of 
gametes at different temperatures. Spearman's Rank test of correlation 
was used in the where antibody levels were variables, due to the 





6.3.1 Phagocytosis of asexual and sexual stage parasites 
The efficiency of phagocytosis of asexual parasites (schizont-infected 
erythrocytes) and sexual parasites (intraerythrocytic gametocytes and 
extracellular gametes) by either neutrophils (PMN) or monocytes (MM) 
in the presence or absence of pooled human malaria-immune sera was 
compared (Figures 6.1 & 6.2). 
Background levels of phagocytosis of uninfected erythrocytes (urbc) by 
MM were minimal and were not affected by the presence of immune 
serum (IS). Phagocytosis of urbc by PMN was marginally higher than by 
MM, but again there was no difference between IS and NS (non-immune 
serum). Phagocytosis of intracellular gametocytes was also low and only 
slightly enhanced by immune serum; phagocytosis rates were not 
different between PMN and MM and no difference was observed between 
phagocytosis rates of uninfected rbc and gametocytes. In contrast, 
phagocytosis of schizont-infected erythrocytes and extracellular gametes 
was enhanced by immune serum. Phagocytosis of schizonts by PMN was 
higher than by MM, especially in the presence of IS. Levels of PMN 
phagocytosis of schizonts and gametes were similar, but in the presence of 
IS, MM phagocytosed more gametes than schizonts (Fig. 6.2). 
Interestingly, intraerythrocytic schizonts were much more vulnerable to 
phagocytosis than were intraerythrocytic gametocytes. 
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Figure 6.1 	In vitro phagocytosis of P. falciparum schizonts, 
gametocytes and gametes by monocytes (MM) or neutrophils (PMN) in 

















gametes gametocytes schizonts 	uRBC 
Phagocytosis is expressed as the percentage of monocytes or neutrophils containing 
identifiable whole P. falciparum parasites. Data represents arithmetic mean of triplicate 
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Figure 6.2 
Difference in percentage phagocytosis of P. falciparum by monocytes 
(MM) or neutrophils (PMN). 
-5 
gametes 	gametocytes schizonts 	uRBC 
parasites 
Values shown represent mean values for immune serum minus mean values for non-immune 
serum. Error bars show 95% confidence intervals for the size of the difference. 
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6.3.2 Effect of individual immune human sera on parasite 
phagocytosis 
As shown above, serum pooled from a number of different immune 
donors enhanced phagocytosis of both schizonts and gametes. To 
determine whether all immune sera mediated phagocytosis, individual 
sera were tested in in vitro phagocytosis assays (Fig. 6.3). There was 
considerable variation from serum to serum in their ability to mediate 
phagocytosis but, in all cases, absolute levels of phagocytosis were rather 
low (see Table 6.1 for values). 
Phagocytosis rates were normally distributed for individual sera, 
therefore parametric analyses were used. The paired t-test was used to 
compare phagocytosis rates between PMN and MM for different parasite 
stages. Phagocytosis of gametocytes and schizonts were consistently 
higher in PMN than in MM (t=-3.83, df=21, p=0.001 for gametocytes; t=-
6.23, df=21, p='z0.0001 for schizonts), but there was no significant 
difference between the two cell types for gamete phagocytosis (paired t-
test: t=0.28, df=21, p=0.78). However, phagocytosis rates for gametes by 
MM were significantly correlated with phagocytosis rates for gametes by 
PMN for individual sera (r 2=0.23, df=21, p=0.02). 
As with pooled immune serum, mean phagocytosis values for gametes 
and schizonts were higher than for gametocytes (which were not 




Phagocytosis of different P. falciparum blood stages by monocytes (MM) 
and neutrophils (PMN) in the presence of individual malaria-immune 
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Data represent arithmetic mean of triplicates minus mean phagocytosis values for 
phagocytosis in the presence of non-exposed European sera (simoultaneous controls). 
Horizontal bar indicates mean values. 
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In MM, phagocytosis rates were significantly higher for gametes 
compared to schizonts (paired t-test: t=2.67, df=21, p=0.02). In PMN no 
differences were found in the rates of phagocytosis of gametes and 
schizonts (t=-0.73, df=21, p=0.48). 
When phagocytosis values for gametes and schizonts were examined for 
correlation within individual sera, a marginally significant correlation 
for PMN (corr=-0.37, n=22, p=0.09) was found. No significant correlation 
was found for MM (corr=-0.25, n=22, p=0.32). 
6.3.3 Association between phagocytosis-enhancing ability of serum 
and the presence of anti-gamete antibodies. 
Gamete-specific antibodies were measured by immunoprecipitation and 
ELISA and compared with in vitro phagocytosis (Table 6.1). All 
correlation analyses were performed using Spearman's Rank Test. 
A positive correlation was found between gamete phagocytosis by 
neutrophils and the level of IgG antibodies to gamete surface proteins 
(r=0.48, n=21, p=0.03). This correlation was found for antibodies against 
Pfs230 (rs  =0.49, n=22, p=0.02), and Pfs48/45 (r s =0.52, n=22, p=0.02),  but not 
for antibodies to the Pfs230 precursor protein, Pfs260 (r  =0.32, n=22, 
p=0.13). When IgG subclass responses to gamete proteins were compared 
with phagocytosis, it was found that the level of IgGi against a gamete 
surface protein extract correlated with phagocytosis by PMN (r=0.47, n=21, 
p=0.03), but not with phagocytosis by MM (r=0.24, n=21, p=0.28). Levels of 
the other IgG subclasses, IgG2, 3 & 4, did not correlate significantly with 
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Data for individual malaria immune sera from The Gambia, showing % 
phagocytosis of P. falciparum gametes (columns 2&3), 
immunoprecipitation scores against gametocyte/gamete surface proteins 
Pfs260, Pfs230 and Pfs48/45 (columns 4-6: see Table 5.1), absorbance values 
for total IgG and IgG subclasses against gamete surface proteins and 
(columns 7-11) and infectivity values for oocyst burdens in mosquitoes 
fed with serum + leukocytes (colunm 12). 
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1 2.5 2.22 0 0 2 1.039 0.128 0.106 0.583 0.178 0.57 
4 -0.75 3.09 0 0 1 0.684 0.169 -0.016 0.263 0.061 0.83 
12 6.71 3.66 2 0 2 1.556 0.454 0.131 1.158 0.390 0.44 
13 6.92 2.5 0 0 1 0.974 0.067 0.062 0.658 0.376 0.31 
15 3 8.75 1 3 3 1.485 0.818 0.253 1.400 0.952 0.31 
28 5.92 5.09 1 0 1 1.396 0.279 0.338 0.944 0.139 0.13 
31 0.42 1.09 2 1 0 1.432 0.187 0.611 0.964 0.390 0.14 
35 3.67 1.95 2 2 3 1.102 0.203 0.084 0.777 0.240 0.21 
45 0.42 1.5 2 1 1 nd rd rd nil nd rid 
50 6.46 3.58 2 2 2 1.235 0.214 0.114 0.343 0.001 1.62 
53 4.34 9.33 2 2 2 1.563 0.177 0.033 1.010 0.419 0.81 
69 1.09 1.56 0 0 1 0.207 0.057 0.051 0.019 -0.015 0.04 
79 7.5 6.08 2 3 3 1.525 0.691 0.467 0.298 0.032 rid 
104 5.84 2.59 2 3 0 1.495 0.520 0.260 1.030 0.815 1.38 
112 1.83 -0.58 0 0 0 0.344 0.015 -0.062 0.067 -0.022 rid 
114 6.09 4.17 2 1 1 1.459 0.447 0.109 0.197 -0.010 rid 
116 6.71 5.25 2 2 1 0.780 0.076 0.077 0.578 0.015 2.5 
117 3.5 8.08 2 3 2 1.498 0.317 0.169 0.924 0.693 2.5 
120 6.13 5.58 1 1 1 1.599 0.675 0.270 0.609 0.026 0.5 
125 1.34 0.61 1 1 0 1.668 0.551 0.219 1.151 0.941 0.9 
127 7.5 5.16 1 0 2 0.784 0.042 0.028 0.510 -0.016 2 
167 -1.34 0.55 1 0 2 0.556 -0.005 -0.031 0.111 -0.011 1.9 
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6.3.4 Parasite phagocytosis within the mosquito 
Phagocytes from vertebrates function optimally at body temperature (37 °C 
in humans), but the temperature within the mosquito gut will reflect the 
ambient temperature of the environment. However, reducing the 
temperature of the blood meal from 37 °C to 26°C or below also serves to 
induce gametogenesis and allows formation of extracellular gametes 
which are susceptible to phagocytosis. To determine whether 
phagocytosis is affected by environmental temperature, phagocytosis rates 
of intracellular gametocytes were compared in in vitro assays conducted 
at 18°C and 37°C. As expected, gametogenesis was enhanced at 18 °C 
compared to 37°C (data not shown) and this was accompanied by 




Phagocytosis of P. falciparum gametes by monocytes (MM) and 
neutrophils (PMN) in vitro in the presence of pooled malaria-immune 














IS 18 	NS 18 	Is 37 	NS 37 
Serum and temperature 
133 
Chapter 6 
However, there are numerous other environmental differences between 
the in vitro system and the conditions inside the mosquito midgut, e.g. 
pH, cation concentrations, presence of digestive enzymes etc. In vivo 
phagocytosis assays were therefore conducted. Mosquitoes were allowed 
to feed on infectious bloodmeals containing MM and PMN and then 
maintained at an ambient temperature of 26 °C. After time intervals 
varying from 0 to 5h, the mosquitoes were killed, dissected and the 
contents of their midguts smeared onto slides and examined. 
Phagocytosis rates in vivo were much lower than those seen in vitro; 
after a 2 hour incubation period, the phagocytosis rate was 4% for PMN in 
vivo, compared with 9.3% in vitro, and for MM, 2.7% in vivo and 7.5% 
in vitro 
Phagocytosis rates were higher in the presence of immune serum than 
with nonimmune serum (t=8.096 n=22, p=0.0149). Phagocytosis rates by 
MM and PMN were similar whether cells were present together in the 
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Time course of in vivo phagocytosis of P. falciparum gametes by 
monocytes (MM) and neutrophils (PMN) in An. stephensi midguts at 
26°C 
a 	monocytes and neutrophils when present in combination in 
mosquito bloodmeals. 
monocytes or neutrophils as discrete populations in mosquito 
bloodmeals. 
1 	2 	3 	4 	5 	6 











6.3.5 Effects of Leukocytes on Transmission 
To determine whether the presence of phagocytic cells in the blood meal 
affected the infectivity of gametocytes to mosquitoes, gametocytaemic 
blood was fed to mosquitoes in the presence or absence of pooled 
immune serum, complement, MM or PMN. Non-engorged mosquitoes 
were removed and the remainder dissected after 10 days and the number 
of oocysts were counted (Figure 6.6). When no leukocytes were present, 
the presence of complement tended to suppress infectivity (r=-0.5, 
p=0.48), and where no complement was present in the bloodmeal, the 
presence of leukocytes tended to suppress infectivity (r=-0.5, p=0.48), but 
no significant differences were detected in the numbers of oocysts 
developing in the different groups of mosquitoes (Kruskall Wallis test: 
d.f.=7, H=5, p=0.66). Neither was there any additive suppressive effect of 
complement + leukocytes. 
Finally, gametocytes were fed to mosquitoes in the presence of individual 
malaria-immune sera, leukocytes and complement. Relative infectivity 
values are shown in Table 6.1. These ranged from 0.04 (transmission 
blocking) to 2.5 (transmission enhancement), but there was no correlation 
found between levels of phagocytosis and infectivity for individual sera 




Relative infectivity of P. falciparum gametocytes to An. stephensi 
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Data represent three independent experiments and the mean infectivity for each 
treatment group is given. Infectivity values were derived from calculations of geometric 
mean (GM) numbers of oocysts in mosquitoes given pooled malaria-immune sera, divided 
by GM for mosquitoes given non-exposed European serum. 
WBC = white blood cells; C = complement. 
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6.4 	 Discussion 
Monocyte- and neutrophil-mediated killing of schizont-infected 
erythrocytes and merozoites has been proposed as a potentially important 
mechanism of protective immunity to malaria(Celada et al. 1983; 
Kharazami & Jepsen 1984; Khushmith & Druilhe 1983; Wozencraft et al. 
1984) but the extent to which this is dependent upon phagocytosis per Se, 
as opposed to activation of other anti-parasitic mechanisms is not clear 
(Bouharoun-Tayoun et al. 1995; Druilhe & Perignon 1997; Kumaratilake 
et al. 1990). In contrast to the large body of work on cellular killing of 
asexual parasites, relatively little is known about cellular control of sexual 
stage parasites. 
Cell-mediated inactivation of intracellular P. falciparum and P. vinckei 
petteri gametocytes, associated with markedly reduced infectivity to 
mosquitoes, has been attributed to cytokine-mediated activation of 
peripheral blood leukocytes and release of nitric oxide (Motard et al. 1993; 
Naotunne et al. 1993); this effect is not dependent on the presence of 
immune serum or anti-gamete antibodies. In contrast, Lensen et a! 
(Lensen et al. 1998; Lensen et al. 1997) have found that the ability of 
leukocytes to reduce the infectivity of P. falciparum gametocytes is 
dependent upon the presence of immune serum and that individual sera 
vary both in their requirement for leukocytes in order to reduce 
transmission and in their ability to mediate leukocyte-dependent 
transmission reduction. Although these authors suggest that the 
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mechanism of cell-mediated transmission-blocking is phagocytosis of 
opsonised gametes (Lensen et al. 1997), this was not directly assessed. 
In this chapter, it is shown that both MM and PMN can phagocytose 
schizont-infected erythrocytes and extracellular gametes, and that 
phagocytosis is significantly enhanced in the presence of immune serum. 
Interestingly, mature intracellular gametocytes were only poorly 
phagocytosed suggesting that few parasite-specific antigens are expressed 
on the erythrocyte surface. Erythrocytes infected with immature 
gametocytes express parasite-derived cytoadherence ligands, allowing the 
developing gametocytes to shelter in the deep vasculature (Rogers et al. 
1996). In a recent study, Day et a! (Day et al. 1998) found that the 
gametocyte cytoadherence phenotype changes as the gametocyte matures. 
Whereas early gametocytes and asexual stages bind to CD36, later stage 
gametocytes did not, suggesting loss of the original cytoadherence ligand 
from the surface of stage II gametocyte-infected erythrocytes. However, as 
stage IT-N gametocytes continue to sequester in vivo, they presumably 
express other ligands on the surface of the infected erythrocyte 
membrane. The data presented in this chapter would suggest that these 
ligands are not widely recognised by immune sera. 
PMN were more efficient at phagocytosing schizonts and gametocytes 
than MM but, overall, levels of phagocytosis were quite low with less 
than 20% of phagocytic cells containing ingested parasites after the 
optimal time of incubation. This may reflect the true ability of these cells 
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to phagocytose malaria parasites or may suggest that phagocytes need to 
be activated by extrinsic factors in order to become fully effective. All in 
vitro assays were conducted using leukocytes from non-immune donors 
and all lymphocytes had been removed from the system. As immune 
lymphocytes are the major source of the inflammatory cytokines which 
are required to activate both Mlvi and PMN (Kumaratilake et al. 1991; 
Shalaby et al. 1985), it is possible that the phagocytic ability of these cells 
may be greatly enhanced in the blood of immune individuals. However, 
Lensen et al found that purified neutrophils were efficiently activated (as 
assessed by a chemiluminescence assay) in the presence of P. falciparum 
gametes and immune serum (Lensen et al. 1997) suggesting that extrinsic 
factors such as cytokines may not be required. 
The marked variation between immune sera in their ability to promote 
phagocytosis of gametes is consistent with the data of Lensen et a! (Lensen 
et al. 1997) who found similar variation in the ability of immune sera to 
activate neutrophils. 
Importantly, the results presented show that phagocytosis of extracellular 
gametes by PMN correlates with the presence of antibodies to the gamete 
surface proteins Pfs230 and Pfs48/45. The IgGi subclass of antibody was 
positively correlated with phagocytosis, which is consistent with the 
cytophilic nature of this IgG subclass. Although very high levels of 
gamete-specific IgG3 were also present in the sera, these antibodies do not 
appear to mediate phagocytosis. IgGl is known to be a more efficient 
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opsonin than IgG3, and has higher affinity for Fc'yRI than IgG3 (Janeway 
& Travers 1997). 
In these experiments, phagocytosis of live parasites could not be be 
differentiated from that of dead or damaged parasites. Although every 
effort was made to count only phagocytes with morphologically intact 
parasites, this still does not rule out the possibility that phagocytosis acts 
to scavenge parasites which are already dead or damaged. 
Considerable caution must be exercised in extrapolating in vitro data to 
the in vivo situation as the environment within the mosquito midgut is 
very different from that in the culture vessel. It was shown that 
phagocytosis of gametocytes is enhanced at 18 °C compared with 37°C as, 
although phagocytes might be expected to function less efficiently at 18 °C, 
the lower temperature stimulates gametogenesis and exposes surface 
antigens of the extracellular gamete to antibody and phagocytic cells. 
However, in common with a previous study (Sinden & Smalley 1976), 
phagocytosis rates in these experiments were significantly lower in the 
mosquito than in vitro indicating that the efficiency of phagocytosis in 
the mosquito midgut may be too low to be functionally significant. This 
was true even when phagocytes were present with complement, which is 
known to enhance Ig-mediated phagocytosis by MM and PMN (Snapper 
& Finkelman 1993). Accordingly, no significant effect of leukocytes on the 
transmission-reducing effect of either pooled or individual immune sera 
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could be found. Although some individual sera blocked transmission, 
this was not correlated with their ability to mediate phagocytosis in vitro. 
In summary, these data suggest that although both MM and PMN can 
phagocytose malarial gametes in vitro, absolute levels of phagocytosis are 
low and phagocytosis of intracellular gametocytes is extremely inefficient. 
In vivo, although conditions within the mosquito midgut facilitate the 
formation of extracellular gametes which are susceptible to phagocytosis, 
the phagocytic process itself proceeds less efficiently than in vitro. This 
may be due to unfavourable conditions inside the mosquito midgut, with 
respect to pH, and the presence of digestive enzymes (Billingsley & 
Sinden 1997). Finally, although a correlation was found between the 
ability of a serum to promote phagocytosis in vitro and the presence of 
antibodies against transmission blocking target antigens, no role for MM 
or PMN in transmission reduction in mosquitoes could be demonstrated. 
However, it remains to be seen whether phagocytes from immune 
individuals, in the presence of immune T-lymphocytes, may mediate 




The effect of serum concentration on transmission of 
P. falciparum 
7.1 	 Introduction 
The extracellular gamete stage of P. falciparum is vulnerable to immune 
destruction from antibodies contained within the bloodmeal, when it 
emerges from the erythrocyte within the mosquito midgut (Carter et al. 
1988). It is hoped that this phenomenon, known as transmission-blocking 
immunity, can be exploited to prevent the spread of malaria, via 
vaccination. Previous studies of various Plasmodium species of humans 
and animals have shown the feasibility of transmission-blocking vaccines 
(Carter & Chen 1976; Gwadz & Green 1978; Kaslow 1997; Mendis & Targett 
1979; Munesinghe et al. 1986; Rener et al. 1983). However, as is the case 
with most protective immune responses against P. falciparum , the exact 
mechanism of antibody-mediated transmission-blocking is unknown. 
Studies with certain monoclonal antibodies against P. falciparum sexual 
stage antigens have described a prerequisite for complement to be active 
in the bloodmeal (Quakyi et al. 1987; Read et al. 1994; Roeffen et al. 1995b), 
and others have indicated that the presence of complement gives a more 
potent blocking effect of the antibody (Carter et al. 1990; Graves et al. 1985; 
Premawansa et al. 1994). One previous study of naturally-acquired 
transmission-blocking immunity to P. falciparum found a correlation 
between high levels of antibodies against the gamete-surface antigen 
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Pfs230, and reduction of transmission (Graves et al. 1988b). The results 
included in chapter 5 of this thesis also seem to suggest that antibody 
concentration (against Pfs230) is an important factor in the ability of sera 
to reduce P. falciparum transmission. However, as effects of Ab 
concentration have not been examined for P. falciparum, we must move 
to studies of transmission-blocking immunity in other malaria species to 
get a clearer picture of the effect of serum concentration on infectivity. 
Both MAbs against, and human sera exposed to P. vivax, blocked 
transmission at high serum concentrations and enhanced transmission at 
low serum concentration (Peiris et al. 1988). Similar effects on 
transmission were found in a longitudinal study of transmission-blocking 
immunity to P. cynomolgi in its natural monkey host, where suppression 
of infectivity was observed at high Ab concentrations and enhancement 
of infectivity observed at low Ab concentrations (Naotunne et al. 1990). 
The aim of the experiments in this chapter was to investigate the effect on 
transmission of different concentrations of malaria-endemic human 
serum fed to mosquitoes along with gametocytes, in the presence or 
absence of human complement. The results reveal a complex biological 
interaction between mosquito bloodmeal components, which can lead to 
either increased or decreased transmission of P. falciparum. 
144 
Chapter 7 
7.2 	 Materials and Methods 
Details of procedures used in this chapter are described in chapter 2 as 
follows: 
Parasite culture 	 2.2 
Infectivity experiments 	 2.9 
7.2.1 Sera 
Five malaria-endemic sera were chosen from a population which had 
been previously tested in transmission assays (Chapter 5). The selection 
criteria were that they originally had different effects on transmission at a 
fixed concentration (16%) in the presence of complement, and that they 
had different antibody specificities against P. falciparum sexual-stage 
antigens (Table 7.1). 
Non-immune serum was obtained from a non-malaria exposed European 
donor (blood group 0+) and either frozen immediately at -70°C, or heat-
inactivated at 56°C for 40 minutes before freezing. Complement activity 
was confirmed before use (see section 5.2.1). 
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Table 7.1 	Characteristics of individual malaria-immune sera selected 
for titration experiments (data extracted from Table 5.1). 
Serum 	1U 1 	Pfs230 Ab2 	Pfs48/45 	anti-gamete anti-gamete 	Effect on Transmission 
Ab3 	1g04 	IgGl4 
1 0.1 0 1 0.344 0.015 blocking 
2 0.06 19.7 2 1.525 0.691 blocking 
3 0.1 1.2 2 1.556 0.454 blocking 
4 2.02 0.8 3 1.102 0.203 enhancing 
5 0.34 1.1 0 0.207 0.057 reducing 
1R1: average infectivity of Plasmodiurn falciparum gametocytes to 
Anopheles stephensi mosquitoes fed with immune human serum 
relative to controls fed with non-immune human serum in the presence 
of C' 
2Pfs230 Ab values determined from phosphorimaging of 
immunoprecipitated aqueous TX-114 extract of 1 125-labelled gamete surface 
proteins. 
2Pfs48/45 Abs determined from visual analysis of autoradiographs of 
immunoprecipitated TX-100 aqueous extract of I 25-label1ed gamete surface 
proteins. 
4Anti-gamete IgG and IgGi antibodies were measured by ELISA against TX-
114 soluble gamete extracts. 
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7.2.2 Infectivity Assay 
Suspensions of gametocyte-infected erythrocytes were fed to mosquitoes 
via water-jacketed membrane feeders as described previously (2.9). Sera 
were serially diluted in non-immune serum (Table 7.2) and fed to 
mosquitoes with suspensions of gametocyte-infected erythrocytes in 
complement-intact serum, or with heat-inactivated serum, to examine 
transmission effects in the presence or absence of complement. The 
membrane feeder volume was 340il in all cases. Packed 0+ erythrocytes 
(Blood Transfusion Service, Edinburgh) were mixed with gametocyte-
infected erythrocytes from in vitro culture, such that the bloodmeal 
haematocrit was 40%, with gametocytaemia of 1.5-2%. Daily variation in 
assay conditions was accounted for by the inclusion of a standard control 
serum in every experiment. 
Relative infectivity (RI) = 
GM oocysts (test) 
GM oocysts (control) 
or, where indicated, 
Relative infectivity 	
= proportion infected mosquitoes (test) 
proportion infected mosquitoes (control) 
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Table 7.2 Composition of bloodmeals containing P. falciparum 
gametocytes fed to individual pots of 40 mosquitoes (volume in jil). 
final proportion of 
bloodmeal 
represented by 
immune serum (%) 
C+feeds 	 C-' feeds 
volumes in p.1 	 volumes in p.1 
non- 	immune non-immune immune 
immune serum 	serum 	serum 
serum 
30 0 100 100 100 
15 50 50 150 50 
8 75 25 175 25 
4 87.5 12.5 187.5 12.5 
2 93.75 6.25 193.75 6.25 
1 96.85 3.15 196.85 3.15 
0.5 98.4 1.6 198.4 1.6 
0 (control 1) 100 0 200 0 
0 (control 2) 100 0 200 0 
volume of RBC + 140 140 
Gametocytes 
Volume of C+ 
serum 
100 0 
= complement-intact serum 
= complement-inactivated serum 
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7.2.3 Statistical analysis 
The Mann-Whitney U-test was used to calculate significant differences 
between oocyst burdens in mosquitoes fed with malaria-immune human 
serum compared with their pair-matched controls (fed with non-immune 
European serum). 
To allow for multiple comparisons between the oocyst numbers in 
mosquitoes fed on seven different concentrations of the same immune 
serum with those fed control serum, the cut-off value for statistical 
significance was p=0.0019 (p=0.05 divided by 'tJ). 
Although the frequency distribution of oocyst numbers per mosquito does 
not assume a normal distribution, a normal distribution is found if all 
zero values are excluded. Analysis of variance (ANOVA) was therefore 
used to interpret the data. All oocyst numbers (including zeros) were 
included in the ANOVA. 
To determine whether or not there are significant differences between 
oocyst frequency at different immune serum concentrations, or in the 
presence or absence of active C', and to see whether there is a significant 
interaction between serum concentration and the presence or absence of 
active C', a 2-way ANOVA was applied to log(oocyst number+1) minus 
the mean(log oocyst number+1) of control mosquitoes for each endemic 







7.3.1 Day-to-day variation in infectivity in the presence of control serum 
To allow comparison of transmission experiments performed on different 
days, each experiment was carried out with two control pots of 
mosquitoes which were given non-exposed European serum in place of 
malaria-immune serum. Table 7.3 shows details of control infections. The 
Mann-Whitney U-test was employed to test for significant differences in 
oocyst numbers between control pairs fed at the same time (results not 
shown). The only experiment in which a significant difference was found 
was with serum 1 (+C'). In this case, GM number of oocysts was 0.86 and 
1.35, with prevalence of oocyst infection of 35% and 71%, respectively. 
Statistical analysis of the effect of serum concentration and presence of 
complement on oocyst numbers was carried out with average values of 
the two pairs of controls (Table 7.2). 
The mean number of control mosquitoes per experiment was 44. The 
lowest % prevalence in control mosquitoes was 42%, and the highest was 
96%. The overall average prevalence was 76%. 
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Table 7.3 	Infectivity of P. falciparum gametocytes in non-immune 
serum to A. stephensi mosquitoes, used as controls for the 5 
immune sera. 
in presence of C' 
control oocyst values in two pots combined 
for mean mean total no. of % 
immune no. no. mosquitoes mosquitoes 
serum oocyst oocyst GM max mea 	sd V dissected infected 
no. spoti spot2 n 
1 1.9 2.3 1.1 55 2.1 	3.5 12 44 55 
2 8.0 5.6 2.2 67 6.8 13.2 174 40 60 
3 4.4 8.2 3.8 48 6.7 	10.7 115 38 60 
4 2.8 5.0 0.9 46 3.8 9.5 90 40 60 
5 2.4 nd 1.9 21 2.4 	5.1 26 20 45 
in absence of C' 
control oocyst values in two pots combined 
for mean mean total no. of % 
immune no. no. 0 mosquitoes mosquitoes 
serum oocyst oocyst GM max mea 	sd V dissected infected 
no. spoti spot2 n 
1 46.4 41.3 32.1 97 45.2 	26 676 25 96 
2 4.8 5.2 0.5 37 5 7.6 58 40 60 
3 3.7 2.9 2.2 19 3.4 	5.8 34 33 42 
4 8.6 nd 2.8 52 8.6 12.8 164 30 53 
5 3.7 1 	3.3 1 	2.1 16 3.5 	4.1 17 40 75 
Numbers represent pooled oocyst counts from 2 pots of mosquitoes fed from different 
membrane feeders containing identical bloodmeals. 
GM = geometric mean oocyst number per group 
Max = maximum no. of oocysts on an individual mosquito 	midgut. 
Mean = average number of oocysts per group 
sd = standard deviation, V = variance from the mean 
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7.3.2 Testing for statistically significant differences between oocyst 
numbers in test mosquitoes compared with controls 
A total of 1656 mosquitoes were dissected. 827 midguts were examined 
from mosquitoes given bloodmeals containing complement-intact sera, 
829 from those given complement-inactivated sera. From oocyst counts, 
68 individual relative infectivity (RI) values were calculated for the 
malaria-immune sera, representing seven serial dilutions of the sera, 
with and without complement (2 RI values from serum 4 were not 
included due to insufficient numbers of surviving mosquitoes: Table 7.4). 
RI was calculated based on infection intensity (Table 7.4a), and infection 
prevalence (Table 7.4b). 
The Mann-Whitney U-test was employed to test for significant differences 
between test and control mosquitoes. Of the 68 RI measurements of oocyst 
intensity for the malaria-immune sera, 15 (22%) showed significant 
reduction of transmission and 4 (6%) showed significant enhancement of 
transmission. Of the 15 observations of reduced RI values, 8 (53%) 
occurred in the presence of C' and 7 (47%) in the absence of C'. 
Transmission blocking, (previously defined as a reduction of 
transmission by >90% of controls (Lensen et al. 1996) was found in 6 (40%) 
of these observations. Only two of the five sera were able to mediate 
transmission-blocking at any concentration, and only once did 
transmission-blocking occur in the absence of C' (Table 7.4a). 
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Of the 4 measurements in which significant (p<0.018) transmission 
enhancement was found, three were attributable to serum 3, and one to 
serum 4 (Table 7.4a). When RI was calculated from the proportions of 
mosquitoes infected (prevalence of infections), significant transmission 
enhancement (p<O.Ol) was found only once (serum 3, Table 7.4b). 
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Table 7.4 	Relative infectivity of P. falciparum gametocytes to A. 
stephensi mosquitoes in different dilutions of 5 immune (endemic) sera. 
RI values for malaria-immune sera in the presence (C+) or absence (C-) of 
complement. 
Relative infectivity values calculated a) from GM oocyst number per 
immune serum group divided by GM oocyst number in controls. 
Se r urn 
1 2 3 4 5 
serum +C -C +C -C 
conc. (%)  
+C -C +C -C +C -C 
0.5 0.28 1.76 0.79 1.25 1.24 1.96 1.21 ND 1.03 0.26 
1 0.09 0.93 0.69 1.76 2.99 1.27 0.64 ND 1.65 0.69 
2 0.09 0.95 1.06 0.38 1.34 0.58 0.59 3.0 1.12 0.21 
4 0.36 0.44 0.02 1.1 1.72 0.73 0.82 0.36 1.18 1.81 
8 0.18 0.11 0.28 0.76 0.33 0.64 1.05 0.60 1.6 1.30 
15 0.18 0.45 1.43 0.55 3.0 1.24 5.52 0.29 1.74 1.61 
30 0 0.12 0.09 0.06 0.33 0.83 1.6 0.21 0.67 2.30 
Relative infectivity values calculated b) from the proportions of 
mosquitoes with oocysts fed immune serum divided by proportion of 
mosquitoes with oocysts in controls. 
Serum 
2 3 4 5 
serum +C -C +C -C 
conc._(%)  
+C -C +C -C +C -C 
0.5 0.56 1.04 0.83 1.00 0.90 1.95 0.58 ND 0.91 0.53 
1 0.11 0.99 0.70 1.33 1.25 1.19 0.33 ND 1.11 0.87 
2 0.19 0.94 1.08 0.50 1.03 0.71 0.58 1.42 1.00 0.48 
4 0.46 0.89 0.33 0.92 1.00 0.71 0.27 0.81 1.00 1.13 
8 0.22 0.52 0.50 0.58 0.33 0.48 0.58 0.87 1.33 0.93 
15 0.28 0.94 0.98 0.75 1.40 0.31 1.02 0.62 1.82 1.07 
30 0.00 0.57 0.22 0.08 0.13 0.83 0.75 0.57 0.27 1.07 
Red indicates where numbers of oocysts were significantly lower control than controls as 




7.3.3 Relative infectivity of gametocytes in the presence of different 
concentrations of malaria-immune sera 
Figure 7.1 shows the variation in relative infectivity (based on oocyst 
numbers), at different concentrations of malaria-immune human serum 
in the presence and absence of C'. Data values are given in Appendix to 
chapter 7. 
Serum 1 
In the absence of C', serum 1 (Fig. 7.1a) enhanced transmission at the 
lowest concentration and reduced transmission at higher concentrations. 
In the presence of C', serum 1 reduced transmission, with complete 
transmission-blocking at the highest concentration (at 30% serum, no 
oocysts were observed). 
In the Mann-Whitney U-test (MWU), oocyst numbers were significantly 
different from controls at 4 different concentrations of serum 1 in the 
presence of C', and at 3 different concentrations in the absence of C' (Table 
7.4a). Proportions of infected mosquitoes were significantly lower than 
controls for the same 4 serum concentrations in the presence of C', but in 
only 2 cases, were the numbers of infected mosquitoes significantly 
different from controls in the absence of C' (Table 7.4b). In all of these 
cases, infectivity was reduced relative to controls. 
ANOVA results indicated that both the concentration of serum 1 and the 
presence of C' had a highly significant effect on transmission. 
Additionally, there was a significant interaction observed between 
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complement and serum concentration which could be interpreted as a 
synergistic effect between complement and immune serum, leading to 
reduction of infectivity in the presence of serum and C', which is greater 
than the reduction seen with either serum or C' alone (Table 7.5). 
Serum 2 
In the absence of C', serum 2 (Fig. 7.1b), also enhanced infectivity at low 
concentrations, and reduced infectivity at high concentrations. When C' 
was active, enhancement of infectivity was observed at the 15% serum 
concentration, although this was not significantly different from controls 
(Table 7.4). Significant reduction of both oocyst numbers and proportions 
of infected mosquitoes was observed at two different immune serum 
concentrations in the presence of C' (Table 7.4) Transmission-blocking 
occurred at the highest immune serum concentration in both the 
presence and absence of C'. 
ANOVA confirmed that overall, immune serum concentration had a 
significant effect on transmission, but the presence of C' had not. 
However, as described for serum 1, there appeared to be an interaction 
between C' and immune serum(Table 7.5). This could possibly be 
explained by the observation that, although serum concentration alone 
acts to reduce transmission, lower RI values were observed in the 




In both the presence and absence of C', serum 3(Fig. 7.1c) mediated 
significantly enhanced numbers of oocysts at low serum concentrations 
(Table 7.4a). The proportions of mosquitoes infected were significantly 
enhanced only in the absence of C' (Table 7.4b). No significant reduction 
of transmission was observed in the absence of C'. In the presence of C', 
reduction of transmission occurred only at higher serum concentrations, 
with significant enhancement of oocyst numbers occurring in the 
presence of 15% immune serum (Fig. ic & Table 7.4b). 
ANOVA results confirmed that overall, serum concentration had a 
significant effect on transmission, but the presence of C' did not (Table 
7.5). However, as described for sera 1 & 2, there appeared to be a significant 
interaction between serum concentration and complement, which acted 
to reduce infectivity when the concentration of immune serum was high. 
Serum 4 
Serum 4 (Fig. id) appeared to enhance infectivity at low serum 
concentration in the absence of C' (however this was not statistically 
significant: Table 7.4), although no RI values were available for the lowest 
2 serum concentrations. As the concentration of this serum was increased, 
RI was reduced ( although not statistically significant: Table 7.4). In the 
presence of C', infectivity increased with serum concentration, with 
significant enhancement of oocyst numbers, but not proportion of 
infected mosquitoes, at 15% immune serum (Fig id & Table 7.4). 
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By ANOVA, both immune serum concentration and complement had 
significant effects on transmission (Table 7.5). An interaction was 
observed between C' and serum concentration; however, in this case, 
transmission appeared to increase, rather than decrease, at higher serum 
concentrations in the presence of C. 
Serum 5 
In the absence of C', serum 5 (Fig. 7.1e) significantly reduced transmission 
at low concentrations, and appeared to enhance transmission at high 
concentrations. When C' was active, transmission was reduced at the 
highest serum concentration (Table 7.4). 
ANOVA revealed a significant interaction between serum concentration 
and complement activity, which appeared to act to reduce infectivity at 
higher serum concentrations, in a manner similar to that observed with 
sera 1, 2 & 3 (Table 7.5). 
Thus, in the presence of C', the highest immune serum concentration 
gave the lowest RI values for sera 1, 3 & 5 (Fig. 7.1 & Table 7.4). In the 
absence of C', low immune serum concentration (:5 2%) was associated 
with transmission enhancement (4/5 sera). High serum concentration 
was associated with transmission reduction in sera 1, 2 & 4 (Fig. 7.1). In 
4/5 cases, in the presence of C', infectivity peaked at the second highest 
immune serum concentration. Significant, or marginally significant 
transmission enhancement was observed in two of these cases, 
accounting for 50% of all significant transmission enhancement. 
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Figure 7.1 Relative infectivity of P. falcipa rum gametocytes to A. stephensi 
mosquitoes in the presence of individual malaria-immune sera at 
different serum concentrations in the presence (black triangles) or 
absence (open squares) of active C. 
ed line indicates relative infectivity =1, where sera neither reduce nor enhance 
ransmission. * indicates significant difference between malaria-exposed and non-
xposed serum (p<0.018).*=CI  inactive, *(F  active serum 
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Table 7.5 	Results of 2-way ANOVA for effects of individual malaria- 
immune sera on infectivity of P. falciparum gametocytes to A. stephensi 
mosquitoes. 
Serum concentration Complement (+/-) Interaction 
Serum F p F p F p 
1 4.9, 239 0.0001 83.81, 239 <0.0001 2.86, 239 0.01 
2 5 .56 266 <0.0001 2.01 266 0.16 4.86 266 0.0001 
3 8.46,256 <0.0001 0.8 239 0.37 4.06,2m 0.0008 
4 3.24,200 0.02 0.001 <0.0001 
5 2.56, 239 0.02 4.1 1,239 0.05 3106,239 0.007 
Subscript values represent degrees of freedom for each F-ratio. 
The ANOVA is a two-tailed test, and while indicating whether there are 
any significant differences between groups, gives no information 
regarding the direction of differences. In this case, the grouping variables 




7.4 	 Discussion 
In this chapter, the effect of diluting sera from malaria-immune 
individuals on the infectivity of P. falciparum gametocytes was tested. 
Also examined was the effect of complement and of interactions between 
C' and serum concentrations. It was found that, at different 
concentrations, infectivity to mosquitoes was both reduced and enhanced. 
Each serum behaved differently in its effects on malaria infectivity at 
different concentrations. This is presumably because each has different 
levels of antibodies which mediate transmission enhancement or 
reduction (assuming that these phenomena are antibody-mediated). As 
well as differences in titre, the antibodies could be expected to have other 
differences which could also affect infectivity i.e. in their epitope 
specificity, affinity and subclass. Generalisations between different sera are 
difficult, however some general trends were observed. The highest serum 
concentration usually led to the biggest reduction in infectivity, whether 
or not C' was active in the bloodmeal. In the absence of C', low serum 
concentrations were more likely to induce enhancement of infectivity 
than to reduce infectivity, although in most cases, these were not 
significantly higher than controls. Similar results were obtained in a 
study of P. vivax transmission, where both human sera and MAbs were 
found to enhance infectivity at low concentration and block infectivity at 
high concentration (Peiris et al. 1988). 
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In the present chapter, transmission was both significantly reduced and 
enhanced in the presence and in the absence of C'. Only one of the five 
sera (serum 3) mediated significant enhancement and reduction of oocyst 
numbers at different concentrations in the presence of C'. 
Various P. vivax studies have detected significant enhancement of 
transmission by human sera (Gamage-Mendis et al. 1992; Peiris et al. 1988; 
Ramsey et al. 1996; Ranakawa et al. 1988). In one study, it was found that, 
with some sera, significant transmission enhancement occurred in the 
presence of active, as compared with inactive C' (Ramsey et al. 1996). The 
same study found transmission-enhancement to be associated with mid-
range anti-gametocyte IFA titres. 
Other evidence for antibody-mediated transmission enhancement comes 
from a range of studies in animal malarias. In P. cynomolgi, early in 
infection in its natural monkey host and again late in infections after 
transmission-blocking antibody titres had waned, significant 
enhancement of infectivity was found (Naotunne et al. 1990). In the same 
malaria species, mosquito infections from Rhesus monkeys previously 
infected with P. knowlesi were significantly enhanced compared with 
those fed on naive monkeys (de Arruda-Mayr et al. 1979). In the rodent 
malaria P. berghei, mice immunised with suboptimal doses of affinity-
purified ookinete antigen Pbs2l, gave rise to higher oocyst burdens in 
mosquitoes than did controls (Tirawanchai et al. 1991). 
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Enhancement of P. falciparum transmission has been mentioned in 
several studies, but surprisingly, has received little attention. In a study of 
transmission-blocking immunity in Papua New Guinea, 21% of sera 
mediated transmission enhancement relative to controls (Graves et al. 
1988b). In all of these sera, antibody titres to Pfs230 were very low. In 
chapter 5, a similar proportion of enhancing sera (27%) was found and 
the mean level of antibodies to Pfs230 was lower in enhancing sera than 
in sera which had no significant effect or reduced transmission. In 
addition, a significant association between infectivity enhancement and 
low levels of anti-gamete IgG was found. In another study of P. 
falciparum transmission-blocking immunity in Sri Lanka, 44% of sera 
mediated transmission enhancement; again, in the majority of sera, 
antibodies to both Pfs230 and Pfs48/45 were very low (Premawansa et al. 
1994). Interestingly, in another study of transmission-blocking immunity 
against different P. falciparum gametocyte isolates, some sera reduced 
transmission of some isolates while enhancing transmission of others 
(Drakeley et al. 1998). One potential explanation of this is the presence of 
strain-specific, transmission-blocking antibodies. Transmission 
enhancement of P. falciparum has also been demonstrated in non 
complement-fixing isotypes of MAb against Pfs230 (Read et al. 1994). A 
single serum concentration was used in all of these studies. 
No attempt to correlate levels of anti-gamete antibodies with 
transmission reduction or enhancement was made in this chapter. 
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However, it was clear that serum 1, which had the most effective C'-
dependent transmission-blocking activity, had low levels of anti-gamete 
IgG and IgGi as determined by ELISA; it also contained no Abs to Pfs230, 
and little against Pfs48/45, the two main candidate gamete antigens for 
inclusion in a transmission-blocking vaccine. This implies that Pfs230 is 
not the only target of transmission-blocking antibodies. Rather 
surprisingly, serum 5, which had the lowest level of anti-gamete IgG, was 
found to reduce infectivity at low immune serum concentrations in the 
absence of C. These two findings are not consistent with the results of the 
previous chapter, in which an association was found between levels of 
antibodies against Pfs230 and reduction of transmission, and between low 
levels of anti-gamete IgG and transmission enhancement. 
Another finding of this chapter which is somewhat difficult to explain, is 
the peak in infectivity at the 15% serum concentration in the presence of 
active C' (sera 2, 3 & 4). As each serum has different antibody 
characteristics, it was an unexpected finding that a fixed concentration of 
serum would have such a markedly similar effect in the majority of sera 
tested. Since each serum was tested on a different day, with separate 
controls, these values cannot be explained as being due to abnormally 
high gametocyte infectivities, or to low oocyst numbers in control 
mosquitoes. Membrane feeders were washed extensively and dried, and 
badrouche membranes were changed between each experiment. 
Following each feed in which C' was active, the corresponding sera was 
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fed to mosquitoes in the presence of heat-inactivated serum. Moreover, 
this concentration (15% immune serum) was closest to that used in 
previous assays (16% immune serum; all C'+) in which enhancement of 
infectivity was observed with some sera, and blocking was observed with 
others (Chapter 5). However, these two studies may not be directly 
comparable due to small differences in bloodmeal composition. 
In conclusion, the results of this study demonstrate that human sera 
from malaria-exposed individuals can, at different concentrations, both 
enhance and block transmission of P. falciparum. However, it appears 
that small changes in bloodmeal composition with respect to the 
proportion of immune serum, can have a considerable effect, either to 
reduce or enhance infectivity of gametocytes. A simple linear 
relationship between antibody level and infectivity does not appear to 





8.1 	 Aims of the project 
The main aim of this thesis was to define mechanisms of naturally-
acquired transmission-blocking immunity to P. falciparum. These are of 
interest not only from a biological viewpoint, but perhaps more 
importantly, for future transmission-blocking vaccine design: it is 
important to identify which responses cause maximum reduction of 
malaria infectivity, and which have no functional significance against the 
parasite in order to induce such responses by vaccination. Identification 
of responses which have the potential to enhance malaria infectivity is 
also an important part of this study, as it would be important to avoid 
induction of an enhancing response by vaccination. 
Specifically, experiments were designed in order to address the following 
questions: 
What proportion of sera from malaria-exposed individuals of 
different ages, and from different malaria-endemic regions, recognise 
the P. falciparum sexual stage-specific antigens Pfs230 and Pfs48/45, 
which are the major targets of naturally-acquired transmission-
blocking immunity? 
Do sera from malaria-exposed individuals mediate complement-
dependent lysis of P. falciparum gametes in vitro? Is this associated 
with antibodies to particular gamete-surface antigens? 
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Is phagocytosis a major mechanism of P. falciparum transmission-
blocking immunity? Is this associated with Abs to particular gamete-
surface antigens? 
Do sera from malaria-immune adults mediate transmission-blocking 
immunity against P. falciparum? Is this associated with antibodies 
against specific gamete-surface antigens? 
What effect does serum dilution, and therefore antibody 
concentration, have on the transmission modulatory effects of 
malaria-immune serum? Does the presence of complement affect the 
transmission-modulatory activity of malaria-immune serum? 
8.2 	Maturation of the Immune Response 
One theme in which I was particularly interested was whether potential 
transmission-blocking responses were fixed early in life, or whether there 
was a potential for these to develop with age. Previously, it has been 
found in a longitudinal survey of anti-gamete Ab responses in a group of 
immune adults from the Gambia, that responses to Pfs230 were more or 
less stable despite the seasonal endemicity of malaria in this region (Riley 
et al. 1994). I wanted to explore the possibility that responses to Pfs230 
matured with increasing exposure to the parasite. 
In support of this, it emerged from the study that the prevalence of 
antibody responses to Pfs260 and Pfs230 (Chapter 3) were different 
between adults and children (although not statistically significant). When 
sera from PNG children were compared with those from The Gambia, 
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similar proportions of seronegatives for both Pfs260/230 and Pfs48/45 
were found. The same was found when adults' sera were compared. 
When differential responsiveness to Pfs260 and Pfs230 were compared 
among the different age groups, it was found that on average, more 
children's sera than adult's contained antibodies to Pfs260 and not Pfs230. 
Correspondingly, there appeared to be a shift in adulthood towards the 
production of antibodies to epitopes within Pfs230. By comparing 
responses in ELISA and immunoprecipitation, it was deduced that 
children predominantly recognised linear epitopes of Pfs260/230, whereas 
adults recognised both linear and conformational epitopes. This could be 
interpreted as evidence of epitope selection with exposure to gametocytes, 
with affinity maturation of Abs towards conformational epitopes, and 
could have implications for transmission-blocking immunity at the 
population level. Some individuals may be capable of mounting a 
transmission-blocking response in adulthood even when, as children, 
they did not possess transmission-blocking antibodies. Transmission-
blocking MAbs against Pfs230 are all directed against conformational 
epitopes (Read et al. 1994). Unfortunately there is no single assay available 
to directly study the immune responses to conformational versus linear 
epitopes of Pfs230, due to the lack of recombinant proteins which 
accurately reproduce the tertiary structure of the molecule. 
It could be speculated upon that experiments in Chapter 4, which tested 
for the ability of individual sera to mediate C'-dependent gamete lysis, 
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may also lend some support to the hypothesis of functional maturation 
of a potential transmission-blocking immune response. In these 
experiments more adult's sera than children's tended to be positive in the 
gamete lysis assay (although not statistically significant). The increase in 
C'-mediated lysis among adults' sera was proportionate to the increase in 
Pfs230 response. 
In retrospect, it would have been very interesting to compare 
transmission-blocking responses of adults and children using membrane 
feeding assays, in order to see whether the observed shifts in Ab 
responses to Pfs230, and in C'-mediated lysis of gametes in vitro were 
borne out in functional transmission-blocking capacity. As far as I am 
aware, this type of comparative study has not been done. However, due to 
the lack of adequate amounts of malaria-exposed sera from children, this 
was not attempted in this study. 
8.3 	Mechanisms of naturally acquired transmission- 
blocking immunity 
It is important to understand the mechanisms behind transmission-
blocking immunity in order to design effective vaccines. Several Ab-
mediated mechanisms of transmission-blocking immunity have been 
proposed including agglutination of gametes, blocking of receptor sites for 
fertilisation, C'-mediated gamete lysis and phagocytosis (Carter et al. 1988; 
Lensen et al. 1998; Quakyi et al. 1987). The first two mechanisms could not 
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be easily tested in our system. Purification of P. falciparum microgametes 
was not possible by the discontinuous Nycodenz gradient procedure used 
to purify macrogametes. A detectable level of macrogamete agglutination 
occurred even in the absence of immune serum. Gamete receptors for 
fertilisation have not yet been characterised. A more feasible means of 
characterising specific fertilisation receptors would be through the use of 
specific MAbs. Nevertheless, the possibility of C'-mediated gamete lysis 
and gamete phagocytosis as potential transmission-blocking mechanisms 
represented two testable hypotheses. 
In keeping with studies using MAbs, particularly those against Pfs230 
(Quakyi et al. 1987; Read et al. 1994; Roeffen et al. 1995b) but also some 
studies of Pfs48/45-specific MAbs (Carter et al. 1988), it was believed that 
C'-mediated gamete lysis would be a major mechanism of naturally 
acquired transmission-blocking immunity to P. falciparum. I set out to 
test if malaria-immune sera could mediate C'-dependent gamete lysis; if 
so, was this always associated with Abs to Pfs230, and did all sera 
containing Abs against Pfs230 mediate gamete lysis 
8.3.2 Complement-mediated gamete lysis 
In an in vitro assay (Chapter 4), it was found that approximately half the 
sera tested were able to lyse gametes in a C'-dependent manner. This was 
strongly associated with the presence of Abs to Pfs230 in sera, but not with 
Abs against Pfs260, Pfs48/45 or Pfg27/25. Since some Pfs48/45 MAbs can 
mediate gamete lysis in a complement-dependent manner (Carter et al. 
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1988), it may be possible that serum antibodies to specific epitopes of 
Pfs48/45 are able to mediate gamete lysis, but that any effect of Pfs48/45 
Abs in the immune sera tested in Chapter 4 was probably masked by the 
effect of Pfs230 Abs also present in the sera. Sera in which Abs to both 
Pfs230 and Pfs48/45 were present, were more likely to mediate gamete 
lysis, suggesting some interactive effect of the two populations of 
antibodies. Perhaps steric effects of Abs binding to Pfs48/45, although not 
lytic in themselves, may enhance or enable the binding of C'-fixing Abs 
against Pfs230. A potentially interesting experiment would have been to 
deplete Pfs230 Abs from the sera, and then look for C'-mediated lysis. 
The observation that some Pfs230 Ab-positive sera failed to mediate 
gamete lysis suggests that epitope specificity of Abs, as well as their IgG 
subclass and affinity, is an important factor in the ability of a serum to 
mediate gamete lysis. 
It is possible that another (undefined) gamete-surface Ag may be 
involved in C' mediated lysis, as it was found that some sera which were 
apparently negative for Abs to Pfs230 and Pfs48/45 were able to lyse 
gametes. However, this may be due to the relatively crude method of 
detection of these Abs, which was by visual analysis of 
immunoprecipitation band intensity. In Chapter 5, where a more 
sensitive method of Pfs230 Ab detection was used (phosphorimaging), 
many of the sera previously defined as seronegative, were actually 
positive for Pfs230 Abs, albeit at very low levels. 
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Another possible explanation for complement-mediated gamete lysis in 
the apparent absence of an anti-gamete surface antibody response is the 
presence of 1gM antibodies which would be undetectable by the 
immunoprecipitation test. 
We progress from examining the incidence of anti-gamete responses and 
their effects on parasites in vitro, to the functional significance of these 
Abs in vivo in Chapter 5. Despite the relatively small study size, 
significant correlations were found between the reduction of P. 
falciparum infectivity, both in terms of the numbers of oocysts 
developing within mosquitoes, and in the proportions of mosquitoes 
infected, and the levels of serum Abs against Pfs230. This finding was in 
agreement with a previous study (Graves et al. 1988b), and with the 
association between Pfs230 Abs and in vitro gamete lysis. However, the 
complement-dependence of this naturally acquired transmission-
blocking immunity was not directly tested in chapter 5, as all membrane 
feeding assays were done in the presence of active C'. Nevertheless, in 
these experiments, the ability to mediate C'-dependent gamete lysis in 
vitro was significantly associated with reduction of infectivity in vivo. 
Also found to be significantly associated with reduction of oocyst 
numbers was the level of anti-gamete IgGi, which is a complement-fixing 
subclass of IgG. No association between Abs against Pfs48/45 and 
transmission reduction could be found. 
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The finding that levels of transmission-blocking were higher in the 
presence of C' is consistent with studies of P. vivax transmission-blocking 
immunity (Mendis et al. 1987), and with those of P. falciparum 
transmission-blocking MAbs Pfs230 and Pfs48/45 (Carter et al. 1990; 
Quakyi et al. 1987; Read et al. 1994; Roeffen et al. 1995b). This finding also 
lends support to the hypothesis that C'-mediated lysis is a major 
mechanism of naturally acquired transmission-blocking immunity to P. 
falciparum. 
8.3.2 Phagocytosis of gametes 
In the recent literature, it has been proposed that phagocytosis of gametes 
within the mosquito midgut may be an important mechanism of Ab-
mediated transmission-blocking immunity against P. falciparum. Lensen 
et a! (Lensen et al. 1998; Lensen et al. 1997) propose that leukocytes present 
in the bloodmeal reduce gametocyte infectivity in a serum-dependent 
manner. This contrasts with an earlier study (Sinden & Smalley 1976), 
which concluded that although malaria-immune serum was capable of 
mediating gamete phagocytosis in vitro, within the mosquito midgut the 
level of phagocytosis was so low as to be functionally insignificant as a 
mechanism of transmission-blocking immunity. The results presented in 
Chapter 6 of this thesis are consistent with the latter study. Like Sinden 
and Smalley, little phagocytosis of gametes was observed in vivo, even in 
the presence of pooled immune serum. In membrane feeding 
experiments with pooled immune serum, the addition of C', or WBC 
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reduced relative infectivity, but this was not statistically significant. If 
phagocytosis were a major mechanism of transmission-blocking 
immunity, it might be expected that in the presence of C', which acts as an 
opsonin for WBC-mediated phagocytosis (Roitt 1994), together with 
WBC, infectivity would be much reduced compared to when C' or WBC 
were present alone. In fact, lowest relative infectivities were found when 
C' was present without WBC indicating that C'-mediated lysis is a more 
important mechanism for transmission-blocking immunity than gamete 
phagocytosis. 
8.4 	 Enhancement of Transmission 
The phenomenon of enhancement of P. falciparum transmission has not 
been widely studied, but nevertheless has important implications for 
both transmission-blocking vaccine design and malaria life-history 
biology. 
It has been demonstrated that sera from malaria patients in Sri Lanka 
mediate enhancement of P. vivax transmission (Gamage-Mendis et al. 
1992; Mendis et al. 1987; Peiris et al. 1988), and in some cases, sera which 
block transmission at a high serum concentration, are able to enhance 
infectivity when diluted (Peiris et al. 1988). MAbs against P. vivax which 
block transmission at high concentration can also enhance transmission 
when diluted (Peiris et al. 1988). This indicates that antibodies of the same 
specificity can cause both transmission-blocking and transmission-
enhancement at different concentrations. In these studies, it appears that 
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transmission-enhancement is a transient effect seen only over a narrow 
range of Ab concentrations. 
I believe that results presented in Chapters 5 and 7 demonstrate that Ab-
mediated enhancement of P. falciparum infections occurs, and that this is 
related to low titres of anti-gamete Abs. Whether serum mediated-
transmission enhancement represents an adaptation by the parasite to 
increase its transmission is an open question. If the host is capable of 
mounting a transmission-blocking response against the parasite, as is 
often seen even after a primary infection with malaria (Gamage-Mendis 
et al. 1992; Graves et al. 1988b; Premawansa et al. 1994; Ranakawa et al. 
1988), it would be beneficial to the parasite to avoid this response, and 
even more advantageous to subvert this response to increase, rather than 
decrease its transmission. I would postulate that Ab-mediated 
enhancement of P. falciparum infectivity is an important mechanism by 
which the parasite increases its transmission. In one study of P. vivax 
transmission-blocking immunity, it was found that not only did 
transmission enhancement occur, but some P. vivax isolates which were 
not previously infectious to mosquitoes produced viable infections in the 
presence of certain malaria-exposed sera (Peiris et al. 1988). 
It is possible that Ab titres during a P. falciparum infection are sufficient 
to enhance infectivity early on, then rise to titres capable of blocking 
transmission, only to wane if exposure to gametocytes is infrequent or 
seasonal, aiding transmission again, as seen in P. vivax and P. cynomolgi 
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infections (Naotunne et al. 1990; Peiris et al. 1988). If this is the case, then 
perhaps by taking a one-off serum sample, we are only seeing part of the 
picture of transmission-modulatory activity in an endemic region. 
Longitudinal sampling would be required to address this possibility. 
It is tempting to speculate of transmission-modulatory effects seen in 
malaria-exposed sera, that there are several populations of Abs within 
malaria-exposed sera which react with many epitopes on various gamete-
surface Ags. Some of these Abs have the capacity to block transmission at 
various titres, and some have the ability to enhance transmission, but 
possibly within a much narrower titre range. It is possible that antigenic 
diversity among epitopes on gamete surface proteins may affect 
transmission of P. falciparum, perhaps by affecting the affinity of Ab 
binding. Enhancement of P. cynomolgi infectivity was observed in rhesus 
monkeys previously infected with P. knowlesi. (de Arruda-Mayr et al. 
1979). Abs present against P. knowelsi in these monkey sera may not be 
sufficiently cross-reactive against P. cynomolgi to block its transmission, 
but could have enough affinity towards certain epitopes to cause 
enhancement of P. cynomolgi transmission. Waning of Ab titres due to 
low gametocyte exposure may also deplete transmission-blocking Abs to a 
suboptimal level, allowing infectivity enhancement operate. Dilution of 
the serum, as in Chapter 7, apparently has the same effect. 
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8.5 	Potential mechanisms of Ab-mediated 
transmission enhancement 
Mechanisms by which anti-gamete responses may enhance parasite 
infectivity are purely speculative, but several have been proposed in the 
literature. Cross-linking of male and female gametes to promote zygote 
formation (Peiris et al. 1988), requires that Ags are present on gametes of 
both sexes. This is true for Pfs230 and Pfs48/45 (Alano 1991), and probably 
most other surface Ags. Binding of non-C' fixing subclasses or isotypes of 
Ab resulting in inhibition of C'-mediated gamete lysis is another possible 
mechanism of transmission enhancement. It has been demonstrated 
with MAbs against Pfs230, that non-complement fixing subclasses which 
have the same epitope specificity as C'-fixing MAbs can inhibit 
transmission-blocking against P. falciparum (Roeffen et al. 1995b). Peiris 
et al (Peiris et al. 1988) also propose that protection from anti-parasitic 
factors in the bloodmeal could be an Ab-mediated enhancement 
mechanism. 
Another interesting mechanism which has been proposed is that Ab-
binding somehow signals the parasite to speed up development (Peiris et 
al. 1988). One observation which was made many times during this 
project was that oocysts (of the same P. falciparum clone), appear to 
develop at different rates, and there was quite a large degree of variability 
in oocyst size at day 9-10 post-infection. Whether all of these oocysts go on 
to produce viable sporozoites is not known. 
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8.6 	Potential implications for development of a malaria 
transmission-blocking vaccine 
How do the results presented in this thesis relate to the development of a 
transmission-blocking vaccine? One's first reaction may be that if we were 
to immunise a group of individuals, we would run the risk of causing 
enhanced transmission, rather than reduced transmission. This may be 
so, and we need to study the phenomenon of transmission-enhancement 
more closely in order to find a way of circumventing this. However, if 
transmission-enhancement is the result of low Ab titres, as the evidence 
seems to imply, then vaccination should, in theory, encourage levels 
which would cause transmission-blocking rather than enhancement. 
This hypothesis assumes that transmission-blocking and enhancing Abs 
are of the same specificity, as has been shown in P. vivax studies (Peiris et 
al. 1988). Another means by which we could encourage a transmission-
blocking response would be to induce Abs of C'-fixing isotypes. Perhaps a 
transmission-blocking vaccine, even if it were not capable of universal 
blocking of infectivity in highly endemic regions, would have an added 
effect of preventing transmission enhancement, which for all we know, 





8.7 	Implications for further studies on malaria 
transmission-blocking immunity 
It was hoped, at the outset of this study, that it might have been possible 
to predict the transmission-modulatory activity of particular sera from a 
combination of their Ab profile and their ability to mediate in vitro C'-
dependent gamete lysis. However, this study demonstrates that the effects 
of a serum on parasite infectivity cannot be inferred from these indicators 
alone. There is an association between high levels of Abs against Pfs230 
and transmission-blocking, but it is not always the case that a serum 
containing Pfs230 Abs, as determined by immunoprecipitation, will 
reduce malaria transmission. Additionally, many of the sera which were 
able to mediate gamete lysis in vitro were not effective transmission 
blockers in vivo. We have to resign ourselves to the fact that membrane 
feeding assays, although not perfect in themselves, are the only feasible 
way to test transmission-blocking activity in malaria-exposed sera; for a 
transmission-blocking vaccine trial, this would be a huge undertaking. 
8.8 	 Overall Conclusions 
• Naturally-acquired antibodies to the gamete surface protein Pfs230, are 
associated with reduction of transmission of P. falciparum. 




• Antibody-mediated complement-dependent gamete lysis is a major 
mechanism of naturally-acquired transmission-blocking immunity to 
P. falciparum. 
• Phagocytosis is not a major mechanism of transmission-blocking 
immunity to P. falciparum. 
• Antibody-mediated enhancement of P. falciparum occurs, and it is 
associated with low titres of anti-gamete IgG. 
• There is a suggestion of an age-related functional maturation of 
transmission-blocking immune responses to P. falciparum. 
I believe that the results presented in this thesis support the inclusion of 
Pfs230 as part of an anti-malaria vaccine. What is now required is the 
employment of suitable recombinant technology which would allow us 
to accurately recreate Pfs230 epitope structure, as found in the native 
molecule. Coupling these with appropriate adjuvants which would 
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Appendix 1 
Appendix to Chapter 2 
A2 Reagents used for SDS-PAGE 
A2.1 2X reducing sample buffer: 
Tris.Cl (pH6.8) 	100mM 
SDS 4% 
bromophenol blue 0.2% 
glycerol 	20% 
2-mercaptoethanol (Sigma) 	1% 
A2.2 gel running buffer.4x: 
Tris.Cl (pH8.8) 	1.5M 
A2.3 10% minigel (per gel): 
Acrylamide (40%) 1 .25ml 
4x running buffer 1.25m1 
10% SDS 0.05m1 
dH20 2.45m1 
Ammonium pesuiphate (10%) 25m1 
TEMED 	1.65m1 
A2.4 Coomassie blue gel stain: 
Coomassie blue (Sigma) 2g 
destain solution 11 
A2.5 Destain solution: 
Methanol 250 ml 
Acetic acid 75m1 
dH2O 11 
A3 Reagents used in ELISA 
A3.1 Coating buffer: 
Na2CO3 	1.59g 
NaHCO3 2.93g 
Made up to 11 with dH20. 
A3.2 Washing buffer: 
PBS powder (pH7.4) 	48g 
Tween-20 	 2.5m1 
Made up to 51 with dH20 
A3.3 Blocking buffer: 
skimmed milk powder 5% 
Diluted in washing buffer solution. 
A3.4 Incubation buffer: 
skimmed milk powder 1% 
Diluted in washing buffer solution. 
A3.5 Developing buffer: 
Citrate buffer (O.1M) 	6m1 
Phosphate buffer (0.2M) 6.4m1 
Made up to 25m1 with dH201 then added 
OPD (0-phenylenediamine) 	10mg 
H202 10m1 
Appendix 2 
Serum donors, age and parasite status 
ONDR AGE AGEGROUP AREA 	Parasitaemia 
1 1401 8 1 Farafenni - 
2 1402 6 1 Farafenni 	- 
3 1403 7 1 Farafenni - 
4 1404 16 2 Farafenni 	- 
5 1406 6 1 Farafenni - 
6 1407 7 1 Farafenni 	- 
7 1 408 8 1 Farafenni - 
8 1 409 2 1 Farafenni 	- 
9 1410 1 1 Farafenni - 
10 1411 7 1 Farafenni 	- 
11 1414 8 1 Farafenni - 
12 1415 6 1 Farafenni 	- 
13 1416 9 1 Farafenni - 
14 1417 9 1 Farafenni 	- 
15 1419 7 1 Farafenni - 
16 1420 2 1 Farafenni 	- 
17 1422 8 1 Farafenni - 
18 1423 7 1 Farafenni 	- 
19 1424 5 1 Farafenni - 
20 1425 8 1 Farafenni 	- 
21 1426 9 1 Farafenni - 
22 1427 9 1 Farafenni 	- 
23 1428 6 1 Farafenni - 
24 1429 6 1 Farafenni 	- 
25 1430 2 1 Farafenni - 
26 1431 8 1 Farafenni 	- 
27 1432 4 1 Farafenni - 
28 1435 6 1 Farafenni 	- 
29 1436 3 1 Farafenni - 
30 1437 6 1 Farafenni 	- 
31 1439 1 1 Farafenni - 
32 1442 10 1 Farafenni 	- 
33 1443 10 1 Farafenni - 
34 1444 10 1 Farafenni 	- 
35 1445 12 1 Farafenni - 
36 1446 6 1 Farafenrii 	- 
37 1448 3 1 Farafenni - 
38 1449 10 1 Farafenni 	- 
39 1450 7 1 Farafenni - 
40 1451 11 1 Farafenni 	- 
41 1452 4 1 Farafenni - 
42 1454 5 1 Farafenni 	- 
43 1455 9 1 Farafenni - 
44 1456 6 1 Farafenni 	- 
45 1457 10 1 Farafenni 	- 
46 1458 4 1 Farafenni - 
47 1459 11 1 Farafenni 	- 
48 1460 5 1 Farafenni - 
DGtsCR AGE AGE GROUP AREA 	Parasitaemia 
49 1461 5 1 Farafenni - 
50 1462 1 1 Farafenni 	- 
51 1463 1 1 Farafenni - 
52 1464 9 1 Farafenni 	- 
53 1465 7 1 Farafenni - 
54 1466 3 1 Farafenni 	- 
55 1467 8 1 Farafenni - 
56 1468 8 1 Farafenni 	- 
57 1469 4 1 Farafenni - 
58 1470 6 1 Farafenni 	- 
59 1471 4 1 Farafenni - 
60 1473 7 1 Farafenni 	- 
61 1474 6 1 Farafenni - 
62 1475 8 1 Farafenni 	- 
63 1476 4 1 Farafenni - 
64 1477 8 1 Farafenni 	- 
65 1479 5 1 Farafenni - 
66 1480 9 1 Farafenni 	- 
67 1481 6 1 Farafenni - 
68 1482 8 1 Farafenni 	- 
69 1483 5 1 Farafenni - 
70 1484 8 1 Farafenni 	- 
71 1485 7 1 Farafenni - 
72 1486 12 1 Farafenni 	- 
73 1487 31 2 Farafenni - 
74 1488 32 2 Farafenni 	- 
75 1490 14 1 Farafenni - 
76 1491 9 1 Farafenni 	- 
77 1492 2 1 Farafenni - 
78 1493 15 1 Farafenni 	- 
79 1495 16 2 Farafenni - 
80 1496 6 1 Farafenni 	- 
81 1 497 13 1 Farafenni - 
82 1498 14 1 Farafenni 	- 
83 1499 18 2 Farafenni - 
84 1500 20 2 Farafenni 	- 
85 1501 6 1 Farafenni - 
86 1502 14 1 Farafenni 	- 
87 1503 12 1 Farafenni - 
88 1504 2 1 Farafenni 	- 
89 1505 38 2 Farafenni - 
90 1506 61 2 Farafenni 	- 
91 1507 23 2 Farafenni - 
92 1508 2 1 Farafenni 	- 
93 1509 9 1 Farafenni 	- 
94 1510 6 1 Farafenni - 
95 1511 2 1 Farafenni 	- 
96 1512 63 2 Farafenni - 
97 1513 9 1 Farafenni 	- 
98 1514 11 1 Farafenni 	- 
99 1515 53 2 Farafenni - 
OG'CR AGE AGEGRO(JP AREA 	Parasitaemia 
100 1516 17 2 Farafenni - 
101 1517 13 1 Farafenni 	- 
102 1518 58 2 Farafenni 	- 
103 1519 10 1 Farafenni 	- 
104 1520 26 2 Farafenni 	- 
105 1521 11 1 Farafenni 	- 
106 1522 30 2 Farafenni 	- 
107 1523 9 1 Farafenni 	- 
108 1 524 8 1 Farafenni 	- 
109 1525 15 1 Farafenni 	- 
110 1526 58 2 Farafenni 	- 
111 1527 77 2 Farafenni 	- 
112 1528 19 2 Farafenni 	- 
113 1529 16 2 Farafenni 	- 
114 1530 65 2 Farafenni 	- 
115 1531 34 2 Farafenni 	- 
116 1534 50 2 Farafenni 	- 
117 1536 3 1 Farafenni 	- 
118 1537 42 2 Farafenni 	- 
119 1537 42 2 Farafenni 	- 
120 1538 40 2 Farafenni 	- 
121 1539 6 1 Farafenni 	- 
122 1540 6 1 Farafenni 	- 
123 1541 17 2 Farafenni 	- 
124 1542 20 2 Farafenni 	- 
125 1543 10 1 Farafenni - 
126 1545 11 1 Farafenni 	- 
127 1546 2 1 Farafenni - 
128 1547 4 1 Farafenni 	- 
129 1 548 7 1 Farafenni - 
130 1549 53 2 Farafenni 	- 
131 1550 11 1 Farafenni - 
132 1551 17 2 Farafenni 	- 
133 1552 9 1 Farafenni - 
134 1553 16 2 Farafenni 	- 
135 1 554 11 1 Faratenni 	- 
136 1556 9 1 Farafenni - 
137 1557 14 1 Farafenni 	- 
138 1558 16 2 Farafenni - 
139 1 559 15 1 Farafenni 	- 
140 1 560 9 1 Farafenni - 
141 1561 24 2 Farafenni 	- 
142 1562 33 2 Farafenni - 
143 1563 49 2 Farafenni 	- 
144 1564 35 2 Farafenni - 
Donor AGE agegroup area Parasitaemia serum no. serum no. 
Chapter 5 Chapter7 
145 1 MS 62 2 Brefet - 1 
146 4FB 37 2 Brefet - 13 
147 7SC 39 2 Brefet - 14 
148 12 TS 67 2 Brefet - 6 3 
149 13 AJ 58 2 Brefet - 15 
150 15TS 48 2 Brefet - 5 
151 28BC 60 2 Brefet - 8 
152 31 SS 47 2 Brefet - 7 
153 35 BS 40 2 Brefet - 3 4 
154 45 JK 60 2 Brefet - 10 
155 500S 41 2 Brefet - 16 
156 53MG 62 2 Brefet - 2 
157 69 JC 52 2 Brefet - 17 5 
158 79 AJ 53 2 Brefet - 12 2 
159 95SS 44 2 Brefet - 18 
160 104 FK 19 2 Brefet - 19 
161 105 MK 27 2 Brefet - 20 
162 109 FNS 20 2 Brefet - 21 
163 110 BS 19 2 Brefet - 22 
164 112 FSS 19 2 Brefet - 23 
165 114 MSS 31 2 Brefet - 10 
166 116 	JJJ 20 2 Brefet - 9 
167 117FB 68 2 Brefet - 11 
168 120 MS 31 2 Brefet - 24 
169 125 1K 44 2 Brefet - 25 
170 127 1K 19 2 Brefet - 26 
171 167WK 19 2 Brefet - 4 
172 A20 24 2 PNG - 
173 A21 25 2 FNG - 
174 A29 45 2 FNG - 
175 A34 18 2 PNG + 
176 A40 19 2 PNG - 
177 A41 33 2 P1')3 - 
178 A65 19 2 PNG - 
179 T314 23 2 PNG - 
180 1315 20 2 PNG - 
181 T350 37 2 PNG - 
182 T370 74 2 R'JG - 
183 T373 45 2 FNG - 
184 1374 41 2 PNG - 
185 T375 20 2 PNG + 
186 1380 51 2 FNG - 
187 1381 50 2 PNG - 
188 1450 21 2 A'JG + 
189 1547 20 2 PNG - 
190 A68 14 1 FNG - 
191 1336 10 1 FNG - 
192 T353 11 1 FNG + 
193 1376 14 1 FNG + 
T377 11 194 	 + 1 
 
195 T378 4 1 
 
196 T384 9 1 
 
197 1451 14 1 
 
Appendix 3 
Data included in chapter 3 
A 3.1 
X2  tests for independence between anti-gametocyte antibody response, age 
and area. 
Variables n x2 d.f. p value 
anti-260 and AGE 192 0.028 1 0.866 
anti -230 and AGE 192 2.621 1 0.106 
anti -48/45 and AGE 143 0.626 1 0.429 
anti -260 and AREA 192 1.000 2 0.607 
anti -230 and AREA 192 0.506 2 0.776 
anti -48/45 and AREA 143 3.850 2 0.146 
A 3.2 
No significant differences were found between antibody responses of 
Adults or kids from different geographical areas to gametocyte/gamete 
antigens. 
Variables 	 n 	x2 	d.f. 	p value 
Adults anti -260 responses 	11 	0.744 	2 	0.689 
7 
Adults anti -230 responses 	11 	0.101 	2 	0.951 
7 
Adults anti -48/45 responses 14 	3.244 	2 	0.198 
3 
Kids anti -260 responses 
	75 	0.288 	1 	0.591 
Kids anti -230 responses 
	75 	0.470 	1 	0.493 
Kids anti -48/45 responses 
	54 	0.211 	1 	0.646 
A 3.3 
No differences were found in responsiveness to Pfs230 and/or Pfs260 in 
individuals of different ages, and between age groups from different 
geographical locations. 
Variables 	 - n x2 d.f. p value 
anti -260/230 responses and AGE 19 3.381 1 0.184 
2 
Adults anti -260/230 responses 11 1.063 4 0.900 
7 
Kids anti -260/230 responses 75 0.525 2 0.769 
10 
Appendix 4 
Appendix to Chapter 5: Mosquito infectivity, and antibody data 
serum no. serum ID 'feed 2GM test 3GM control 
4  mean RI 5jyj. 6230a 7230b 11 48145 
1 1MS 7 2.7 0.462 3.813 0 2.61 0 2 
26 3.5 1.965 
2 53MC 12 0.45 1.39 0.324 0 12.1 3 1 
3 35BS 27 5.46 2.698 2.024 1 0.8 2 1 
4 167WK 25 1.96 1.14 1.719 0 0.0 0 2 
5 15TS 11 0.27 0.836 1.382 1 20.8 0 2 
26 6.943 1.965 
30 2.49 8.638 
6 12TS 8 2.19 21.37 0.102 1 1.2 0 0 
7 31SS 11 0.388 0.836 1.987 0 0.0 0 1 
27 9.47 2.698 
8 28BC 5 10.91 2.89 1.929 0 0.2 1 0 
11 0.137 0.836 
26 3.63 1.965 
9 116MJJ 24 0.807 2.497 0.323 1 1.1 0 1 
10 114MS 23 2.751 3.43 0.802 1 0.4 0 2 
11 117FB 24 1.735 2.497 0.695 1 0.3 0 1 
12 79AJ 3 0.24 2.01 0.060 1 19.7 0 1 
5 0.2 2.89 
12 0.07 1.39 
28 0 5.12 
13 4FB 7 10.29 0.462 11.698 1 0.0 1 1 
26 2.206 1.965 
14 7SC 7 8.8 0.462 10.058 0 1.2 1 3 
26 2.1 1.965 
15 1 3AJ 26 3.997 1.965 2.034 0 0.2 3 3 
16 500S 1 8.4 14.67 0.703 0 2.7 1 1 
12 0.74 1.39 
27 2.71 2.698 
17 69JC 12 0.89 1.39 0.343 0 1.1 3 2 
21 1.8 39.5 
18 95SS 6 6.8 8.95 0.557 1 0.3 0 2 
13 4.47 12.58 
21 21.9 39.5 
19 104FK 22 3.15 1.8 1.750 0 26.4 0 1 
20 105MK 22 4.79 1.8 1.560 0 1.6 2 0 
29 2.46 5.35 
21 109FNS 22 3.95 1.8 2.194 0 0.2 0 0 
22 11OBS 23 5.439 3.43 1.586 0 0.0 0 1 
23 112FSS 23 3.158 3.43 0.921 1 0.0 3 2 
24 120MS 24 0.569 2.497 0.228 1 3.1 0 0 
25 1251K 25 1.05 1.14 0.921 1 9.1 1 1 
26 127JC 25 1.47 1.14 1.289 1 0.9 1 1 
serum no. serum ID Lcj Q 2 Lq-3 jg4 
1 1MS 0.106 0.583 0.178 
2 53MG 0.033 1.010 0.419 
3 35BS 0.084 0.777 0.240 
4 167WK -0.031 0.111 -0.011 
5 15TS 0.253 1.400 0.952 
6 12TS 0.131 1.158 0.390 
7 31SS 0.611 0.964 0.390 
8 28BC 0.338 0.944 0.139 
9 116MJJ 0.077 0.578 0.015 
10 114MS 0.109 0.197 -0.010 
11 117FB 0.169 0.924 0.693 
12 79AJ 0.467 0.298 0.032 
13 4FB -0.016 0.263 0.061 
14 7SC 0.059 0.226 -3.364 
15 13AJ 0.062 0.658 0.376 
16 500S 0.114 0.343 0.001 
17 69JC 0.051 0.019 -0.015 
18 95SS 1.012 1.407 0.048 
19 104FK 0.260 1.030 0.815 
20 105MK 0.125 0.122 0.031 
21 109FNS 0.084 0.136 0.059 
22 11OBS 0.140 1.055 0.563 
23 112FSS -0.062 0.067 -0.022 
24 120MS 0.270 0.609 0.026 
25 1251K 0.219 1.151 0.941 
26 127JC 0.028 0.510 -0.016 
1Number of mosquito feed 
2Geometric mean of oocyst numbers in group of 20 mosquitoes fed on bloodmeal containing 
immune serum 
3Geometric mean of oocyst numbers in group of 20 mosquitoes fed on bloodmeal containing 
non-immune serum 
4Average relative infectivity over all feeds performed with this serum 
5result of in vitro complement-mediated gamete lysis 
6quantitation of amount of Pfs230 antibody in serum determined by phosphorimager 
7quantitation of amount of Pfs230 antibody in serum determined by visual analysis of 
autoradiograph bands 




Appendix to Chapter 7 
Infectivity data for all sera in titration experiment 
RI (oocyst number) - relative infectivity of P. falciparum to mosquitoes as 
determined by oocyst number. 
RI prevalence - relative infectivity of P. falciparum to mosquitoes as 
determined by proportions of mosquitoes infected. 
serum serum no complement serum concRi (oocyst no) p RI prevalence p n 
12 1 + 0.5 0.273 0.02 0.56 0.07 20 - 
1_ 1 + 1 0.091 0.01 0.11 0.0006 17 
12 1 + 2 0.091 0.0005 0.19 0.0008 20 - 
12 1_ + 4 0.364 0.16 0.46 0.13 8 - 
12 1_ + 8 0.182 0.05 0.22 0.03 8 - 
12 _1_ + 15 0.182 0.007 0.28 0.003 20 - 
11 P _1_ + 30 0 <0.0001 0.00 <0.0001 20 
112 _1_ - 0.5 1.76 0.05 1.04 0.37 20 
112 _1_ - 1 0.931 0.85 0.99 0.87 20 
112 _1 - 2 0.953 0.97 0.94 0.43 20 
112 _1_  4 0.439 0.08 0.89 0.2 20 
112 _1_ - 8 0.109 0.0005 0.52 0.0004 20 
112 _1_ - 15 0.452 0.002 0.94 0.42 20 
112 1  30 0.118 <0.0001 0.57 0.001 20 
79 2 + 0.5 0.793 0.58 0.83 0.44 24 
79 _2_ + 1 0.691 0.34 0.70 0.2 19 
79 2_ + 2 1.06 0.74 1.08 0.71 20 
79 _2 + 4 0.018 0.003 0.33 0.004 20 
79 2 + 8 0.276 0.03 0.50 0.03 20 
79 2 + 15 1.428 0.62 0.98 0.94 22 
79 2 + 30 0.092 0.003 0.22 0.002 15 
79 2 - 0.5 1.254 0.73 1.00 1 	1 20 
79 2 - 1 1.756 0.04 1.33 0.12 20 
79 2 - 2 0.375 0.01 0.50 0.03 20 
79 2 - 4 1.101 0.95 0.92 0.71 20 
79 2  8 0.763 0.22 0.58 0.07 20 
79 2 - 15 0.547 0.07 0.75 0.27 20 
79 2 . 30 0.065 <0.0001 0.08 <0.0001 1 	20 
12 3 + 0.5 1 	1.239 0.65 0.90 0.74 22 
12 3 + 1 2.987 0.006 1.25 0.23 20 
12 3 + 2 1.336 0.45 1.03 0.78 24 
12 3 + 4 1.7195 0.22 1.00 0.94 20 
12 3 + 8 0.332 0.004 0.33 0.01 15 
12 3 + 15 2.995 0.006 1.40 0.06 19 
12 3 + 30 0.333 0.005 0.13 0.002 13 
12 3 - 0.5 1.96 0.008 1.95 0.008 17 
12 3 - 1 1.268 0.5 1.19 0.59 20 
12 3 - 2 0.58 0.15 0.71 0.37 20 
12 3 - 4 0.728 0.31 0.71 0.37 20 
12 3 - 8 0.643 0.9 0.48 0.2 20 
12 3 - 15 1.241 0.43 1.31 0.38 20 
1 2 3 - 30 0.826 0.5 0.83 0.6 20 
continued on next page 
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Appendix 5 continued. 
serum 	Iserum ndcomplementlserum conciRl (oocyst no)I p RI prevaIence p n 
35 4 + 0.5 1.21 0.73 0.58 0.7 20 
35 4 + 1 0.64 0.41 0.33 0.41 20 
35 4 + 2 0.593 0.95 0.58 0.7 20 
35 4 + 4 0.814 0.26 0.27 0.25 20 
35 4 + 8 1.046 0.66 0.58 0.7 20 
35 4 + 15 5.523 0.01 1.02 0.03 18 
35 4 + 30 1.628 0.29 0.75 0.26 20 
35 4 - 2 2.298 0.08 1.42 0.1 24 
35 4 - 4 0.357 0.18 0.81 0.47 21 
35 4 - 8 0.604 0.4 0.87 0.59 24 
35 4 - 15 0.293 0.06 0.62 0.14 24 
35 4 . 30 0.207 0.03 0.57 0.11 20 
69 5 + 0.5 1.026 0.95 0.91 0.82 17 
69 5 + 1 1.654 0.33 1.11 0.75 20 
69 5 + 2 1.12 0.81 1.00 1 20 
69 5 + 4 1.183 0.73 1.00 0.98 11 
69 5 + 8 1.602 0.16 1.33 0.35 20 
69 5 + 15 1.738 0.03 1.82 0.02 17 
69 5 + 30 0.67 0.05 0.27 0.04 16 
69 5 - 0.5 0.263 0.002 0.53 0.008 20 
69 5 . 1 0.694 0.32 0.87 0.42 20 
69 5 - 2 021 0.009 0.48 0.02 11 
69 5 . 4 1.813 0.07 1.13 0.38 20 
69 5 - 8 1.301 0.68 20 
69 5 - 15 _1.608 
~O. 
~10 0.67 20 69 5 . 30 2.297 0.67 20 
14 
Appendix 6 
Healer, J., McGuinness, D., Hoperoft, P., Haley, S., Carter, R. & Riley, E. 
1997 Complement-mediated lysis of Plasmodium falciparum gametes 
by malaria-immune human sera is associated with antibodies to the 
gamete surface antigen Pfs230. Inf. Immun. 65, 3017-3023. 
15 
INFECI1ON AND IMMUNITY, Aug. 1997, p. 3017-3023 
	
Vol. 65, No. 8 
0019-9567/97/$04.00+0 
Copyright © 1997, American Society for Microbiology 
Complement-Mediated Lysis of Plasmodium falciparum Gametes 
by Malaria-Immune Human Sera Is Associated with Antibodies 
to the Gamete Surface Antigen Pfs230 
JULIE HEALER,*  DAVID McGUINNESS, PHILIP HOPCROFT, SUSAN HALEY, RICHARD CARTER, 
I 	
AND ELEANOR RILEY 
Institute of Cell, Animal and Po'puliuion Biology, Division of Biological Sciences, University of Edinburgh, 
Ashworth Laboratories, Edinburgh EH9 3JT, Scotland, United Kingdom 
Received 24 January 1997/Returned for modification 13 March 1997/Accepted 5 May 1997 
Antibodies to the sexual-stage surface antigens of Plasmodium fakiparum, Pfs230 and Pfs48/45, can abolish 
the infectivity of gametes to mosquitoes; these antigens have been proposed as candidates for inclusion in a 
malaria transmission-blocking vaccine. One possible mechanism of antibody-mediated transmission blocking 
is complement-mediated gamete lysis. We have used a panel of human sera from geographically distinct 
regions where malaria is endemic to investigate whether this may be a mechanism of naturally acquired 
transmission-blocking immunity to P. fakiparum. By immunoprecipitation, we have shown that antibody 
recognition of Pfs230 and Pfs48/45 is limited, despite universal exposure to P. falciparum gametocytes. In vitro 
complement-mediated lysis of P. falciparum gametes was positively associated with the presence of antibodies 
to Pfs230 but not with antibodies to the N-terminal region of the precursor molecule (Pfs260), which is shed 
from the gametocyte surface at the time of gametogenesis. Similarly, antibodies to two other gametocyte-
specific proteins, Pfs48/45 and Pfg27/25, were not associated with gamete lysis. All sera which mediate gamete 
lysis contain immunoglobulin Gi (IgGi) and/or IgG3 antibodies to gamete surface proteins as determined by 
an enzyme-linked immunosorbent assay. These data suggest that Pfs230 is a major target of complement-fixing 
antibodies which may be important for antibody-mediated transmission-blocking immunity. 
Transmission of malaria is dependent upon the successful 
completion of the sexual phase of the life cycle within the 
mosquito vector. Interrupting the development of the sexual 
stages by preventing fertilization or the establishment of zy -
gotes on the mosquito midgut is recognized as a potential 
strategy for the control of malaria transmission. 
Gametocytes, gametes, and zygotes express novel, stage-spe-
cific antigens on their surfaces (16, 31), rendering them sus-
ceptible to immune attack. Both antibody-mediated and cell-
mediated effector mechanisms are believed to play a role in 
transmission-blocking immunity (28), although most attention 
has focused on defining the antigenic targets of antibody-de-
pendent mechanisms. The major gametocyte and gamete sur-
face antigens of Plasmodium falciparum, Pfs230 and Pfs48/45, 
which might form the basis of a transmission-blocking vaccine, 
are known to be targets of transmission-blocking monoclonal 
antibodies (MAbs) (19, 22, 30). Both proteins are synthesized 
early in gametocyte development (16). Pfs230 is derived from 
processing a precursor molecule which has been traditionally 
termed Pfs260 (19, 32). The predicted size of the precursor 
gametocyte form is 360 kDa, and that of the mature protein is 
310 kDa (34). In this paper, we shall refer to the proteins as 
Pfs260 and Pfs230. It is believed that at the time of gameto-
genesis (emergence of the gamete from the host erythrocyte in 
the mosquito gut), Pfs260 is specifically cleaved, with the mem-
brane-associated Pfs230 fragment remaining on the gamete 
surface (32, 35), where it exists as a complex withPfs48/45 (16). 
All Pfs230-specific transmission-blocking MAbs studied to 
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mail: Julie.healer@ed.ac.uk.  
date are directed against conformational epitopes and do not 
recognize the protein in reduced form (21). Another common 
feature is that they are all of complement-fixing immunoglob-
ulin G (lgG) subclasses and do not block parasite development 
unless complement is present (21, 26). Furthermore, immuni-
zation of mice with part of Pfs230 produced as a bacterial 
fusion protein induced antibodies which block transmission in 
the presence of complement (36). The doublet Pfs48/45 is 
produced by differential processing of the products of a single 
gene. Studies using Pfs48/45-specific MAbs have revealed iden-
tical epitopes on both components of the doublet (31). Some of 
these MAbs block infectivity without the requirement for com-
plement, while others are dependent on the presence of com-
plement; some require the presence of other MAbs with syn-
ergistic blocking effects (4, 22, 28, 31). 
Antibodies against both Pfs230 and Pfs48/45 are found in 
human sera collected in regions where malaria is endemic (5, 
8, 23, 24, 27). Graves et al. (8) demonstrated a correlation 
between suppression of infectivity of gametocytes to mosqui-
toes in membrane feeding assays and the presence of antibod-
ies to Pfs230 in sera from Papua New Guinea. However, stud-
ies elsewhere have found no significant correlation between 
infectivity of gametocytes and the presence of antibodies to 
Pfs230 (18, 25). 
Antibodies to the gametocyte and gamete-specific intracel-
lular protein Pfg27/25 are found in the sera of most, if not all, 
people exposed to gametocytes (23), but these do not appear to 
play a significant role in transmission-blocking immunity. Al-
though MAbs against Pfg27/25 have been shown to mediate 
transmission blocking (37), this may be due to a cross-reaction 
with Pfs230. Pfg27/25 antibodies do, however, serve as a useful 
marker for exposure to P. falciparum gametocytes. 
In animalmalaria models, several potential antibody-medi-
ated mechanisms of transmission-blocking immunity have been 
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bodies to other gametocytc-speciflc proteins (Pfs48/45, the N- 
terminal region of the Pfs26() precursor molecule, and l'fg27/ 
25) are not. All sera which mediated gamete lysis contained 
IgGI and/or lgG3 antibodies (human lgG subclasses which fix 
complement in antibody-mediated reactions) to gamete sur-
face antigens, but not all antibody-positive sera were able to 
mediate lysis, suggesting that the epitope specificity of the 
antibody, as well as its isotype, may he important for its func-
tion. 





FIG. I. In vitro lysis of P. falcipanim gametes in the presence of immune 
serum and complement (a) or of immune serum and inactivated complement (b). 
described, including complement-mediated lysis (14), aggluti-
nation of gametes (1), and antibody-dependent phagocytosis 
(20). The former two mechanisms have also been demon-
strated in MAb-mediated transmission-blocking immunity 
against P. rIeiparwn gametes (22). However, the mechanisms 
by which naturally acquired antibodies to gametocyte and ga-
mete antigens mediate transmission-blocking immunity have 
not yet been elucidated. In the present study, we have tested 
human sent from The Gambia and Papua New Guinea for 
their ability to mediate complement-dependent lysis of mac-
rogametes of P. falciparwn in vitro. We have also looked, by 
imniunoprecipitation, for antibodies to Pfs260, Pfs230, Pfs48/ 
45. and Pfg27/25 and have determined the lgG subclass of 
antibodies to ganietocvte antigens by an enzyme-linked immu-
nosorhent assay (ELISA). We have evaluated the relationship 
between the ability of scra to mediate gamete lysisand anti-
body status and have found that while antibodies to Pfs230 are 
positively associated with complement-dependent lysis. anti- 
Parasites. Garnetocytes of I' ftulciparwn clone 3D7A (33) were grown in 
culture as described previously ( 12). with RPM! 104() (Gihco, Paisley. Scotland: 
p11 8.7) supplemented with tOi heat-inactivated normal human serum, 25 mM 
1-IEPES (N-2-hydroxvethylpiperazine-N'-2-ethanesulionic acid), hypoxanthine. 
and 5% NaHCO (complete medium). 
Fifteen to 17 days after expansion of a culttire with fresh crvthrocytes, mature 
gametiicytcs were harvested and stimulated to undergo gametogenesis tor I It in 
complete medium to which an extract of mosquito pupae had been added (17). 
Gametes were enriched on it discontinuous Nycodenz (Nijcgn'ard, Norway) gra-
dient (30) in M190 medium (Gihco). The gamete traction was recovered from 
the interface between 11 and 6% Nyeodenz gradients and washed twice in RI'MI 
1641). 
Gametocytes destined for I251 labelling of internal antigens were harvested 
after 14 days in culture and enriched on discontinuous Percoll (Pharmacia. 
tippsala. Sweden) gradients 
(6). 
 Mature gametocytes were isolated from the 
interface between 3)) and 45% Pereoll gradients. 
Human sera. Sera were collected during the malaria transmission season from 
Of villagers, aged between I and 77 years, living near the town of Farafenni. 
situated on the north hank of the Gambia River. We also analyzed sera lrom 27 
adults, collected as part of it longitudinal survey. from the village of Bretet. south 
iii the Gambia River. Malaria is seasonally endemic in all areas of The Gambia 
(10). Finally, samples collected in Papua New Guinea as part of a cross-sectional 
malaria survey of individuals over 4 years of age from the villages of Tau. in Fast 
Sepik Province, and Agan. in Madang Province, were used (i))  Malaria is highly 
endemic in both of these villages (5) (sera from these areas are termed malaria 
exposed). 
Control scra (ii = 41)) were obtained from nonexposed European donors 
(nonexposed European vera). 
Assay for complement-mediated lysis of gametes. Approximately 2 X lll 
gametes of I'. fakipariini, in 10 id ii) Ml 91)  medium, were aliquiitcd into each 
well of it sterile, round-bottom, 96-well microtiler plate. Ten mieriiliters of 20% 
fresh, nonimmune human serum in pliiisphate-hullercd saline (PBS) was added 
to each well as a sotiree of complement. This serum had been absorbed on 
swollen agarose and preineubated for 30 min with 5 x It)' gametes to remove 
nonspecific cyttitoxie activity. ('ontrol wells received 10 il if nonimmune human 
serum which had been heat inactivated at 50C for 30 miii to dest roy the 
complement activity, rest vera (malaria exposed) were heat inactivated at 36C, 
and 10 l of each serum was then added to paired gamete wells, one which 
contained active complement and the other which contained heat inactivated 
complement. The final dilution of lest serum was 311 11c. Plates were incubated at 
37C for 411 mm. The contents of each well were pipetted onto single wells of a 
multispot slide and allowed to drv overnight at room temperature before being 
stained with (;iemsa stain. Slides were then analyzed (blind) by oil immersion 
microscopy. and restilts were confirmed by a further blind analysis by another 
reader, European vera were used as negative controls. 
1251 labelling. immunoprecipitation, and sodium dodet-yl sulfate-polyac,lam. 
ide gel electrophuresis (SDS-PA('.E) analysis of P.fakipanun gametocytes. Ma-
ture gametocytes were puntied on discontinuous Pereoll gradients as described 
above. Approxiniately fi K Ill gamctocytes were washed twice in incomplete 
medium and extracted with 51) 0 of NEIl] (6) (0.15 M Na( ....S mM EDTA, 50 
mM Tris IPFI 741, 0.5% Triton X-lttt), 0.05 Na azide, and the priiteasc inhib-
hors [Sigma. Poole. England] phenvlmethvlsulfonyl fluoride II mMl. pepstttin 
It.) mMl. TPCK IN-tosyl-i -phenylalanvl chloromethyl ketone: )).l mM[, EDTA 
II rnMl. EGTA II mMl, and N-ethylrnaldimide Il rnM) by viirtexing for I nun 
and then spinning at top speed in a mierocentrifuge for 5 miii at 4CC. The extract 
was labelled with l  by the IO[)OGEN method as described previously (11). 
Labelled ganietoeytc proteins were made up to 5 ml with NETFI and then 
stored at 4CC. Twenty-live microliters of gametocyte protein was incubated with 
2)) ii.) of neat, heat-inactivated human serum, 40 t d of 25 11e protein G.Sepharose 
(Pharmacia ). and 41)1) el of NEIr (NIIl without protease inhibitors). 'lhis was 
incubated on a rotating wheel overnight at 4CC. The heads were washed once 
with NEFF. then with NETFS (NEFF with 1165 M NaCI), and finally svitlt NEIl' 
again. After washing, the heads were resuspended in (ill ii of nonredueing 
SDS-PAGE sample buffer (62.5 mM Tris,5"% SDS, 10% glycerol. lOIn? bro-
rnophenol blue). Samples were incubated at IDIEC for 5 min and spun at top 
speed in it mierocentrifuge for 5 inin before being loaded onto a S to 15% 
gradient SS-PAGE gel. Positive control immunoprecipitations were pertornied 
with the P6,230-specitic MAb 12Flt) (21). Nonexposed European sera showed no 
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TABLE 1. Proportions of sera from regions where malaria is endemic mediating complement-dependent lysis of P. falciparum gametes in 
vitro and antibody recognition of specific gametocyte or gamete antigens 
No. of sera 
Serum source Antibody positive  
(region and subjects) 	 Total 	
Lysis 	
Pfs260 positive Pfs260/230 	
(N terminus only) 	 Pfs48/45  
Farafenni, The Gambia 
Children 20 8 (40.0)" 8(40.0) 7(35.0) 11(55.0) 
Adults 41 18 (43.9) 19 (46.3) 17 (41.5) 24 (58.5) 
Brefet, The Gambia, 27 13 (48.2) 15 (55.6) 8(29.6) 21 (77.8) 
Adults 
Papua New Guinea 
Children 8 3(37.5) 2(25.0) 3(37.5) 4(50.0) 
Adults 18 12 (66.7) 8(44.4) 4(22.2) 10 (55.6) 
Overall total 114 54(47.4) 52(45.6) 39 (34.2) 70(61.4) 
Values in parentheses are percentages 
reactivity with Pfg27/25, Pfs260/230, or Pfs48/45 (data not shown), and sera of 
subjects from regions of endemicity negative for Pfs260/230 and Pfs48/45 are 
included in all gels. 
1251 labelling of gamete surface antigens. Purified gametes were labelled as 
described for gametocytes except that detergent extraction was performed after 
surface proteins were iodinated such that only those proteins on the gamete 
surface were radiolabelled. Immunoprecipitations were performed as described 
above, with the additional positive control using MAb 3E12 which is specific to 
Pfs48/45 (4). Nonexposed European sera showed no reactivity with Pfg27/25, 
Pfs260/230, or Pfs48/45 (data not shown) and sera of subjects from regions of 
endemicity negative for Pfs260/230 and Pfs48/45 are included in all gels. 
IgG subclass analysis by ELISA. Mature gametocytes, purified on Percoll as 
described above, were prepared by the methods of Bordier (2), Kumar (15), and 
Roeffen et al. (25) for enrichment of Pfs230 by extraction of gametocytes in 
Triton X-114 (1% in 10 mM Tris-HCI buffer [pH 7.4] containing protease 
inhibitors). The aqueous phase derived from this procedure was used as the 
antigen source for the ELISA. 
lmmulon-4 microtiter plates (Dynatech, Billinghurst, United Kingdom) were 
coated with 1% poly.L-lysine in PI3S (25) and washed six times with PBS-0.05% 
Tween 20 before the addition of the aqueous gametocyte extract (see above) to 
give an equivalent of 105  gametocytes per well. Plates were incubated overnight 
at 4°C, washed six times, and then blocked with 5% skim milk in PBS-Tween 20 
at 37°C for 3 h; this was followed by a further six washes. Human sera diluted at 
1/200 in 1% skim milk in PBS-Tween 20 (incubation buffer) were added to 
duplicate wells containing the gametocyte extract and also to control plates 
containing poly.L-lysine alone. These were incubated for 90 min at 37°C and then 
washed a further six times. Mouse monoclonal anti-human lgG subclass sera 
(anti-IgGi, -lgG2, and -lgG4 [Boehringer Mannheim, Lewes, United Kingdom] 
and anti-IgG3 [Serotec, Oxford, United Kingdom]) were added at the following 
concentrations in incubation buffer: anti-IgGi (clone, NL16) at 1/2,000, anti-
lgG2 (clone, ROM 1) at 1/250; anti-lgG3 (clone, HP 6050) at 1/2,000, and 
anti-lgG4 (clone, RJ4) at 1/1,000. These were incubated for I h at 37°C and 
washed six times, a 1/1,000 dilution in incubation buffer of horseradish peroxi-
dase-conjugated rabbit anti-mouse lgG (Dako, Denmark) was added, and the 
plates were incubated for I h at 37°C. The subclass specificity of these MAbs has 
been reported previously (13, 29) and was reconfirmed before use. Plates were 
developed with H2O, as the substrate and o-phenylenediamine (Sigma) as the 
chromogen, and the reaction was stopped after 10 min by the addition of 20 iii 
of 2 M H2SO4  per well. The optical density (OD) was measured at a wavelength 
of 492 nm. The antigen-specific OD (sOD) was calculated by subtracting the OD 
of the poly-L-lysine wells from the OD of the gametocyte extract-containing 
wells. Sera were considered positive for each isotype if the sOD was greater than 
the hormal range (mean + 2 standard deviations) for the 40 nonexposed Euro-
pean sera tested for each subclass. 
Statistical analysis. Multiple logistic regression was used to test for an asso-
ciation between lysis and each of the antibody variables. Odds ratios (ORs) and 
95% confidence intervals (CI), corrected for potential confounding by age and 
geographical area, were calculated. All computation was carried Out with GLIM 
3.77 software. 
RESULTS 
Complement-mediated lysis. Sera from 114 malaria-exposed 
individuals were screened for their ability to mediate in vitro  
lysis of P. falciparum macrogametes in the presence or absence 
of active human complement. Each serum sample was classed 
as either positive or negative based on microscopic analysis of 
Giemsa-stained slides. Lysis was detectable as fragmentation 
of gametes, with extracellular malaria pigment scattered liber-
ally across the slide. Sera were scored positive if few or no 
intact gametes were seen and if gametes remained intact in the 
serum-matched control (in the absence of complement) (Fig. 
la); however, in most cases where lysis occurred, few, if any, 
intact gametes were found. A serum sample was given a neg-
ative score if most gametes remained intact following incuba-
tion with active complement (Fig. ib). Since lysed gametes are 
detectable only as pigment granules, it was not possible to 
obtain an exact figure for percentage lysis. Each serum sample 
was tested on at least two separate occasions, and repeatable 
results were obtained. No nonspecific cytotoxicity was ob-
served when sera were incubated with gametes and heat-inac-
tivated complement. European control sera were negative in 
the assay. Table 1 shows the numbers of sera which mediated 
complement-dependent gamete lysis. Overall, 47% of the sera 
were positive in the assay (CI, 38.5%, 56.5%). No significant 
differences were found in the proportions of sera which medi-
ated complement-dependent gamete iysis based on age, sex, or 
geographical origin of the donor (P > 0.2 in all cases). 
Immunoprecipitation of total gametocyte antigens. The sera 
were used to immunoprecipitate radioiodinated proteins from 
a Triton X-100 aqueous extract of gametocytes (Fig. 2). Im-
mune complexes were absorbed with protein G-Sepharose 
beads which bind all subclasses of human IgG. Autoradio-
graphs of gels revealed that all sera of subjects from regions of 
endemicity were positive for antibodies to the gametocyte-
specific protein Pfg27/25. Thus, it is likely that all of the indi-
viduals tested had been exposed to P. falciparum gametocytes. 
In contrast, recognition of Pfs230 was limited. All sera which 
immunoprecipitated Pfs230 also recognized Pfs260, the pre-
cursor form of the protem (Fig. 2, lanes 6, 7, 9, and 11). Certain 
sera which were negative for Pfs230 did, however, possess 
antibodies to Pfs260 (e.g., Fig. 2, lanes 4, 8, and 10). Presum-
ably, these antibodies recognize epitopes within the N-terminal 
region of the molecule which is cleaved off at gametogenesis. 
Some sera (e.g., Figure 2, lanes 8 and 10) showed faintbands 
which appeared to have sizes intermediate between those of 
Pfs260 and Pfs230; these were recorded as Pfs230 negatives, 
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FIG. 2. P. fu/ciparuin garnetocyte proteins extracted with Triton X-ItJ(l 1 la-
belled with 1I,  and immunoprecipitated with immune human sera (Brefet. The 
Gambia). Lanes: 1, MAb 12F10, specific for Pfs230; 1 3, and 5, P1s260/230-
negative sera: 4. 8. and II). P1s260-unlv-positive scra: 6, 7.9. and 11. Pfs260(230-
positive scra. 
and this was confirmed by immunoprecipitation of gamete 
surface antigens. 
Inimunoprecipitation of gamete surface antigens. Immuno-
precipitallons were also performed with 1 1-labelled gamete 
surface antigens extracted with Triton X-100. By use of this 
method. Pfs48/45 as well as Pfs230 was detectable (Fig. 3). 
These experiments confirmed the limited recognition of Pfs230 
and showed that recognition of Pfs48/45 was also limited. Sc-
ropositivity to Pfs230 did not correlate with recognition of 
Pfs48/45 (e.g.. Fig. 3, lanes 3, 10, 12, and 14). Of the 114 serum 
samples tested. 46% were positive for antibodies to Pfs230 
(Table 1). An additional 34% of the sera recognized only the 
N-ternlinal region of Pfs260. Sixty-one percent of all sera were 
positive for anti-Pfs48/45 antibodies. Thirty-three percent (38 
of 114) of the sera were positive for antibodies to Pfs260, 
Pfs230. and Pfs48/45, whereas 12% (14 of 114 sera) were pos-
itive for Pfs260 and Pfs230 antibodies but negative for Pfs48!45 
antibodies. A further 10% (12 of 114 scra) were positive for 
anti-Pfs48/45 antibodies but negative for anti-Pfs260/230 anti-
bodies. We found no differences in responsiveness to Pfs230. 
Pfs260, or ['fs48/45 based on sex, age, or location of the donors. 
Relationship between the presence of antigametocyte anti-
bodies and complement-mediated lysis of gametes. Each of the 
114 sera were coded for their ability to mediate gamete lysis 
and whether they were positive for antibodies to Pfs260. 
Pfs230, and Pfs48/45. All sera were positive for antibodies to 
Pfg27/25. We were then able to look for associations between 
the ability to mediate gamete lysis and the presence of each of 
these antibodies by logistic regression analysis (Table 2). This 
revealed if highly significant association between gamete lysis 
and antibodies to Pfs230 (P < 0.0001). A serum sample in 
which anti-Pfs23() antibodies were present was 13 times more 
likely to mediate gamete lysis than an anti-Pfs23() antibody-
negative serum sample. with 73% of sera containing anti- 
- 
.1 	1 
FIG. 3. ? Jdlcipaniin gamete surface proteins labelled with 125 1 and immu-
nopreeipitated with Immune human sera (Farafenni. The Gambia). Lanes: I. 
negative control, scra of subjects from regions of endemicity negative for anti-
bodies to P1`s230 and Pfs48/45: 2. MA6 12Fttt specific for Pfs230: 3, MAb 3E12 
specific br Pfs48/45: 4, 7, 8, and Ii, Pts230- and Pfs48/45-posilive scra; 14. 
Pfs230-positivc. Pfs48/45-positive sera: 3. 10. and 12. Pfs2311-ncgativc, Pfs48/45-
positive sera: 6 and 9. Pfs230-ncgative, Pfs48/45-scra. 
Pfs230 antibodies able to mediate gamete lysis. In contrast, no 
association was found between antibodies to either Pfs260 or 
Pfs48/45 and lysis. However, lysis in the absence of antibodies 
to Pfs230 was detectable in a few sera (it = 16): antibodies to 
Pfs48/45 were detectable in the majority of these sera (9 of 16) 
but not all, suggesting that antibodies to another antigen may 
also he mediating lysis. The adjusted OR for the relationship 
between anti-Pfs230 antibodies and lysis increased substan-
tially after the effects of the other antibodies were accounted 
for (Table 2), indicating that these other antibodies may have 
a synergistic effect on the ability of anti-Pfs230 antibodies to 
mediate lysis. When the regression estimates for lysis in the 
presence of anti-Pfs230 antibodies are adjusted for age and 
area, an increase in the OR (Table 2) is again observed, which, 
TABLE 2. Association of in vitro complement-niedialcd gamete 
lysis and presence of antibodies to Pfs260. Pfs230. and Pfs48/45 
Antibody 
to: 




OR (95% CI) P value 
PIs260 48.9(44) 41.7(10) 1.34 (0.54, 3.33)" 0.53 
1.45 (0.56, 3.74)' 0.71 
0.37(0.11, 1.2)" (1.11) 
Pfs230 73.1 (38) 25.8 (16) 7.81 (3.39, 17.96)" <0.0001 
8.79 (3.1)5. 21.18 )' <0.000 I 
12.88 (4.53, 36.64)" <(((10(11 
Pfs48/45 51.4 (36) 40.9(18) 1.53 (071, 3.28)" 0.28 
1.56 (0.71, 3.43)' 0.27 
1.05 (0.42, 2.65)" 0.91 
Ab. antibody. 
('rude OR comparing the odds of lysis between antibody-positive and anti-
body-negative sera (based on 114 sera). 
OR adjusted for age and area. 
OR adjusted for age, area, and the effect of the other two antibodies. 
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TABLE 3. IgG subclasses of antibodies present within sera which recognize the gametocyte-specific proteins Pfs260, Pfs230, and Pfs48/45 
No. of antibody-positive sera 
Antibody to: Lysis positive Lysis negative 




7 	6 (85.7) 
36 26 (72.2) 






















Values in parentheses are percentages 
although not statistically significant, is indicative of a difference 
between sera from adults and children in their ability to me-
diate gamete lysis (50% of adult sera mediated lysis compared 
with 39% of sera from children). In contrast, the OR for 
Pfs48/45 decreases when adjustments are made for other an-
tibodies, suggesting that any effect of anti-Pfs48/45 antibodies 
may be due to the simultaneous presence of antibodies against 
Pfs230. 
Gametocyte-specific IgG subclass analysis. The IgG sub-
class of gametocyte-specific responses was determined for the 
majority of sera, by use of a Pfs230-enriched gametocyte anti-
gen preparation in an ELISA. Extraction of gametocyte anti-
gens in TX-114 has been shown previously to produce an 
enriched source of Pfs260/230 (15). This was confirmed by 
SDS-PAGE analysis. Three major bands were observed when 
the whole extract was run (molecular sizes, 260, 230, and -100 
kDa), but only Pfs260/230 was immunoprecipitated with im-
mune human serum (data not shown). Pfs260/230 therefore 
appears to be the major antigen in the extract, although other, 
less immunogenic proteins were also present. It was apparent 
that IgGi and IgG3 were the predominant isotypes in both 
lysing and nonlysing sera (Table 3); this was the case in both 
children and adults (data not shown). However, the broad 
similarity in the isotypes of lysing and nonlysing sera hides 
some interesting differences. First, IgG2 is more prevalent in 
children (26%) than in adults (18%), and IgGi and IgG3 are 
less prevalent in children (IgGi was present in 82.4% of adults 
compared with 48.1% of children). Importantly, all sera which 
mediated complement-dependent lysis contained IgGi and/or 
IgG3 antibodies specific for the Pfs230-enriched gametocyte 
extract. Table 4 shows a summary of the results obtained from 
logistic regression analysis, which was used to test for a rela-
tionship between IgG subclass and lysis. No associations were 
found between the isotype of the antigametocyte antibodies 
present and their ability to mediate gamete lysis; however the 
number of IgG2- and IgG4-positive sera was low compared to 
the number of IgGi- and IgG3-positive sera. Of the 13 nonl- 
TABLE 4. Association of in vitro complement-mediated gamete 
lysis and IgG subclass of gamete-specific antibodies 
IgG subclass 
% (No.) Lysis-positive sera 
Ab" positive 	Ab negative 
OR (95% Cl)" P value 
1 46.8 (36) 41.4 (12) 1.15 (0.44, 2.97) 0.78 
2 47.4(9) 44.8 (39) 1.22 (0.39, 3.77) 0.73 
3 47.7 (41) 35 (7) 1.63 (0.55, 4.83) 0.38 
4 33.3(3) 46.4 (45) 0.50 (0.10, 2.38) 0.39 
1 and/or 3 46.5 (46) 28.6(2) 1.83 (0.31, 10.84) 0.51 
2 and/or 4 42.9 (12) 46.2 (36) 0.89 (0.35, 2.28) 0.81 
Ab, antibody. 
OR is based on 106 sera adjusted for age, area, and the other subclasses, of 
which 48 (45%) were lysis positive.  
ysing sera which were anti-Pfs230 antibody positive and tested 
in the ELISA, all appeared to contain IgGi and/or IgG3 an-
tibodies; thus, the lack of complement-fixing antibodies is not 
an adequate explanation for their failure to mediate lysis. Of 
the 10 sera which were negative by immunoprecipitation for 
antibodies to Pfs260, Pfs230, and Pfs48/45, 8 were positive by 
ELISA, albeit weakly so. It is possible that these sera recog-
nized the other protein components of the gametocyte extract. 
A potentially interesting, although not statistically significant, 
finding was that IgG2 was more prevalent in anti-Pfs230/260 
antibody-positive, nonlysing sera than in anti-Pfs230/260 anti-
body-positive, lysing sera (OR = 0.39 [95% Cl, 0.08, 1.76], P = 
0.17) (Table 3). 
DISCUSSION 
The aims of this study were to test a panel of human sera 
from various regions where malaria is endemic for their ability 
to mediate complement-dependent lysis of gametes in vitro, to 
look for antibodies against P. falciparum gametocyte antigens 
and the dominant surface antigens Pfs230 and Pfs48/45 in 
particular, and to look for an association between specific 
antibodies and gamete lysis. When results from the comple-
ment assay were compared with those from the immunopre-
cipitations, it was clear that gamete lysis was strongly associ-
ated with the presence of antibodies against Pfs230 but not 
with antibodies to either Pfg27/25, Pfs48/45, or the N-terminal 
processing product of Pfs260. Although not statistically signif -
icant, minor differences were found in the ability of sera from 
individuals of different ages, and from different geographical 
locations, to mediate gamete lysis when anti-Pfs230 antibodies 
are present. This may represent age-related maturation of the 
immune response towards effective transmission blocking. 
Gamete lysis was not significantly associated with antibodies 
to Pfs48/45, but it was more likely to occur in the presence of 
antibodies to both Pfs230 and Pfs48/45 together, perhaps sug-
gesting some functional interactions between the two sets of 
antibodies. 
An ELISA was designed to assess the influence of antibody 
isotype on gamete lysis. In particular, we were seeking an 
explanation as to why some sera failed to mediate gamete lysis 
when they appeared to recognize Pfs230 by immunoprecipita-
tion. There are considerable practical difficulties in obtaining 
purified Pfs230 to use in immunoassays. The majority of 
epitopes recognized by transmission-blocking antibodies are 
dependent on preserving the intact secondary and tertiary 
structure of the molecule (19, 21), and it has not yet been 
possible to express the Pfs230 gene in a manner which pro-
duces conformationally correct proteins. In this study, we used 
an extract of gametocyte proteins as the antigen source for the 
ELISA, which, although enriched for Pfs260/230, also con-
tained other gametocyte proteins. In humans, gamma globulins 
of subclass IgGi and IgG3 fix complement, whereas IgG2 and 
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IgG4 do not (3). We found that all sera which mediated lysis 
contained IgGi and IgG3 antibodies, but a lack of comple-
ment-fixing isotypes did not appear to explain the failure of 
Pfs230-positive sera to mediate gamete lysis since all Pfs230-
positive, lysis-negative sera contained gametocyte-speciflc 
IgGi or IgG3. The inability to obtain pure Pfs230 does impose 
some limitations on the direct comparison of the ELISA re-
sults with those obtained by immunoprecipitation and the ga-
mete lysis assay and may explain why some sera which recog-
nized neither Pfs230 nor Pfs48145 by immunoprecipitation 
were positive in the ELISA. Also, since most of the Pfs230 was 
in the precursor form, the detectable IgGi and IgG3 may be 
directed towards epitopes in the N-terminal 50 kDa (which is 
absent from the mature gamete surface protein) and, as such, 
have no role in mediating gamete lysis. It is also possible that 
epitopes not exposed in the native proteins may be accessible 
to antibodies in the ELISA system, where partial degradation 
of the antigens may occur. Despite these reservations, the 
ELISA system was suitable for isotyping specific antibodies to 
gametocyte antigens, with up to 79% of malaria-exposed sera 
giving OD values above the normal range for nonexposed sera 
for one or more of the four subclasses tested. 
Approximately 12% of the sera (13 of 114) contained anti-
bodies to Pfs230 (by immunoprecipitation) which appeared (by 
ELISA) to be of complement-fixing isotypes but did not me-
diate gamete lysis. It is possible that these antibodies recognize 
epitopes which are not accessible on the gamete surface and 
are thus unable to bind live gametes. Alternatively, the prox-
imity of the epitope to the plasma membrane of the gamete 
may be critical in determining whether lysis can occur (36); the 
epitopes furthest removed from the parasite membrane may 
bind antibodies, but formation of the membrane attack com-
plex, the ultimate step in the complement cascade, may be 
inhibited. Such evasion mechanisms exist in bacteria (7), and 
with a large, complex molecule such as Pfs230, such a scenario 
is conceivable. Another possible explanation for Pfs230-posi-
tive sera failing to lyse gametes is that non-complement-fixing 
antibodies compete for epitopes with complement-fixing anti-
bodies. It is known from MAb studies that non-complement-
fixing antibodies can compete for epitopes with complement-
fixing antibodies, resulting in inhibition of transmission-
blocking activity (26). In our study, over half of the anti-Pfs230 
antibody-positive non-lysing sera contained IgG2 or IgG4 an-
tibodies to gametocyte antigens, suggesting that competition 
may be an explanation in some cases. 
Sixteen of the sera tested were able to lyse gametes in the 
absence of antibodies to Pfs230, and although most of these 
were positive for anti-Pfs48/45 antibodies (9 of 16 sera), some 
appeared to be seronegative for both of these antigens. It is 
possible that another surface antigen is the target of comple-
ment-fixing antibodies in these sera. 
Although antibodies to the mature, processed form of 
Pfs230 are associated with complement-mediated lysis, anti-
bodies to the N-terminal processing product of Pfs260/230 are 
not. A recent study demonstrated that the 50-kDa N-terminal 
polypeptide of Pfs260/230 is absent from the surface of extra-
cellular gametes (35). Our data indicate that this may repre-
sent an adaptation for the evasion of transmission-blocking 
immunity, since antibodies to the N-terminal region should not 
bind to the gamete surface within the mosquito. Given the high 
proportion of sera which recognize only the 260 form of 
Pfs230, the role of processing of Pfs260/230 in immune evasion 
warrants further study. 
The results of the present study indicate that naturally ac-
quired antibodies to Pfs230 act to suppress gamete develop-
ment in a complement-dependent manner and are consistent  
with findings of previous studies using MAbs raised against this 
protein. Studies using mosquito membrane feeding experi-
ments are under way to assess the role of these antibodies in 
transmission-blocking immunity in vivo. 
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